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Viruses are small infectious agents that replicate only inside the living cells of other 
organisms. Herpesviruses belong to a diverse family of viruses that infect all 
vertebrates from fish to mammals causing important human health problems 
associated with the spread of the infection. In order to establish a productive 
infection, viruses employ a variety of strategies to usurp and control cellular 
activities and herpesviruses, in particular, commonly take advantage of and use host 
cell proteins and pathways to support their infections. After using the cell machinery 
for synthesis and production of new viral particles within the nucleus of infected 
cells, herpesviruses must overcome the nuclear envelope, a double membrane 
barrier surrounding the cell nucleus, in order to escape and produce mature viral 
particles. Previous studies have identified the involvement of three critical viral 
proteins in the process of herpesvirus egress from the nucleus of infected cells. 
However little is known about which cellular factors might be aiding this key step in 
the life cycle of herpesviruses.  
The presence of numerous proteins within the nuclear envelope of host cells, and 
the usurpation of host machinery during different phases of the herpesvirus life cycle 
led me to investigate the potential contribution of cellular proteins to the escape 
strategy of herpesvirus from the nucleus of infected cells. 
This thesis focuses in the characterization of a specific group of cellular proteins, 
vesicle fusion proteins, during the escape of new herpesvirus particles from the 
nucleus of infected cells. These vesicle fusion proteins were identified in a proteomic 
analysis performed as part of the study presented in this thesis. 
Furthermore, this thesis studies the novel role of NET23/STING, a protein localized 
in part at the nuclear envelope that has been shown to be involved in innate immune 







The nuclear envelope is a highly organised double membrane system that 
separates the activities of the nuclear and cytoplasmic compartments in eukaryotic 
systems. The wide range of functions recently associated with the NE and the 
identification of hundreds of proteins associated with this cellular structure indicates 
that it is a major signalling node for the cell. Recent work indicates NE functions in 
signalling innate immune responses to herpesviruses.  The viruses, on the other 
hand, often target or usurp NE functions in different ways. The NE is also a physical 
barrier that must be overcome for viruses like the herpesviridae that assemble 
capsids in the nucleus. This thesis addresses two important questions: 1) How do 
herpesviruses cross the NE after new viral particles are produced in the nucleus? 
and 2) What is the nuclear envelope role of NET23/STING in the activation of 
immune factors upon herpesvirus infection? To address the first question, I followed 
two different approaches. The first used the isolation of microsomes from HSV-1 
infected cells to identify possible host factors involved during herpesvirus exit 
through the NE on the prediction that such proteins would disperse into the ER 
during infection. I identified a group of vesicle fusion proteins that play a role in this 
herpesvirus exit through the NE. Depletion of three identified vesicle fusion proteins 
decreased the growth of HSV-1 in host cells, yielding accumulation of viral particles 
in the nucleus. The second approach was to follow the fate of nuclear envelope 
transmembrane proteins (NETs) during HSV-1 infection.  
To address the question of how NET23/STING is involved in innate immunity I 
tested the hypothesis that this NET acts as a transport receptor to carry signals 
through the peripheral channels of the NPC when central channel transport is 
blocked by pathogens. FRAP was used to quantify the mobility of NET23/STING 
upon the induction of the innate immune response, finding an increase of the 
mobility for this protein in the NE. To further elucidate its role within the NE I tested 
whether some NE-NET23/STING binding partners were being redistributed 
between the nucleus and cytoplasm during innate immune responses. This revealed 
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two of these binding partners normally redistribute upon innate immune response 
activation and this is blocked in cells knocked down for NET23/STING. Finally, I 
confirmed that NET23/STING contributes to chromatin remodelling during infection 
involving an increase in the H3K9Me3 epigenetic mark. Collectively, these data 
argue the identification of novel host proteins involved in herpesvirus nuclear egress 
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Chapter 1    
Introduction 
 
1.1. The Nuclear Envelope (NE) 
 
The nucleus of the host cell is usurped by multiple DNA and RNA viruses for genome 
replication and/or virion formation. The nuclear envelope (NE), a double membrane 
system surrounding the nucleus, represents a formidable physical and functional 
barrier to infection that must be overcome for virus production. Moreover, the NE 
acts as a signalling structure regulating the transport of molecules and signals in 
response to viruses. Thus, getting viruses and immune signals across the NE is a 
highly regulated process that must be understood.  
 
1.1.1. Nuclear envelope and lamina architecture   
 
The NE – also called the nuclear membrane- is a unique organised structure that 
first appears roughly 3 billion years ago providing a physical barrier between the 
nucleus and the cytoplasm in eukaryotic cells. The nucleus was the first cell 
organelle to be discovered by the Dutch microscopy pioneer Anton von 
Leeuwenhoek in the red blood corpuscles of fish in 1700.  
Since the early days of microscopy, our view of the nucleus has developed 
dramatically. It was in 1833, when the Scottish botanist Robert Brown, named and 
discovered the nucleus in the cells of an orchid. Additionally, Brown observed by the 
first time the NE using a light microscope. Later, in the 1940s evidence from electron 
microscopy (EM) began to accumulate and within a few years the main structural 
features of the NE became clear. The earliest EM studies specifically focusing on 
the NE were those of Callan and Tomlin who performed EM on Amphibian oocytes 
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demonstrating that this structure is a double membrane with layers divided into the 
inner nuclear membrane (INM) and outer nuclear membrane (ONM) (Callan and 
Tomlin 1950).  
The two membranes are two concentric lipid bilayers connected at sites where 
Nuclear Pore Complexes (NPCs) are inserted. The NPCs are large protein 
structures (~60 MDa), composed of multiple copies of approximately 30 different 
proteins called nucleoporins (Nups) that selectively regulate bidirectional transport 
between the nucleus and the cytoplasm. The central channel is filled with 
phenylalanine-glycine (FG)-rich repeat-containing nucleoporins (FG-Nups), which 
are responsible of limiting the diffusion of molecules with a molecular weight of ~40-
60 KDa (Margalit, Vlcek et al. 2005, Eibauer, Pellanda et al. 2015). In addition to 
central channels, 10 nm peripheral channels are presented between the NPC core 
and the pore membrane and they can accommodate the diffusion of globular 
proteins with a mass of < 60 KDa (Hinshaw, Carragher et al. 1992). 
The ONM is continuous with the endoplasmic reticulum (ER) and it is thought to 
contain many of the same proteins and lipids (Franke, Scheer et al. 1981, Gerace 
and Burke 1988). Between the ONM and the INM there is the lumen, a compartment 
that has been shown to be continuous to the ER lumen. On the other hand, the INM 
encloses the nucleoplasm, containing the chromosomes and nucleoli (Figure 1). 
Both, INM and ONM, contain unique sets of integral membrane proteins called 
Nuclear Envelope Transmembrane Proteins (NETs). Most NETs principally are 
accumulated in the INM interacting with the lamin intermediate filament polymer 
maintaining the NE structure. The INM presents a unique enrichment for distinct 
integral membrane proteins (Schirmer and Gerace 2005, Schirmer and Foisner 
2007) that have been identified in several proteomic analyses, most of which are 
uncharacterized. It is suggested that it contains at least 100 unique components and 
may contain over 1,000 proteins. Some of these specific INM proteins, apart from 
interacting with the lamin polymer, also bind chromatin (Mattout-Drubezki and 
Gruenbaum 2003) 
Underneath the INM is the nuclear lamina, a dense meshwork of lamin polymers 
and lamin associated NETs that are embedded in the INM and that was first 
described in vertebrate cells using EM by Fawcett in 1966 (Fawcett 1966) (Figure 
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1). Lamins are type V intermediate filament proteins that interact with the 
nucleoplasmic domains of many INM proteins and they include: B-type, lamins 
encoded by the LMNB1 and LMNB2 genes and the A-type, lamins A and C which 
are different isoforms from the same gene. The lamin filament meshwork is 
anchored to the INM via interactions with lamin associated NETs such as the Lamin-
B Receptor (LBR), emerin, MAN1 and LAP2β. All the interactions between lamin 
associated NETs, lamin filaments and chromatin, result in the formation of a stable 
network that supports the architecture of the NE and anchors the INM to chromatin 
and lamins providing mechanical stability to the nucleus and maintaining nuclear 
shape.  
The lamina network presents a certain nuclear stiffness due to the presence of NETs 
that stabilize this network and ensure an adequate response to mechanical stress 
(Dahl, Kahn et al. 2004, Dahl, Ribeiro et al. 2008). The binding of some proteins 
with lamins depends on the different requirements for nuclear mechanical stiffness 
and chromatin organization of the cell. The biggest change in lamina architecture 
occurs during the process of cell division. During mitosis, the NE breaks apart 
involving the depolymerization of the lamina and the dissociation of proteins from 
chromatin (Smoyer and Jaspersen 2014). These events are driven by the 
phosphorylation of lamins and lamin binding proteins such as LBR (Courvalin, Segil 
et al. 1992) and LAP2 (Dechat, Gotzmann et al. 1998) by protein kinase C (PKC) 









1.1.2. Integral proteins of the INM 
 
The INM of eukaryotic cells is a membrane that harbours a unique set of integral 
membrane proteins required for nuclear structure, chromosome positioning, DNA 
repair and control of gene expression.  
Different proteomic studies have shown the existence of over a hundred different 
NE proteins that localize to the INM, many of which are expressed in a tissue-
specific manner (Dreger, Bengtsson et al. 2001, Schirmer, Florens et al. 2003, 
Schirmer, Florens et al. 2005, Korfali, Wilkie et al. 2010, Wilkie, Korfali et al. 2011). 
Notably, only a few of these proteins have been characterized in detail (Olins, 
Rhodes et al. 2010, Berk, Tifft et al. 2013). LBR, a type II integral membrane protein 
was the one of the first INM proteins to be identified and it is suggested that the 
interaction of this protein with chromatin might be important for the attachment of 
chromatin to the NE (Worman, Yuan et al. 1988, Worman, Evans et al. 1990).  
Figure 1. Schematic of the nuclear envelope (NE). The NE is a double lipid bilayer consisting of 
the ONM and INM and both lipid membranes are joined at areas where nuclear pore complexes 
(NPCs) are inserted. Between the INM and ONM there is the NE lumen that is continuous with the 
ER lumen. The INM presents a unique set of integral membrane proteins (NETs) that together with 
the lamin filaments constitute the nuclear lamina underlying the INM. At the same time lamins and 
NETs are known to interact with chromatin.  
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Lamina-associated-polypeptide 1 (LAP1) is a type II integral nuclear membrane 
protein, that included three variants, LAP1A, 1B and 1C.  LAP1A and LAP1B have 
been shown to specifically interact with lamin A/C in vitro (Senior and Gerace 1988). 
Lamina-associated polypeptide 2 (LAP-2) is another family of lamin binding proteins, 
including up to six mammalian isoforms. It was show that LAP2 binds lamin B and 
it presents chromosome-binding properties in vitro (Foisner and Gerace 1993).   
Another identified and largely characterized INM protein was emerin. Emerin is a 
ubiquitously expressed type II integral membrane protein that binds to both A- and 
B- type lamins in vitro and its localization at the NE depends on its interaction with 
lamin A (Manilal, Nguyen et al. 1996, Maison, Pyrpasopoulou et al. 1997). Emerin 
as well as LBR, LAP1 and LAP2 appear to have important functions in anchoring 
the INM to the NE, maintaining the stability of the nucleus (Holmer and Worman 
2001).  
 
1.1.3. Interactions of INM proteins with heterochromatin 
and transcription factors  
 
Recently, it has become increasingly apparent that the genome follows a non-
random organisation. It was in 1956 when early EM studies revealed darker stained 
areas of dense chromatin within the interphase nucleus that were named as 
heterochromatin and areas presenting an asymmetric distribution of lighter stained 
regions of chromatin termed euchromatin (Moses 1956). 
Heterochromatin tends to dominate proximal areas to the NE while euchromatin 
tends to be present within the nuclear interior. Previous studies have shown that a 
small portion of an internal chromosome can stretch out to interact with proteins 
present in the nuclear periphery (Kupper, Kolbl et al. 2007), suggesting that 
components present in the NE could contribute in the patterns of chromosome 
organization. More recent studies have shown that chromosomes follow a discrete 
non-overlapping territory within the nucleus of interphase cells, occupying a specific 
radial position. Thus, the NE is considered a tethering point for chromatin in which 
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NETs might mediate genome organization by interacting with chromatin proteins or 
epigenetic silent marks. 
For instance, A and B-type lamins have been reported to bind directly to telomeric 
and heterochromatin DNA sequences (Shoeman and Traub 1990, Baricheva, 
Berrios et al. 1996). Furthermore, lamins can also interact and assemble around 
chromatin, binding to core histones such as H2A and H2B (Hoger, Krohne et al. 
1991, Taniura, Glass et al. 1995, Goldberg, Harel et al. 1999).  
In addition to lamins, many NETs bind directly with DNA. For example, MAN1 binds 
DNA via its C-terminal domain (Caputo, Couprie et al. 2006) while LAP2β binds 
DNA by its N-terminal domain (Cai, Huang et al. 2001). NETs also associate with 
DNA indirectly via interactions with chromatin-binding partner proteins; LBR was 
reported to bind DNA via human HP1-type chromodomain proteins (Ye and Worman 
1996) and directly interact with the core histone H3 carrying K9 tri-methylation that 
promotes gene silencing (Polioudaki, Kourmouli et al. 2001). This implies that LBR 
acts as a chromatin tethering.  
Multiple interactions between NE proteins and transcription factors have also been 
observed (Heessen and Fornerod 2007). MAN1, for example binds R-SMADs 
(Osada, Ohmori et al. 2003) whilst Ringer Finger Binding protein (RFBP), a novel 
INM protein, directly interacts with SWI/SNF transcription factors that model 
chromatin (Lee, Haraguchi et al. 2001). Similarly, lamin A and lamin B1 interact with 
transcription factors cFos and Oct-1 (Malhas and Vaux 2009). These observations 
suggest that the association of chromatin with the NE may directly regulate 
transcription processes.  
Recently studies have identified novel NETs affecting genome organization. Multiple 
studies carried out in our lab found that ten novel NETs could alter the position of a 
chromosome or gene locus to the nuclear periphery (Korfali, Wilkie et al. 2010, 
Zuleger, Boyle et al. 2013, Robson, de Las Heras et al. 2016). In addition, another 
study aimed to identify NETs involved in chromatin modification, ran visual screens 
of 31 NE proteins identifying different NETs affecting chromatin compaction (Malik, 




1.1.4. Trafficking of nuclear membrane proteins to the INM 
 
The cell has to deal with the problem of transporting proteins in and out the nucleus. 
This problem was solved for soluble proteins through the use of the NPC. In addition, 
the transport of transmembrane proteins seems to be more enigmatic. The transport 
of these proteins includes multiple translocation mechanisms which allow NETs to 
reach their final destination, the NE. 
The NE is a hermetic structure, which covers the whole surface of the nucleoplasm 
forming a physical barrier interrupted only in areas where NPCs are inserted 
(Prunuske and Ullman 2006).  NPCs are considered to be the gatekeepers of the 
NE, controlling the trafficking of molecules in and out the nucleus. 
The nucleo-cytoplasmic transport of soluble cargos has been extensively studied 
(Gorlich and Kutay 1999). This process takes place in the central channel of the 
NPC and involves a wide range of transport receptors called karyopherins (also 
known as importins and exportins) that bind to soluble cargoes via the recognition 
of targeting information such as nuclear localization sequences (NLSs) for entry or 
nuclear export sequences (NESs) for exit. These transport receptors interact with 
phenylalanine/glycine (FG) motifs present in the nucleoporins (nups) of the central 
channel allowing the diffusion of soluble cargoes up to 60 KDa. This process 
depends on the small GTPase Ran (Ras-related nuclear protein). A gradient is 
formed with Ran-GDP in the cytoplasm and Ran-GTP in the nucleus facilitating the 
binding and release of transport receptors to cargoes and thus allowing the 
movement of molecules through the central NPC channel (Cook, Bono et al. 2007).  
In contrast to the transport of soluble molecules, nuclear transport of NETs remains 
less understood. The journey for a NET starts in the ER, where NETs are 
synthesized and inserted into the ER membrane. The observation of the 10 nm 
peripheral channels together with the ability of a protein to move from the ER to the 
ONM, as the ER is continuous with the ONM, led to the development of the lateral 
diffusion-retention hypothesis. This stated that INM proteins freely exchange 
between the ER-ONM and the INM by simple lateral diffusion through the peripheral 
channels. Proteins are retained at the INM through their ability to bind lamins and/or 







Figure 2. Diffusion-retention hypothesis for NET translocation. NETs distribute by free 
diffusion within the continuous membranes of the ER, ONM and INM. After synthesis in the 
ER, NETs rapidly can diffuse into the ONM and then can further diffuse while still in the 
membrane into the INM through the peripheral channels of the NPC. Once in the INM, NETs 
are retained by interactions with lamins and chromatin. 
 
The first study aimed to test this hypothesis was done by Bruno Soullam and Howard 
Worman. They fused the nucleoplasmic domain of LBR, which binds to lamin B, with 
a transmembrane span of chicken hepatic leptin which is a transmembrane protein 
that is localized in the ER and in the plasma membrane (Chiacchia and Drickamer 
1984). After the fusion of these two domains, the chicken hepatic leptin was able to 
translocate by diffusion from the ER into the INM where it was retained by interaction 
of the nucleoplasmic domain of LBR with lamin B (Soullam and Worman 1993). 
Afterwards, two more studies confirmed the lateral diffusion/retention hypothesis 
using the lamin-binding region of LAP2β (Furukawa 1999) and MAN1 (Wu, Lin et al. 
2002). 
Moreover, fluorescence recovery after photo-bleaching (FRAP) and photo-
activation (PA) studies have confirmed the retention part of the hypothesis. When 
performing FRAP on NETs fused with GFP present on the INM, the total 
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fluorescence recovery was never achieved after bleaching. This observation implied 
that a portion of the NET must be highly immobile within the membrane due to 
interactions with nuclear elements such as lamins or chromatin (Rolls, Stein et al. 
1999, Wu, Lin et al. 2002). Another study published in 2006 showed that emerin 
presented higher mobility in cells lacking its binding partner, lamin A (Ostlund, 
Sullivan et al. 2006).  
Even stronger support for the retention part of the hypothesis came from 
observations made in our lab. Zuleger et al. studied the transport of NETs to the 
INM using FRAP and PA techniques. In this study, they directly compared the 
diffusion characteristics of multiple NETs. They found two different time recoveries 
in the ER, one faster than the other, suggesting two types of NETs mobility. The 
NETs presenting faster recovery likely move freely within the ER without any 
impediment. On the other hand, the slower set may be clustered with other proteins 
resulting in a slower diffusion. This could be due to association with proteins that, 
for example, have roles in targeting NETs to the INM such as transport receptors. 
Furthermore, the retention part of the hypothesis was additionally supported in this 
study by the fact that FRAP on NETs in the NE never recovered the prebleach 
fluorescence levels. For example, SUN2 fluorescence recovery was around 50% of 
the total signal within the NE. This indicated that a pool of SUN2 might be highly 
retained at the INM due to interactions with lamins or chromatin. 
This study showed that the dynamics of NET exchange between NE and ER 
compartments creates the presence of several pools of NETs (ER pool, ER-NE pool, 
INM pool and ONM-INM pool). The fluorescence recovery in the NE is principally 
due to exchange of NETs between the ER and the INM rather than on movement of 
the NETs within the INM itself. This was further supported by PA experiments in 
which different NETs photoactivated within the ER showed a fast accumulation in 
the NE that was similar to the rate of recovery in NE FRAP experiments. After the 
translocation of some NETs to the INM, they are trapped and remain in this 





1.1.5. The NE and disease 
 
Mutations in lamins and NETs have been recently shown to be responsible for at 
least 20 heritable human diseases, the nuclear envelopathies, that range from 
muscular dystrophy to neuropathies and progeria syndromes (Worman and 
Schirmer 2015).  
Structural changes of chromatin have been observed in a variety of diseases linked 
to the NE. The higher-order organization of genomes is functionally important for 
gene regulation and control of gene expression. Thus, it is not surprising to 
hypothesize that defects in chromatin organization and distribution might cause 
disease.  
As mentioned before, multiple NETs present direct connections to chromatin and 
lamins contributing to genome organization and gene regulation. These NE-genome 
interactions are suggested to be disrupted in some NE human diseases as 
consequences of mutations in NETs or lamins. The disruption of genome 
organization and gene regulation together with the alteration of the nuclear and 
cellular mechanical stability could explained how mutations in NETs cause nuclear 
envelopathies.  
All these disorders are distinct and have restricted tissue pathologies. Several 
mutations in the LMNA (lamin A) gene are involved in the development of many 
human diseases. The first human disease identified to be caused by LMNA 
mutations was Emery-Dreifuss muscular dystrophy, an autosomal dominant 
disorder that affects muscles (Bonne, Leturcq et al. 1993).  LBR has also been linked 
with an autosomal dominant disorder named Pelger-Huët anomaly (PHA). This 
disorder is characterized by abnormal nuclear shape and chromatin organization in 
blood granulocytes. The gene encoding LBR was mutated affecting its expression 
levels with a corresponding effect on NE-heterochromatin interactions (Hoffmann, 







1.2. General overview of Herpesviruses 
 
1.2.1. Herpesvirus classification 
 
Herpes Simplex Virus type I (HSV-1) also known as human herpes virus I (HHV-1) 
is a large enveloped double-stranded DNA virus of 220 nm diameter. The 
Herpesviridae family includes more than 120 identified members sharing a common 
virion structure that, in addition to humans, infect other mammals, birds and reptiles.  
To date, nine human herpesviruses have been identified: herpes simplex virus types 
1 and 2 (HSV-1, HSV-2), varicella zoster virus (VZV), Epstein–Barr virus (EBV), 
cytomegalovirus (CMV), roseolaviruses HHV-6 (A and B) and HHV-7, and Kaposi 
sarcoma-associated herpes virus (HHV-8) (McGeoch, Rixon et al. 2006, Fossum, 
Friedel et al. 2009). 
In nature, all herpesviruses can establish latent infection within tissues that are 
characteristic for each virus, reflecting the unique tropism of each member. The 
Herpesviridae have been classified by the International Committee of Taxonomy of 
viruses into three subfamilies (Davison 2010): Alpha-, Beta- and 
Gammaherpesvirinae. HSV-1 and the closely related HSV-2 together with the VZV 
are members of the human Alphaherpesvirinae subfamily, which are characterized 
by short replication cycle (hours) with a wide host range and establishment of 
latency in sensory ganglia. In contrast, members of Betaherpesvirinae, such as 
CMV, have a restricted host range and their reproductive life cycle is much longer 
(days) than members in the alpha-subfamily, establishing latent infection in epithelial 
cells of the secretory glands and kidneys. Lastly, the human Gammaherpesvirinae 
subfamily present the most limited host range and they are known for their 
oncogenic potential and their ability to develop human malignancies such as EBV 
causing leukaemia and KSHV causing Kaposi sarcoma (Reiman, Powell et al. 2003, 
Wen and Damania 2010). 
The classification of the known human herpesviruses, together with the associated 




Table 1. Human Herpesvirus classification and associated diseases 
 
Subfamily Virus Acronyms Primary target Disease 
Alpha Human herpes 
virus 1 
HSV-1/HHV-1 Epithelial and 
keratinocyte 
Herpetic Stomatitis 
Alpha Human herpes 
virus 
HSV-2/HHV-2 Epithelial and 
keratinocyte 
Herpetic Stomatitis and 
genital herpes 
Alpha Human herpes 
virus 3 
VZV/HHV-3 Epithelial and 
keratinocyte 
Chickenpox,shingles 





Beta Human herpes 
virus 6A 
HHV-6A T-cell Roseola 
infantum,encephalitis 
Beta Human herpes 
virus 6B 
HHV-6B T-cell Roseola 
infantum,encephalitis 
Beta Human herpes 
virus 7 
HHV-7 T-cell Roseola 
infantum,encephalitis 
Gamma Human herpes 
virus 4 
HHV-4/EBV B-cell and epithelial Mononucleosis, Burkitt´s 
lymphoma 
Gamma Human herpes 
virus 8 














1.2.2. Herpesvirus significance and treatment 
 
As mentioned above, HSV-1 and HSV-2 have a wide tropism allowing these viruses 
to produce a huge range of clinical manifestations in humans. HSV-1 is the 
prototypical and best studied member of the alpha subfamily. In contrast to other 
HHV, HSV-1 is able to infect different animal species in experimental infection due 
to its broad cell tropism and high infectivity ratio. Therefore, HSV-1 is an attractive 
biological model to study different aspects of the Herpesviruses. 
HSV-1 is a highly successful virus as it is estimated that 45% to 98% of the adult 
human population is HSV-1 seropositive. The prevalence of the virus depends on 
demographic factors including age, location and socioeconomic status (Fatahzadeh 
and Schwartz 2007). A critical factor for herpesvirus infections is the requirement 
for intimate contact between a person who is carrying the virus and a susceptible 
host. Typically, in humans, primary infection is acquired during early childhood via 
direct contact of mucosal membranes. After viral inoculation onto the skin or mucous 
membranes, a rapid incubation period of four to six days is required for herpes 
simplex virus replication in epithelial cells. Cell lysis and local inflammation take 
place resulting in characteristic vesicle lesions. Subsequently, the virus enters nerve 
cells and is transported along axons to the dorsal root ganglia where it establishes 
a latent infection for a lifetime (Diefenbach, Miranda-Saksena et al. 2008).  
Clinical manifestations produced by HSV-1 infection depend on a variety of factors 
such as immune status of the infected host, age as well as viral load and viral 
replication rate. Symptomatic outcomes of HSV-1 infection range from mild orofacial 
watery blisters also known as cold sores to serious manifestations such as 
encephalitis. Herpes simplex encephalitis is a severe infection of the central nervous 
system presenting a 70% mortality rate if left untreated. Other symptoms can vary 
from ocular infections to genital lesions (Hill, Ku et al. 2014).   
HSV is a prevalent virus in the population leading to a huge range of clinical 
outcomes that can compromise the life of the host. Due to the establishment of latent 
infection in neurons, herpesviruses are mostly impossible to detect and eradicate 




At this time, there are a variety of antiviral drugs such as acyclovir or penciclovir but 
none of these drugs can eradicate the latent form of the virus, as they only target 
the replication viral stage (Martinez, Caumes et al. 2008). There is a high need for 
the development of pharmaceutical treatments that will stop the spread of the 
infection as well as decrease the toxic side effects of the current medication.  
 
1.2.3. HSV-1 virion structure 
 
Early EM studies together with recent cryoEM studies have shown that a typical 
HSV-1 mature viral particle is observed as a spherical multilayer particle with a size 
ranging from 180-200 nm (Bruns 1980, Mettenleiter, Klupp et al. 2009). The HSV-1 
mature virion is composed of an icosahedral capsid that stores an electron-dense 
core, the viral genome. The capsid is surrounded by an amorphous protein layer 
called the tegument containing 30 or more viral proteins and an outer lipid bilayer 
envelope derived from the infected cell Golgi apparatus containing glycoproteins 
that are essential for HSV-1 entry into cells (Reske, Pollara et al. 2007) (Figure 3). 
Herpesvirus infection can lead to the production of three viral particle forms within 
the nucleus of host cells; empty A-, scaffold-containing B- and DNA-containing C- 
capsids. While C-capsids are capable to produce mature infectious virions, A- and 
B- capsids are considered to be defective particles; B-capsids failed to package viral 
DNA, and A-capsids represent empty capsids as they do not contain either scaffold 
proteins or viral DNA (Tandon, Mocarski et al. 2015).  
The herpesvirus genome packaged inside the core is a linear double strand-DNA 
viral genome that ranges from about 125 to 250 kbp, encoding over 80 viral genes. 
Upon infection, the linear viral DNA is injected into the nucleus where it circularises 
to form a viral episome. The herpesvirus genome is characterised by the presence 
of unique and repeat sequences. Two covalently joined segments S and L form a 






These regions are flanked by inverted repeat sequences (McGeoch, Dalrymple et 
al. 1988). The HSV genome contains three origins of replication and it can be divided 
into three categories depending on the kinetics of their transcription: “immediate 
early” (IE) that allow the expression of further viral genes; “early” (E), responsible of 












Figure 3. HSV-1 virion structure. An electron micrograph image showing a HSV-1 mature 
particle (Mettenleiter, Klupp et al. 2009) next to a schematic representation of a HSV-1 virion.  
It shows the viral genome enclosed in a capsid that is surrounded by a tegument layer 
containing multiple tegument proteins. The tegument together with the capsid and the viral 
genome forms the nucleocapsid. At the same time, the nucleocapsid is encased by a lipid 
envelope derived from host cell membranes containing viral glycoproteins. 
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1.2.4. HSV-1 life cycle: Lytic and latent infection 
 
The life cycle of HSV involves both lytic (productive) and latent (non-productive) 
infection. A large body of evidence has accumulated over the years dividing the HSV 
life cycle in 5 major steps: attachment, entry into the host cell, viral replication, virion 
assembly and egress of new viral progeny. 
The HSV life cycle begins as the virus particle recognizes and binds to receptor 
proteins on the surface of cell membrane presented at the mucosal surface or in the 
skin. Entry of HSV can vary between cell types and it is driven by the attachment of 
viral glycoproteins to targets on the host cell surface. Several glycoproteins are 
known to be involved in this step such as gD, gB, and the heterodimer gH/gL 
(Connolly, Jackson et al. 2011). These glycoproteins are known to be conserved 
among herpesviruses (Eisenberg, Atanasiu et al. 2012). gD can bind to different 
cellular receptors such as nectin-1 and nectin-2, herpes virus entry mediator 
(HVEM) and 3-O-sulfated heparan sulfate (3-O-S-HS) presented in the plasma 
membrane of the host cell. This interaction triggers a membrane fusion event which 
can happen at the plasma membrane or inside endocytic vesicles resulting in the 
deposition of the capsids directly into the cytoplasm of the cell which are then 
transported via interactions with microtubules to the NPC (Akhtar and Shukla 2009) 
(Figure 4).  
At the NPC, the viral genome is injected into the nucleus followed by viral genome 
replication. Viral genome expression is a regulated cascade: IE, E, and L genes 
(Boehmer and Lehman 1997, Mettenleiter 2002). The nucleus is reorganized to form 
replication compartments in which viral DNA is replicated and new progeny viral 
particles are assembled. Subsequently, newly synthesized nucleocapsids acquire 
tegument proteins and leave the NE in a process called primary envelopment/de-
envelopment (Figure 4). This process leads to the budding of nucleocapsids at the 
INM forming primary enveloped particles (PEP) within the lumen of the NE. 
Subsequently, these particles fuse with the ONM releasing nascent capsids into the 
cytoplasm (Skepper, Whiteley et al. 2001, Simpson-Holley, Colgrove et al. 2005) 
(This process will be explained in detail in the next section). 
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Virion maturation then takes place in the cytoplasm, where capsids acquire 
tegument proteins followed by a process called secondary envelopment in which a 
final enveloped-lipid bilayer is acquired by the virus via budding into the trans-Golgi 
or in early endosomes coming from the plasma membrane. This process results in 
a mature and enveloped virion particle inside a vesicle that is transported to the cell 
surface where it fuses with the plasma membrane releasing progeny enveloped 
viruses into the extracellular environment (Kelly, Fraefel et al. 2009, Mettenleiter, 
Klupp et al. 2009) (Figure 4). 
Following primary cutaneous or mucosal infection, HSV spreads from the primary 
site of infection to infect sensory neurons that innervate the affected area by fusion 
with the neuronal membrane at the axonal termini. Nucleocapsids are then 
transported by retrograde axonal transport from the site of entry to the nucleus in 
the cell body of the neuron in the dorsal root ganglia or trigeminal ganglia (Simmons 
2002). At this point two events may occur. First, the lytic replicative cycle described 
above may take place resulting in neuronal death and egress of infectious particles 
leading to encephalitis. Alternatively, viral DNA released into the nucleus of neurons 
may persist in a latent state in a circular episomal form that is associated with 
nucleosomes (Mellerick and Fraser 1987).  
Once latency is established, different stimuli such as stress may cause viral 
reactivation. Reactivation implies the sufficient expression of viral proteins and viral 
DNA replication to produce progeny virions. Nucleocapsids and other envelope 
proteins are transported independently by anterograde axonal transport to the 
peripheral nerve terminals where they are assembled and released to infect new 







Figure 4. HSV-1 life cycle. After recognition of specific receptors present in the surface of 
host cells, the envelope fuses with the plasma membrane releasing the capsids into the 
cytoplasm. Subsequently, the capsid is transported to the nucleus in where it injects its 
genome through the NPC. Once in the nucleus, DNA replication and transcription takes 
place. Single viral genomes are packaged into new viral nucleocapsids and translocated 
into the cytoplasm in a process called primary envelopment/de-envelopment. In the 
cytoplasm the final maturation takes place. Released viral capsids acquire the final 
tegument and bud into membranes from the Golgi (secondary envelopment) resulting in the 
formation of vesicles. These vesicle containing mature particles fuse with the plasma 




1.2.5. Secondary envelopment  
 
Secondary envelopment is a better understood process compared with primary 
envelopment/de-envelopment. In order to understand some of the biological 
processes occurring during primary envelopment, we should first describe how 
secondary envelopment takes place.   
After primary envelopment/de-envelopment at the NE, nascent capsids delivered 
into the cytoplasm have to acquire the complete set of viral tegument proteins and 
the final envelope in a process known as secondary envelopment or re-
envelopment, a step thought to take place in the trans-Golgi (TGN) (Figure 4). 
However, recent studies have suggested that HSV-1 particles present in the 
cytoplasm might acquire its final envelope from endocytic tubules containing 
glycoproteins derived from the plasma membrane. 
Secondary envelopment is driven by interactions between tegument proteins 
present in the surface of capsids and the cytoplasmic tails of various viral 
glycoproteins located in the TGN (Owen, Crump et al. 2015). For example, there is 
evidence that gD, gE-gI (HSV) can interact with the VP22 tegument protein 
promoting secondary envelopment (Duffy, Lavail et al. 2006). These protein 
interactions are responsible to pulling the host membranes around viral particles.  
Studies have shown that while mutations in single glycoproteins have minimum 
defects in secondary envelopment, HSV mutants lacking gD and gE-gI accumulate 
nascent capsids in the cytoplasm (Farnsworth, Goldsmith et al. 2003). Similar 
phenotypes were observed in double PRV mutants in which both gE-gI and gM were 
depleted (Brack, Klupp et al. 2000). Moreover, mutations in the cytoplasmic domain 
of gE and gM (PRV) or gD (HSV) showed the same accumulation defects for 
secondary envelopment (Farnsworth, Goldsmith et al. 2003).  
Once nascent capsids have acquired their final envelope, mature virions within 
membrane vesicles present in the cytoplasm are transported to the cell surface 
where the fusion between the vesicle and the plasma membrane results in the 





1.3. The nuclear envelope in viral infection 
 
Viruses are obligate biological pathogens depending on the exploitation of the 
cellular machinery of their host organism to survive and replicate. To accomplish a 
successful life cycle including cell entry, replication, assembly and release of new 
viral particles, viruses must face a number of obstacles that they overcome by the 
manipulation and usurpation of cellular factors and machinery. One of the biggest 
barriers viruses need to bypass for productive virus replication, is cellular 
membranes.  
During cell entry, enveloped and non-enveloped viruses have to cross the plasma 
membrane using different mechanisms. For the viruses that replicate in the nucleus 
of the cell, the NE is another major barrier that has to be overcome for viral entry 
and release. The majority of the viruses are unable to cross through the 39 nm 
central channel of the NPC because of their large size; therefore, different viral 
families have developed ingenious ways for the nuclear entry of their genomes 
(Cohen, Au et al. 2011, Kobiler, Drayman et al. 2012, Mettenleiter 2016).  
As an example, during herpesvirus infection, the docking of viral capsids at the NPC 
and the release of the genome through it is thought to be depend on two viral 
proteins that are highly conserved within the Herpesviridae, UL25 and UL36, and 
the nuclear pore proteins Nup358 (Copeland, Newcomb et al. 2009) and Nup214, 
known to interact with UL25 (Pasdeloup, Blondel et al. 2009).  Another study has 
shown that the karyopherin importin-β and the GTPase Ran may also mediate the 
docking of viral capsids at the NPC allowing the nuclear import of the herpesvirus 
genome through the central channel of the NPC (Ojala, Sodeik et al. 2000). Other 
viral families as Papillomaviruses, import their viral DNA into the nucleus taking 
advantage of the NE breakdown (NEBD) occurring during mitosis (Aydin, Weber et 
al. 2014). 
Once the viral genome gets access to the nucleus, a coordinated series of events 
takes place producing the assembly of new capsids. Progeny viruses need to 
escape the nucleus to continue their journey to the external cell environment via 
complex routing pathways that can involve the NE in various ways. Many viruses 
leave this cellular compartment by breaching the NE or deforming it for budding 
21 
 
(Mettenleiter 2016). Virus budding at the NE is a complex process that can be 
defined as the envelopment of new viral capsids within the INM involving membrane 
deformation around the capsid and subsequent membrane fission with the ONM to 
release the particle into the cytosol. Some viral families interfere with the integrity of 
the NE causing cellular lysis to allow the release of infectious particles. This is the 
case of Polyomaviruses among others; intranuclear particles target the NE by 
interaction of the JP viral protein with LBR resulting in the destabilization of the NE, 
facilitating virus egress (Okada, Suzuki et al. 2005). However, new evidence 
suggests that other viral families have evolved subtler ways of nuclear egress 
without drastic damage of the nucleus by usurping cellular transport pathways 
through the NPC or developing new ingenious mechanisms to exit from the nucleus 
as is the case of the Herpesviridae family. 
 
1.3.1. HSV-1 nuclear egress, primary envelopment  
 
Once herpesvirus genomes are packaged into nucleocapsids, the complex egress 
pathway by which nucleocapsids move from the nucleus to the extracellular 
environment takes place. During egress, herpesviruses face multiple obstacles that 
they solve by restructuring host membranes. While HSV-1 capsid formation and 
DNA packaging occur in the nucleus, the final virion maturation takes place in the 
cytosol. As the new viral nucleocapsids (~125 nm) are considered too large to pass 
through the NPCs, they need to pass through the NE in a process known viral 
nuclear egress.  
For a long time, the mechanisms by which the nucleocapsid crosses the NE have 
been debated. Three different models have been proposed to describe herpesvirus 
nuclear egress: 
The nuclear pore model predicts that the NPC can dramatically change 
conformation to accommodate viral capsids. This is based on NPCs observed to be 
grossly dilated in the analysis of HSV-1 infected cells using high-pressure freeze-
fracturing. This model has been exclusively based on EM observations and no 
evidence has been obtained using conventional fixation TEM or cryoEM procedures. 
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It suggests that >100 nm herpesvirus capsids cross the NE by enlarging the NPC 
(Leuzinger, Ziegler et al. 2005, Wild, Engels et al. 2005, Wild, Senn et al. 2009). 
In the luminal model (also known as the single envelopment model) credited by 
Johnson and Spear in 1982, nucleocapsids present in the nucleus become budded 
at the INM acquiring a primary envelope resulting in the formation of PEP residing 
in the lumen space (primary envelopment) (Johnson and Spear 1982). PEP travel 
to the ER, as the lumen space is continuous with the ER lumen, and continue their 
journey to the trans-Golgi through the secretory pathway (Galdiero, Falanga et al. 
2005). This model obtained some conventional EM support in the observation of 
PEP in the lumen of the ER. 
Finally, in the envelopment/de-envelopment/re-envelopment model of egress 
proposed in 1961 by Stackpole in a study of frog herpesvirus, the primary 
envelopment step is the same as in the luminal model. However, this model 
proposes that PEP residing in the lumen space fuse with the ONM in a process 
called de-envelopment by membrane scission, depositing nascent capsids into the 
cytoplasm while the primary envelope remains fused with the ONM. Nascent 
capsids released into the cytoplasm travel to the Golgi membranes or TGN where 
they undergo a secondary envelopment step (re-envelopment) acquiring a final 
envelope containing glycoproteins that will be part of the final mature particle (Figure 
5).  This is the most widely accepted model for viral egress at the NE for both HSV 
and VZV and in recent years there have been growing evidences in favour of it 
(Jones and Grose 1988, Granzow, Klupp et al. 2001, Mettenleiter 2002, Schulz, 
Klupp et al. 2015). Moreover, it effectively encompasses the data supporting the 
luminal model as due to the continuity of the NE and ER lumen any particles that 
did not immediately fuse with the ONM would be able to fuse anywhere in the ER 







Figure 5. Envelopment/de-envelopment/re-envelopment model for HSV-1 egress. (A) An electron 
micrograph image showing a HSV-1 egress at the NE by the formation of primary enveloped particles 
(PEP) in the lumen(Mettenleiter, Klupp et al. 2009). (B) Nucleocapsids (NCs) synthesized in the nucleus 
bud at the INM (primary envelopment) resulting in the formation of PEP residing in the lumen. The primary 
envelope is derived from the INM and it contains multiple viral proteins such as UL31/UL34 or 
glycoproteins that are incorporated into PEP. These particles fuse with the ONM (de-envelopment) 
releasing nascent capsids into the cytoplasm while the primary envelope remains fused to the ONM. In 
the cytoplasm, these particles bud into host membranes from the TGN or Golgi (secondary envelopment 
or re-envelopment) acquiring viral glycoproteins that will be part of the final mature particle. Finally, 





A first line of evidence in favour for the envelopment/de-envelopment/re-
envelopment model was EM studies made in HSV-1 infected neurons. They found 
a separate transport of nucleocapsids and viral glycoproteins within axons. The 
transport of glycoproteins within vesicles was observed in distal regions of the axon 
which did not co-localize with nucleocapsids. Thus they hypothesized the presence 
of two pathways of viral transport and assembly within infected cells (Penfold, Armati 
et al. 1994).  
Further evidence in favour for this model came from studies of tegument assembly. 
These studies provided evidence that the site of assembly for herpesviruses was 
the cytoplasm. Elliot and colleagues observed that the tegument protein VP22 was 
exclusively observed in the cytoplasm in a live virus-infected cell, supporting the 
cytoplasm as the main site of tegument assembly (Elliott, Mouzakitis et al. 1995). 
Moreover, they showed that VP22 deletion mutant viruses did not hamper virion 
morphogenesis.  
Another study of tegument assembly in PrV further supports the hypothesis that 
intranuclear capsids presented a different protein composition than cytoplasmic and 
extracellular virions. UL36 and UL37 were demonstrated to be present in the 
cytoplasmic capsids while they were absent from primary virions.  Moreover, UL36 
and UL37 deletions hampered the ability of viral particles released into the 
cytoplasm to mature into enveloped virus. These observations confirmed the 
presence of a different viral composition in primary virions versus cytoplasmic and 
extracellular virions (Klupp, Fuchs et al. 2002). 
Immunocytochemistry of rat dorsal root ganglion neurons infected with HSV-1 
showed that the tegument assembly took place in the cytoplasm of neurons while 
the acquisition of the final envelope took place in vesicles of the Golgi and TGN. 
While tegument proteins such as VP16, VP22 and US9 were present in the nucleus, 
they were not detected in PEP within the lumen. However, these tegument proteins 
were detected in viral particles within the Golgi and extracellular mature particles. 
The same pattern was observed for the viral glycoprotein D (Miranda-Saksena, 
Boadle et al. 2002). 
Recent EM studies have supported the de-envelopment/re-envelopment model.  
Gillian and colleagues observed by EM that enveloped particles present in the 
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lumen of HSV-1 and PRV infected cells showed a difference in composition and 
appearance from viral particles presented in the cytoplasm and virions already 
released into the extracellular environment. The capsid of these viral particles was 
surrounded by a uniform electron dense layer; a sharply and thick bordered rim 
corresponding to tegument proteins. On the other hand, primary virions presented 
a uniform thinner layer. These studies showed that major components of enveloped 
herpesvirus particles in the lumen are absent from cytoplasmic virions, indicating an 
intermediate step between nuclear and extracellular virions (Granzow, Klupp et al. 
2001).  
Further evidence to support this model came from mutation studies. Viruses carrying 
deletions in glycoproteins exhibited defects in virus morphogenesis. For example, 
deletions of gE-gI and gM drastically impaired PRV replication inducing the 
accumulation of viral particles in cytoplasmic compartments, suggesting the 
participation of these proteins in secondary envelopment in the cytoplasm (Brack, 
Dijkstra et al. 1999). gK depleted PRV virus showed defects in viral release of 
primary virions into the cytoplasm. This found the accumulation of PRV primary 
virions within the lumen, suggesting the involvement of gK in promoting the fusion 
of the primary envelope with the ONM (Klupp, Granzow et al. 2001).  
The process of budding of herpesvirus nucleocapsids proposed by the luminal 
model and the envelopment/de-envelopment model require the reshaping of 
multiple host membranes such as the INM and ONM. Nucleocapsid budding results 
in the curvature of the INM around the viral particle leading to membrane 
deformation and scission to allow free access of nucleocapsids to the lumen space 








1.3.2. Primary enveloped particles versus cytoplasmic 
virions 
 
Herpesvirus infection results in the formation of two types of virions within the 
infected cell. Primary enveloped particles (PEP), also known as primary virions, 
reside in the lumen and are new viral nucleocapsids surrounded by an envelope 
derived from the INM. On the other hand, mature virions present in the cytoplasm 
are secondarily enveloped virions inside Golgi or plasma membrane derived 
vesicles 
PEP have been characterised by exhibiting a uniform size. EM observations 
revealed that the primary virion nucleocapsid is surrounded by a clear lucent halo, 
a sharply bordered rim containing the primary tegument and a smooth envelope 
without surface projections. In contrast, mature virions frequently exhibited a size 
variation and the presence of visible surface projections (Granzow, Klupp et al. 
2001, Mettenleiter 2004, Pignatelli, Dal Monte et al. 2007) 
The composition of PEP is largely unknown. This limitation is mainly from the 
difficulties in isolating primary virions from the perinuclear space because their size 
and density are similar to mature virions present in the cytoplasm (Loret, Guay et al. 
2008, Padula, Sydnor et al. 2009). Furthermore, there is the additional problem of 
the weakness that the NE presents upon HSV-1 infection making hard the isolation 
and separation of primary virions from cytoplasmic ones. 
The UL31 and UL34 viral proteins known to be present in the NE of infected cells, 
play a fundamental role during HSV-1 nuclear egress and are generally accepted to 
be constituents of primary virions but absent from mature virions (Klupp, Granzow 
et al. 2000, Reynolds, Wills et al. 2002, Reynolds, Liang et al. 2004). In contrast, 
major tegument and envelope proteins are only present in the cytoplasmic mature 
particles (Naldinho-Souto, Browne et al. 2006). 
 





A proteomic study showed the presence of viral proteins that are restricted to 
primary virions (Padula, Sydnor et al. 2009). This study supports previous EM and 
immunogold studies suggesting that the composition of PEP partly differs to the 
composition in mature virions. Padula´s study attempted to analyse by proteomics 
the composition of PEP (Table 2). For this, they attempted to isolate NE from HSV-
1 infected cells and subsequently harvested these virions. To do so, they harvested 
COS-7 cells after 18 h of HSV-1 infection into a sucrose buffer. After cellular 
disruption, nuclei were pelleted and subjected to different rounds of DNAase 
digestions to eliminate chromatin and enrich for NEs (Padula, Sydnor et al. 2009). 
A caveat to this study is that during HSV-1 infection the NE is partially disrupted 
allowing nucleocapsids to reach the cytoplasm (Maric, Haugo et al. 2014). The NE 
becomes weak and it breaks apart making difficult the isolation of this cellular 
structure from HSV-1 infected cells. Thus, different approaches to study the 
composition of the primary envelope are required to shed light on potential nuclear 
proteins involved in primary envelopment at the INM.  
 
Table 2. Proteins identified in Padula´s study as part of PEP 
(Padula, Sydnor et al. 2009) 
Gene Protein Localization 
UL17 DNA packaging protein capsid 
UL18 VP23 capsid 
UL19 VP5 capsid 
UL26 VP24 capsid 
UL34 UL34 PEP 
UL38 VP19 capsid 
UL49 VP22 tegument 






1.3.3. Heterochromatin modifications during HSV infection 
 
HSV-1 infection is associated with a variety of structural changes in nuclear 
architecture. The infected cell nucleus is irregular in shape and presents peripheral 
displacements of chromatin resulting in a significant increase of the nuclear size 
(Conn and Schang 2013). Monier and colleagues performed different studies using 
histone H2B-GFP to label host chromatin in Hela cells infected with HSV-1. They 
attempted to analyse the heterochromatin dynamics and changes that the nuclei 
suffer upon HSV-1 infection. This study showed that between 8 and 9.5 hpi, the 
nuclei of HSV-1 infected cells increased to 1.75 times that of uninfected cells. Thus, 
this study showed that nuclear size increased by nearly two-fold upon HSV-1 
infection. Most of the increase in volume is due to the expansion of the 
interchromosomal space. Additionally, they also demonstrated the marginalization 
of host chromatin to the nuclear periphery and the disruption of the nucleolar 
morphology by the presence of viral replication centres (VRC). The formation of 
VRCs produces the separation of chromatin as it presents low solubility in the 
concentrated solution of viral replication components resulting in the displacement 
of the host chromatin towards the nuclear periphery (Monier, Armas et al. 2000).  
Another study observed that the nuclei volume of HSV-1 infected Hela cells 
increased four to five-fold compared with mock cells at 16 hpi. This same study 
demonstrated that G-actin was essential to produce nuclear expansion and 
enlargement during HSV-1 infection (Simpson-Holley, Colgrove et al. 2005). 
Later studies have shown that the remodelling of the nuclear structures is a main 
factor to allow nucleocapsids to cross the nuclear space. They used ring-sheet 
microscopy to image and track the movement of nucleocapsids with super resolution 
microscopy. This study showed that transport of nucleocapsids within the nucleus 
is not led by a directed motility and transport. However, the modifications that the 
nuclear structure suffered upon HSV-1 infection allowed viral nucleocapsids to get 





1.3.4. Nuclear lamina and NETs during HSV-1 infection 
 
The 20 to 100 nm deep orthogonal filamentous meshwork of the nuclear lamina 
together with the presence of NETs and attached chromatin present a physical 
obstacle for capsid budding. This complex network hampers the movement of 
nucleocapsids to access the INM (Mou et. al., 2008). To access the INM 
herpesviruses have developed ingenious strategies causing the partial disassembly 
of the lamina. Disruption of the lamina by HSV-1 infection has been shown to be 
coupled with the maturation of VRC involving the activation of both cellular and viral 
proteins (Simpson-Holley, Baines et al. 2004). 
Lamina disassembly requires specific phosphorylation of lamins. Furthermore, 
some NETs have been shown to be hyperphosphorylated during HSV-1 egress 
such as emerin (Leach, Bjerke et al. 2007, Morris, Hofemeister et al. 2007). 
Phosphorylation leads to lamin depolymerisation resulting in the release of some 
NETs associated to lamin as for example LBR (Scott and O'Hare 2001). Multiple 
cellular kinases are known to be activated during mitosis leading to the 
phosphorylation of lamins and NETs which facilitates NE disassembly. This process 
is mediated by the activation of cyclin dependent kinase1 (Cdk1), protein kinase C 
(PKC), mitogen-activated protein kinase (MAPK), protein kinase A (PKA), casein 
kinase II, and AKT (Margalit, Vlcek et al. 2005).  
Disassembly of the nuclear lamina, as a result of the phosphorylation produced by 
different kinases, causes the individual filaments to break apart into individual lamin 
dimers. In consequence, phosphorylation disrupts the lamina protein-protein and 
protein-DNA interactions (Guttinger, Laurell et al. 2009).  
Several pieces of evidence suggest that members of the herpesvirus family have 
adapted analogous cellular mechanisms for phosphorylating lamins to gain access 
to the INM (Gonella et. al., 2005; Reynolds, Liang and Baines, 2004; Muranyi et. al., 
2002). HSV-1, HSV-2 and HCMV infections promote the phosphorylation of all three 
types of lamins (lamin A/C, lamin B1 and lamin B2) (Cano-Monreal et al., 2009; 
Marschall et al., 2005; Mou et al., 2007, 2008; Park and Baines, 2006) while HCMV 
infection induces phosphorylation of lamin A/C (Lee et al., 2008; Muranyi et al., 
2002). Lamin B can be phosphorylated directly by PKC cellular protein and/or other 
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cellular or viral kinases during HSV-1 infection (Park and Baines 2006). On the other 
hand, lamins A/C have been reported to be phosphorylated by US3 viral kinase 
during HSV-1 infection (Mou, Wills et al. 2008) and by PKC in cells infected with 
HCMV (Muranyi, Haas et al. 2002).  
In addition to lamins, NETs have also been reported to be phosphorylated and 
disrupted during herpesvirus infection. The first evidence that a NET can be targeted 
during HSV-1 egress was provided by the O'Hare lab (Scott, E. S. 2001). They used 
live-cell imaging to monitor LBR tagged to GFP during HSV-1 infection showing that 
LBR is translocated from the INM to the ER of infected cells.  Further, they 
performed FRAP analyses to show an increase in the mobility of LBR within the 
nuclear rim of infected cells resulting in its partial redistribution from the INM. Hence, 
this data indicated that LBR becomes increasingly free in order to diffuse laterally 
from the INM suggesting the disruption of the LBR connection to the lamina network 
upon viral infection. This provides an easy access for nucleocapsids to bud at the 
INM (Scott and O’Hare, 2001).  
A few years later the O´Hare and Roller labs reported the targeting of another NET 
during HSV-1 infection. Emerin, a single transmembrane span protein anchored to 
the INM and interacting with lamins was shown to be hyperphosphorylated in HSV-
1 infected cells resulting in an increase of its mobility within the NE. Interestingly, 
the phosphorylation of emerin led to a loss of connections between emerin and 
lamins resulting in a greater extractability of this NET from the NE of infected cells 
(Morris, James B 2007). One last study demonstrated the redistribution of LAP2β in 
a discountinous and punctuate manner within the NE in HSV-1 infected cells 
(Reynolds, Liang et al. 2004, Simpson-Holley, Baines et al. 2004). This argued that 
the same kinases involved in lamin phosphorylation during HSV infection would 
participate in the phosphorylation of NETs.  
All these findings suggested that in order to achieve a successful nuclear egress, 
HSV-1 must target NETs and lamins resulting in the disruption of protein-protein 
connections prior to primary envelopment at the INM. These modifications will 




The interactions between NETs and lamins results in the formation of a complex 
environment for the access of nucleocapsids to the INM. The dismantling of the 
nuclear lamina by the phosphorylation induced during HSV-1 infection would include 
the release of lamins and NETs allowing proteins to diffuse into the ER. This 
diffusion would be caused by the alteration of the tethering of proteins bound to the 
lamina resulting in an increase of nucleocapsid access to the INM.  Emerin as well 
as LBR and LAP2β have been shown to be targeted during HSV-1 infection resulting 
in a loss of these proteins from the INM.  
The modifications observed in the few transmembrane proteins tested might reflect 
a more whole-scale effect on NETs during HSV-1 infection.  As mentioned before, 
the INM is a unique structure containing numerous specific resident nuclear 
transmembrane proteins. Therefore, it is reasonable to deduce that at least some 
other NETs could be targeted by HSV-1 in order to facilitate viral access to the INM. 
Most interesting would be to test, if some of them are being affected or modified by 
the virus during NE egress.  
 
Are there other NETs apart from emerin and LBR being targeted by HSV-1 
during NE egress? 
 
To date several viral proteins that will be discussed in the next section have been 
characterized to regulate HSV-1 primary envelopment from the nuclear membrane. 
However, little is known about cellular proteins that might be involved in this process. 
During secondary envelopment, viral capsids present in the cytoplasm acquire their 
final envelope in either the TGN or the Golgi. As mentioned in the previous section, 
this budding event between cytoplasmic capsids and cellular membranes is thought 
to occur as a result of interactions between tegument proteins present in the 
capsid´s surface and cytoplasmic tails of envelope glycoproteins expressed in 
cellular membranes (Mettenleiter 2004, Mettenleiter, Klupp et al. 2009). Supporting 
this hypothesis, several interactions have been identified between tegument 
proteins and glycoproteins (Elliott, Mouzakitis et al. 1995, Gross, Harley et al. 2003). 
As an example, VP16 was shown to interact with the cytoplasmic tail of gH (Gross, 
Harley et al. 2003). These interactions between glycoprotein tails and tegument 
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proteins might facilitate the budding of capsids into cellular compartments such as 
the TGN or Golgi bending the host membrane tightly around the viral particle.  
Different host cellular proteins have been shown to be utilised by the virus to achieve 
secondary envelopment. For instance, Rab1A activity was suggested to be 
important for the trafficking of viral envelope proteins from the ER to the Golgi, where 
they are incorporated into the virus after glycosylation. During nuclear egress, as in 
the case of secondary envelopment, protein interactions might be needed to pull the 
INM around nucleocapsids triggering the formation of PEP.  
Thus, we postulated that some host cellular proteins such as Rabs and/or proteins 
in the NE such as NETs, are likely to be interacting with viral proteins present in 
nucleocapsids in order to facilitate the budding of these viral particles at the INM. 
 
Are NETs being involved in fusion events facilitating budding at the NE? 
 
 
1.3.5. Cellular kinases activated during nuclear egress 
 
A variety of cellular kinases are activated during herpesvirus nuclear egress 
resulting in the disruption of the nuclear lamina in order for capsids to gain access 
to the INM.  
CDK1 also known as cdc2, has been shown to be involved in the disruption of the 
nuclear lamina during HSV-2 infection via its potential role in emerin phosphorylation 
(Morris, Hofemeister et al. 2007). In addition, recruitment of PKCs to the NE was 
also suggested to be involved during HSV-1 infection. PKC is a family of ten 
serine/threonine kinases involved in a variety of cellular functions (Reyland 2009). 
Different studies have reported the recruitment of PKC alpha and delta to the 
nuclear rim of infected cells between 8 and 12 hpi with HSV-1, resulting in an 
increase in the phosphorylation of lamina components (Park and Baines 2006). The 
concentration of PKC within the nuclear rim of infected cells depends on the 
presence of UL31/UL34 at the NE (Park and Baines 2006) and it is known to induce 
the phosphorylation of lamin B and emerin (Leach, Bjerke et al. 2007, Leach and 
Roller 2010) (Figure 6). Furthermore, there are studies suggesting that the activation 
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of PKC during HSV infection is necessary for nuclear lamina breakdown thus 
facilitating viral egress at the NE (Leach and Roller 2010).  
The involvement of PKCs during nuclear egress seems to be a conserved 
characteristic of herpesviruses. PKCs are also recruited to the nuclear rim of Murine 
cytomegalovirus (MCMV) and Human cytomegalovirus (HCMV) infected cells where 
they phosphorylate lamin proteins, promoting a partial disruption of the lamin 
meshwork (Muranyi, Haas et al. 2002, Milbradt, Webel et al. 2010, Sharma, Bender 


















Figure 6. PKC recruitment at the NE during HSV-1 infection. Lamin B is phosphorylated 
during HSV-1 infection by PKC cellular kinase as well as emerin. The recruitment of PKC at 
the NE depends on the presence of UL31 and UL34. 
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All these previous studies have pointed out the potential role of only three cellular 
kinases during HSV-1 nuclear egress. Additionally, to our knowledge, only lamins 
and three NETs (emerin, LAP2β and LBR) have been shown to be targeted by either 
cellular or viral kinases during HSV-1 infection. 
As lamins and some NETs are phosphorylated by multiple cellular kinases during 
cellular processes and as NETs present connections with chromatin and lamins, it 
is reasonable to hypothesize that some other NETs are being targeted during viral 
infection in order to break connections and mobilize NETs for capsid access to the 
NE. Moreover, additional cellular kinases might be recruited by the virus to promote 
nuclear lamina disruption, facilitating the access of nucleocapsids to the INM.  
 
Are there other cellular kinases facilitating HSV-1 nuclear egress? 
 
1.3.6. Viral factors involved in herpesvirus nuclear egress 
 
Various studies including mutagenesis, genetic and ultrastructural analysis, 
observed the involvement of different viral factors during herpesvirus egress at the 
NE. Here, I will describe the viral proteins that have been described as being main 
factors during HSV-1 nuclear egress: 
 
-The Nuclear Egress Complex (NEC) is a heterodimeric complex composed of two 
conserved viral proteins (UL31/UL34) essential for nuclear budding. Both proteins 
are conserved throughout the Herpesviridae family, suggesting their importance in 
herpesvirus life cycle. The NEC is targeted to the NE and it is thought to be involved 
in various nuclear egress steps such as (1) nuclear lamina disruption by the 
recruitment of viral and cellular kinases to locally dissolve the nuclear lamina, (2) 
interaction between nucleocapsid and the INM allowing membrane deformation (3) 
fusion of PEP with the ONM resulting in the release of naked capsids into the cytosol 
(Mettenleiter, Klupp et al. 2009). 
UL31 is a nuclear phosphoprotein that localizes to the INM via UL34 interaction 
(Chang and Roizman 1993, Reynolds, Wills et al. 2002). This protein is likely 
interacting with the nuclear matrix as it has been shown to be resistant to extraction 
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with detergent and high salt concentrations as are many other nuclear lamina 
components (Chang and Roizman 1993).   
The UL34 protein is a type II integral membrane protein containing a 22 amino-acid 
transmembrane domain at the C-terminus. This protein is anchored to the INM by 
its short C-terminal transmembrane domain with only three residues extending into 
the perinuclear space (Shiba, Daikoku et al. 2000). On the other hand, the 247 
amino-acid N-terminal domain of this protein faces the nucleoplasm in where it 
interacts with the C-terminus of UL31 (Yamauchi, Shiba et al. 2001). UL31 interacts 
with lamin through its N-terminus (Figure 7). In the absence of UL34, UL31 protein 
is localized to the nucleus of infected cells but it does not target the NE (Reynolds, 
Ryckman et al. 2001). Thus, the C-terminus of UL34 is responsible to target the 
NEC complex to the INM while UL31 is exposed to the nucleoplasm where it 
associates with the capsid surface of PEP. The unique structure of the NEC 
reshapes the INM resulting in the deformation and curvature of this membrane 
ensuring that nucleocapsids are tightly enveloped, leading to viral budding and 
formation of PEP. Next, fusion with the ONM releases nascent capsids into the 
cytoplasm while the NEC remains in the ONM where it is exposed to the cytoplasm 






















Different studies have shown that in the absence of the NEC, viral egress is partially 
impaired resulting in the accumulation of nucleocapsids in the nucleoplasm. 
Interestingly, some viral particles were able to reach the cytoplasm after UL31/UL34 
silencing indicating that there is an independent pathway by which viral particles 
cross the NE in the absence of this complex (Fuchs, Klupp et al. 2002, Klupp, 
Granzow et al. 2007, Passvogel, Klupp et al. 2015). Fuchs and colleagues showed 
the impairment in viral titres produced by a UL31 deleted mutant PRV virus (Fuchs, 
Klupp et al. 2002). This mutant showed a decreased plaque formation of more than 
100-fold from those of wild type. In this same study, ultrastructural analyses 
demonstrated that particles undergoing budding at the INM and cytoplasmic or 
Figure 7. NEC viral complex. The heterodimer complex of UL31 and UL34 are involved in 
HSV primary envelopment. UL31 protein is a phosphoprotein that is recruited to the nuclear 
membrane by the interaction of its C-terminus with the N terminus of UL34. At the same time 
UL31 interacts with lamins through its N-terminus. UL34 is an integral membrane protein with 
an N-terminal nucleoplasmic domain and a short C-terminal transmembrane domain TM 
embedded in the INM extending only 3 amino-acids into the lumen. Opposite to UL34, 
nuclear integral proteins (NETs) contain multiple TM domains strongly anchoring these 
proteins to the NE. 
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extracellular virions were absent from cells infected with UL31 mutant PRV virus. 
These defects were also observed in a similar study with a UL34 mutant PRV virus 
(Fuchs, Klupp et al. 2002).  
Moreover, both proteins have been associated with PEP in the lumen and at the 
INM and ONM but are absent from cytoplasmic and extracellular virions. In an 
ultrastructural study performed by Reynolds and colleagues, UL31 and UL34 were 
observed to associate with perinuclear virions but not with extracellular virions in 
HSV-1 infected cells. These observations further support the envelopment/de-
envelopment model of virion egress (Reynolds, Wills et al. 2002).  
The NEC was also shown to be sufficient to drive the formation of vesicles from the 
nuclear membrane in an in vitro study. In (Klupp, Granzow et al. 2007) cell lines 
stably expressing both UL31 and UL34 of the alphaherpesvirus PRV were 
generated. These cells showed the formation of membranous vesicles from the NE 
containing both proteins, UL31 and UL34, localizing at the lumen. These results 
suggested that UL31 and UL34 can induce the formation of perinuclear vesicles that 
mimic PEP without a nucleocapsid in an artificial system.  
The importance of the UL31/UL34 complex has increased the interest in elucidating 
its structural and mechanical features for designing specific drugs targeting the 
complex. Recently cellular electron cryo-tomography has revealed the NEC coat 
architecture. This study argued that only electron density for UL31 and UL34 was 
observed at sites of fusion between the INM and PEP suggesting these two proteins 
function alone during nuclear egress in order to promote viral egress (Hagen, Dent 
et al. 2015). However, this might be an over-interpretation of the results as no 
immunogold EM studies were performed in order to confirm the presence of UL31 
and UL34. Nevertheless, this study does not exclude the possibility of host proteins 
being involved in nuclear egress because there would be no visible 
electron density for a multispanning transmembrane NET with short nucleoplasmic 
region that might be aiding herpesvirus nuclear egress. Another study arguing that 
UL31 and UL34 are sufficient for primary envelopment showed that membrane 
invaginations can be induced by mixing these two viral proteins with liposomes in a 
completely artificial system (Bigalke, Heuser et al. 2014). Neither of these papers 
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measured the efficiency of membrane budding compared to a normal infection and 
neither excluded the possibility of other proteins participating in the egress process. 
It is highly unlikely that primary envelopment will be driven by only these two viral 
proteins as UL31 is not a transmembrane protein and its location at the INM 
depends on its interaction with UL34 and UL34 is targeted to the INM by the 
presence of one single transmembrane domain containing only three residues 
extending into the lumen space (Shiba, Daikoku et al. 2000). Thus, this protein 
presents a weak association to the membrane as compared with other membrane 
proteins presenting multiple transmembrane domains within the NE.  
During HSV budding, the INM must undergo deformation to create membrane 
curvature and budding around nucleocapsids. The generation of curvature in the 
membrane is an enthalpy-driven process that is mediated by protein-protein 
interactions, resulting in the change of membrane topology. Protein interactions 
apply forces to flat membranes surfaces pulling membranes around a cargo 
(Zimmerberg and Gawrisch 2006). 
Thus, there are still lot of questions to be answered in regards to the function of the 
NEC in membrane budding. Does UL34/UL31 complex recruit host proteins (as yet 
unidentified) during in vivo HSV-1 infections or are these two viral proteins able to 
mediate curvature and membrane budding directly without the presence of any other 
host cellular proteins? 
 
UL31/UL34 might interact with host proteins driving INM deformation 
 
Taken together, it is unlikely that the short C-terminal transmembrane domain of 
UL34 would act as a single driving factor of viral budding at the INM unless its 
density in the nuclear membrane at sites of egress becomes sufficiently high for 
protein-protein interactions to bend the membranes. To achieve this density, would 
also require the removal of hundreds of different NETs.  
The involvement of cellular proteins in other steps of viral nuclear egress suggests 
the high possibility of the contribution of other cellular factors in order to facilitate 
membrane budding during HSV nuclear egress. Furthermore, protein-protein 
interactions are needed to help pulling the membrane around the viral particles, as 
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in the case of secondary envelopment where tegument proteins on the surfaces of 
the capsids present in the cytoplasm bridge with viral glycoproteins expressed in the 
TGN or Golgi, resulting in the formation of enveloped particles. 
Thus, we postulate that the NEC complex is interacting with other proteins within 
the NE resulting in the formation of tight interactions allowing the tethering of the 
viral complex at the INM. These protein interactions will pull the INM into a bud 
resulting in the formation of PEP residing in the lumen.   
 
-pUS3 is a viral protein presenting kinase activity that is only found in the alpha-
herpesvirus subfamily and it distributes throughout the infected cell.  It has been 
proposed to phosphorylate UL34, as well as other cellular and viral factors involved 
in nuclear egress. US3 kinase is required for a correct distribution of UL34 at the 
nuclear rim of infected cells where it localizes with US3.  
Different studies have shown that infection of cells with a US3-null virus results in a 
punctuate distribution of UL34 at the NE, as compared with the uniformly even 
distribution presented in cells infected with a wild type HSV-1 (Reynolds, Ryckman 
et al. 2001, Reynolds, Wills et al. 2002). 
Furthermore, US3-null virus infection produces the accumulation of PEP in an 
expanded perinuclear space indicating that this kinase has an important role in de-
envelopment at the ONM (Wagenaar, Pol et al. 1995, Reynolds, Wills et al. 2002). 
In contrast to UL31 and UL34, US3 is a tegument protein not only found on PEPs 
but on cytosolic capsids and in mature extracellular virions (Granzow, Klupp et al. 
2004, Loret, Guay et al. 2008) 
 
-Viral glycoproteins: While the role of viral glycoproteins during HSV entry is well 
characterised, the contribution of these proteins during primary and secondary 
envelopment remains unclear mainly due to a high functional redundancy of these 
proteins. 
Multiple viral glycoproteins such as gM, gB, gH-gL and gD are found in the INM and 
in PEP (Stannard, Himmelhoch et al. 1996, Baines, Wills et al. 2007, Johnson, 
Wisner et al. 2011). After synthesis in the ER, they are laterally transported to the 
ONM. How these proteins reach the INM has not been proved at the moment but it 
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is thought they exploit similar mechanisms as NETs by the use of peripheral 
channels of the NPC.  Additionally, immunogold EM studies have found the 
presence of gB, gC, gD and gM in PEP (Torrisi, Di Lazzaro et al. 1992, Jensen and 
Norrild 1998).  
Another study showed that the recruitment of gM and gD to the INM depends on the 
presence of NEC (Table 3, Table 4). They showed that UL34 interacted directly or 
indirectly with gD and these interactions were needed for the retention of the 
glycoprotein at the INM (Wills, Mou et al. 2009). Interestingly, other studies did not 
observe the presence of these glycoproteins in the primary envelope of PRV virions, 
suggesting that different members of the same family might utilize different 
mechanisms for de-envelopment at the ONM (Klupp, Altenschmidt et al. 2008) 
All the studies showing the presence of viral glycoproteins at the INM and PEP open 
the possibility of the involvement of glycoproteins during herpesvirus nuclear egress. 
As mentioned in the previous section, secondary envelopment is driven by 
interactions between tegument proteins of the cytoplasmic viral particles with 
glycoproteins present in the Golgi or TGN. These interactions drive the deformation 
of the host membrane allowing the viral budding. Thus, it is likely that a similar 
process is taking place during primary envelopment where glycoproteins by 
interactions with other proteins might be anchoring the nucleocapsids at the INM 
resulting in the curvature of the INM. 
There are also evidences pointing out the participation of glycoproteins during de-
envelopment at the ONM. PEP decorated with viral glycoproteins fuse with the ONM 
in an apparently similar process as herpesvirus entry into cells. As mentioned in the 
previous section, gB, gD and the heterodimer gH-gL are necessary for membrane 
fusion during viral entry. These three glycoproteins are also found in PEP as well as 
in the INM and ONM. Evidence for the involvement of these glycoproteins in de-
envelopment came from studies in which infection with a HSV-1 mutant lacking both 
gB and gH showed a decrease in the number of viral particles able to cross the NE 
reaching the cytoplasm suggesting their role in promoting fusion between the 
primary virions and the ONM (Farnsworth, Wisner et al. 2007). Depletion of these 
two glycoproteins increased the number of PEP in the lumen but there are still viral 
particles reaching the cytoplasm.  
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Other viral glycoproteins found in PEP such as gD and gM might promote fusion 
with the ONM although there are studies suggesting the contrary (Johnson, Wisner 
et al. 2011). Thus, there might be other mechanisms by which viral particles fuse 
with the ONM. 
Table 3 contains a list of the known HSV-1 glycoproteins and where they have 
been found to be localized.  Table 4 contains different steps in HSV-1 life cycle 
and the glycoproteins known to be involved. 
The NEC complex present in the PEP might be promoting de-envelopment, however 
it is unlikely that UL31 and UL34 could by themselves direct fusion events as UL34 
only extends three residues from the surface of the PEP and UL31 interacts with 
tegument proteins without any extension from the surface. This opens the possibility 
of roles for glycoproteins during primary envelopment and de-envelopment at the 
NE during nuclear egress as the NEC seems to be insufficient to drive this process 
by itself. Are there other viral glycoproteins involved in these viral steps? 
Furthermore, it is likely that host proteins such as ESCRT proteins might be involved 
in membrane curvature and scission helping during virus budding into the lumen 
(Lee, Liu et al. 2012). 
 
Table 3. HSV-1 glycoproteins and their known localization 
Gene Protein Envelope PEP INM 
UL1 gL YES YES YES 
UL10 gM YES YES YES 
UL22 gH YES YES YES 
UL27 gB YES YES YES 
UL53 gK YES ? ? 
US4 gG YES ? ? 
US5 gJ YES ? ? 
US6 gD YES YES YES 
US7 gI YES ? ? 
US8 gE YES ? ? 
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Table 4. HSV-1 glycoproteins and their involvement in viral life cycle steps 
Viral life cycle step Glycoproteins involved 
Primary envelopment n/a 
De-envelopment gB, gH/gL 
Secondary envelopment gB,gD,gE/gI 
Direct release from cell gE/gI 
 
 
1.3.7. Membrane fusion events during viral infections 
 
As previously mentioned, it is reasonable to suggest the potential interaction 
between UL31/UL34 and host proteins in order to drive budding events at the INM. 
These as yet not identified cellular proteins, could contribute together with the NEC 
complex in the formation of vesicles at the INM resulting in the release of PEP into 
the lumen or in the fusion with the ONM releasing nascent capsids into the cytosol. 
Intracytoplasmic transport between cellular compartments is mainly mediated by 
vesicles. Vesicles are a basic tool for the cell; they are involved in a variety of 
physiological events such as the secretory and endocytic pathways as well as 
transport of cargo molecules between organelles (Bonifacino and Glick 2004).  
Vesicle formation is a highly regulated but conceptually straightforward mechanism 
in which the integrity and composition of the involved organelles is not 
compromised. This process starts with the selection of cargo molecules by cargo 
receptor proteins. After this, coat proteins recruited to the site of assembly impose 
a curvature on the membrane, generating buds that result in the formation of 
vesicles containing the selected cargo. Clathrin, COPI and COPII are the best 
known coat proteins involved in the selection of cargo resulting in vesicle formation 
and membrane deformation into the cytosol, cleaving membrane necks by 
constricting them from the outside (Zeev-Ben-Mordehai, Vasishtan et al. 2014).  
In contrast to this, the ESCRT machinery participates in membrane scission from 
inside the neck and mediates membrane deformation in the opposite direction (away 
from the cytosol) such as secretory body formation or egress of enveloped viruses 
as HIV at the plasma membrane (Wollert, Yang et al. 2009)  
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Once vesicle formation has finished, vesicle transport must be selective in order to 
only recognize in an orderly way the correct target membrane to fuse with in a 
process called vesicle docking. This crucial recognition step is controlled by SNARE 
proteins and Rab GTPases (Zerial and McBride 2001, Geumann, Barysch et al. 
2008, Bhuin and Roy 2014, Wandinger-Ness and Zerial 2014).  
There are 20 SNARE proteins in eukaryotic cells associated with specific 
membrane-organelles (Ungar and Hughson 2003). These transmembrane proteins 
work in combination with Rab GTPases. There are over 60 human Rabs that 
regulate and coordinate multiple cellular processes such as vesicle budding, fusion 
and tethering and vesicle transport. Specific Rabs are associated with distinct 
organelles and transport vesicles to enable a highly regulated delivery of vesicle 
membranes and cargo to specific target compartments. Thus, Rabs have been 
shown to be key regulators of intracellular membrane trafficking by regulating two 
main processes: fusion and transport of vesicle membranes.  
In recent years, a number of studies have provided evidence for the exploitation of 
Rabs function by viruses during budding and secondary egress pathways in the 
cytoplasm, as is the case for HSV-1 (Manna, Aligo et al. 2010, Caillet, Janvier et al. 
2011). Different studies have identified Rab proteins as key players in herpesvirus 
secondary envelopment for the transport of virus glycoproteins from the TGN to the 
PM and vice versa (Zenner, Yoshimura et al. 2011, Hollinshead, Johns et al. 2012, 
Johns, Gonzalez-Lopez et al. 2014). 
One study showed the involvement of Rab6 in a specific exocytosis pathway to 
transport virus glycoproteins from the Golgi/TGN to the PM and how this step was 
essential in HSV-1 secondary envelopment (Gonzalez-Lopez et al. 2014). Another 
study performed by the same group showed a new mechanism for the recruitment 
of glycoproteins by endocytosis from the PM into endocytic tubules in which Rab11 
was involved (Hollinshead, Johns et al. 2012). Finally, a few years later, Rab1a/b 
and Rab43 were shown to be essential for the traffic of viral glycoproteins from the 
ER to the assembly compartment in the cytoplasm of HSV-1 infected cells (Johns, 
Gonzalez-Lopez et al. 2014). 
Recently, vesicle trafficking has been reported to regulate nucleocytoplasmic 
transport of large cargo such as ribonucleoprotein particles (RBP) (Speese, Ashley 
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et al. 2012). This nuclear transport pathway involves vesicle formation at the INM 
and scission from the nucleoplasm into the lumen space of the NE prior to fusion 
with the ONM. This process is similar to herpesvirus egress at the NE. Therefore, it 
is not surprising that vesicle transport might represent a potential mechanism for 
transport of large cargo from the nucleus to the cytoplasm, which viruses such as 
HSV have usurped and exploited during evolution.  
So far, the only vesicle fusion pathways linked to nuclear egress are the involvement 
of ESCRT pathway proteins for EBV nuclear egress. Dominant-negative mutations 
in Vps4, a protein component of the ESCRT machinery that contributes to the 
release of ESCRT complex from membranes and Chmp4b involved in scission, 
result in the reduction of virion release from the nucleus. Interestingly, the cellular 
ESCRT machinery was shown to be recruited by EBV BFRF1, (homologous of UL34 
in alphaherpesviruses), suggesting its participation in the scission of the nucleus-
associated membrane during EBV primary envelopment. However, the involvement 
of ESCRT in the induction of vesicle formation was not found for HSV-1, suggesting 
that alphaherpesviruses require alternate mechanisms for NE egress (Lee, Liu et al. 
2012). 
  
Vesicle fusion pathways are used by EBV during primary envelopment 
 
Hence, this study opens the possibility that vesicle fusion pathways might be 
exploited by other herpesvirus types during nuclear egress. It is therefore 
reasonable to think that, as for other physiological processes in the cell, vesicle 
formation from the INM will require the presence of vesicle fusion proteins that either 
interact with UL31/UL34 to aid in pulling the INM around nucleocapsids promoting 
viral budding or will act following an independent pathway resulting in membrane 






1.4. The NE and its role in innate immunity  
 
1.4.1. The STING / NET23 pathway and its role in innate 
immunity 
 
In vertebrates, there are two complementary systems that have evolved to detect, 
fight and protect the cell against microbial pathogens: the innate and adaptive 
immune systems. Innate immunity is the first and most rapid line of host defence 
against invasion by multiple pathogens. 
The detection of pathogen invasion occurs via the recognition of pathogen-
associated molecular patterns (PAMPs) that are present in all microorganisms, such 
as viral nucleic acids or bacterial cell wall components as lipopolysaccharides, 
through a set of host pattern recognition receptors (PPRs) that in turn induce anti-
pathogen genes. PPRs can be divided into two groups; the first group includes 
several members of the Toll-like receptor (TLR) family that mainly localize in the 
lumen of endosomes and lysosomes allowing the detection of pathogen nucleic 
acids. The second group of receptors are the cytosolic nuclei acid sensors including 
the cytoplasmic DNA sensors as well as the RIG-I like receptors (RLR) family able 
to detect pathogen-derived RNA in the cytosol. RLRs, including RIG-I, MDA5 and 
LGP2 are sensors of viral RNAs in the cytoplasm such as hepatitis C virus (HCV). 
After viral RNA is detected, RLRs associate with MAVs/VISA, an integral protein 
present in the mitochondria, facilitating the activation of Tank Binding Kinase 1 
(TBK1) leading to the phosphorylation of IRF3/7 that then induce type I IFN genes 
(Akira, Uematsu et al. 2006, Wu and Chen 2014, Dempsey and Bowie 2015) (Figure 
8).  
Besides innate immune response activation by RNA, accumulation of foreign DNA 
in the cytosol can also induce dramatic activation of type I IFNs.  STING (stimulator 
of interferon genes), also known as TMEM173, MPYS, MITA, ERIS and NET23 is a 
transmembrane protein localized in the ER, mitochondria and NE, that was found in 
2008 to be an adaptor protein exhibiting a vital role in DNA signalling in the cytosol 
(Ishikawa and Barber 2008).  
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cGAS is a recent identified cytosolic DNA sensor that upon DNA binding catalyses 
the production of cGAMP which acts as a second messenger binding to and 
activating STING on the surface of the ER.  In response to cGAMP binding, STING 
dimerizes and relocalizes from the ER to the Golgi and further to perinuclear 
vesicles. Following STING activation, the downstream kinase TBK1 is recruited to 
STING leading to subsequent phosphorylation of STING and IRF3.  Consequently, 
phosphorylated IRF3 dissociates from TBK1 and dimerizes before translocating into 
the nucleus to activate innate immunity genes (Zhong, Yang et al. 2008, Liu, Li et 
al. 2015).  
It has been recently shown, that STING interacts with both TBK1 and IRF3, 
suggesting STING acts as a scaffold protein to promote the phosphorylation of IRF3 
by TBK1 (Tanaka and Chen 2012). The repertoire of genes induced upon cytosolic-
DNA detection such as type I interferon (IFN) or tumor necrosis factor alpha (TFN-
α) are activated via IRF3 and NF-KB pathways (Paludan and Bowie 2013) (Figure 
8).   
Although the activation of STING by cytosolic DNA is well established, the role of 
this protein in response to RNA is less clear. Different studies have suggested 
STING as a key scaffolding protein that links RIG-I (cytosolic RNA sensor) to the 
mitochondrial protein MAVS, key element of the RNA-sensing pathway. Activated 
MAVS interacts with STING resulting in its dimerization and subsequent IRF3 
activation (Zhong, Yang et al. 2008).  
In 2011, Chen Huihui and colleges demonstrated that RNA virus infection triggers 
the activation of STING via STING interaction with MAVs leading to the recruitment 
of STAT6 (signal transducer and activator of transcription 6), which is 
phosphorylated by TBK1 leading to its nuclear translocation. Once inside the 
nucleus, STAT6 acts as a transcription factor activating multiple genes involved in 
innate immunity (Chen, Sun et al. 2011) (Figure 8).   
The importance of STING in the innate immune defence against RNA viruses has 
been also supported. Different studies involving RNA viruses have reported the role 
of RNA viral proteins as cGAS-STING antagonists. For example, the yellow fever 
virus (YFV), a RNA virus belonging to the Flaviviridae family has been reported to 
directly interact with STING and block STING and RIG-I dependent signalling by the 
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non-structural protein NS4B (Ishikawa, Ma et al. 2009). Another study has shown 
the importance of cGAS in the activation of the IIR to HIV and other retroviruses by 
detecting reverse-transcribed viral cDNA (Maelfait, Seiradake et al. 2014). A recent 
study published by Holm and colleagues has shown the stimulation of a cGAS-
independent STING pathway by enveloped RNA viruses to block the host IIR 
activation. In particular, they observed that the HA2 FP protein of Influenza A virus 
(IAV) targeted this pathway by its direct binding to STING, resulting in the inhibition 
of STING dimerization and therefore TBK1 activation (Holm, Rahbek et al. 2016). 
Despite the fact that STING might be interacting with some proteins involved in RNA 
cascade signalling, the basis for the involvement of STING in controlling RNA 







Figure 8. Overview of IIR activation in response to cytosolic nucleic acids. Cytosolic 
DNA is sensed directly by cGAS or by alternative cytoplasmic sensors leading to the 
activation of STING. STING interacts with TBK1 and IRF3 leading to the phosphorylation of 
IRF3 by TBK1. Once IRF3 is phosphorylated, it translocates into the nucleus where it 
activates IFN and cytokines production. Double stranded RNA generated from multiple viral 
infections is sensed by RIG-1 and MDA-5. These two proteins bind directly to dsRNA 
leading to the activation of MAVs, a protein tethered to the mitochondrial membrane. At this 
point two pathways have been described: (1) MAVS can either activate TBK1 and IKβ 
kinases leading to the activation of IRF3 and NF-kβ inducing the secretion of I-IFN and 
cytokines (2) Recently it has been shown (Chen, Sun et al. 2011) that RNA viruses trigger 
the activation of STING through a STING-MAVS interaction. Subsequently STING recruits 
STAT6 and TBK1, leading to the phosphorylation and activation of STAT6 resulting in I-IFN 
and cytokines activation.   
 
1.4.2. Role of NET23/STING in HSV-1 infection 
 
While host cells have developed various strategies to battle against viruses and 
initiate a robust immune response, over time viruses are also evolving distinct 
mechanisms to escape the host immune responses.  
Different studies have shown that multiple DNA and RNA viruses have gained 
strategies to counteract the cGAS-STING pathway. Some of these viruses, present 
similar mechanisms to inhibit STING-TBK1 binding, while others use more 
sophisticated mechanisms involving STING cleavage and degradation.  
For example the Hepatitis B virus (HBV), a DNA virus, was found to inhibit the 
STING-triggered IFN promoter activation by the HBV polymerase by dampening its 
K63-linked ubiquitination (Liu, Li et al. 2015). Another study identified that 
oncoprotein E7 from Human papillomaviruses (HPV) and EA1 oncoprotein from 
adenovirus bound to STING acting as an antagonist for the cGAS-STING pathway 
preventing the activation of the antiviral response. They showed that the LXCXE 
motif of these oncoproteins, essential for blockade of the retinoblastoma tumor 
suppressor, was also important for antagonizing DNA sensing. Furthermore, the 




The Herpesviridae family has also been reported to evade the cGAS-STING 
pathway. HSV-1 was the first DNA virus reported to activate STING in vivo and in 
vitro. Thus, this virus is widely used in investigations as an activator of the cGAS-
STING pathway. In 2009, Ishikawa and colleges found that STING is necessary for 
the production of type I IFN after HSV-1 infection. They used a STING knockout 
mouse model demonstrating that these mice were more sensitive to HSV-1 infection 
than the wild-type mice, due to the lack of a successful activation of type I interferon 
response (Ishikawa and Barber 2008). Multiple proteins of different viruses 
belonging to the Herpesviridae family have been described to target the cGAS-
STING pathway. For instance, HSV-1 ICP0 E3 ubiquitin ligase was reported by 
Orzalli and colleges in 2012 to degrade the nuclear interferon gamma inducible 
protein 16 (IFI16), inhibiting cytoplasmic STING and IRF3 activation. IFI16 localizes 
in the nucleoplasm and nucleoli and interacts with p53 and retinoblastoma-1 tumor 
suppressors regulating its function (Orzalli, DeLuca et al. 2012).  
Another study performed a screen using 90 KSHV open reading frames (ORFs) to 
identify potential proteins from KSHV that could inhibit the activation of the cGAS-
STING pathway. They found that the viral interferon regulatory factor 1 (Virf1) 
interacts with STING preventing its binding to TBK1. Consequently, STING 
phosphorylation is inhibited resulting in an overall repression of the DNA sensing. 
In another study, Kaposi’s sarcoma- associated herpesvirus ORF52 protein was 
found to directly inhibit the enzymatic activity of cGAS (Gillen, Li et al. 2015). All 
these studies showed different mechanisms by which the Herpesviridae family 
evades the cGAS-STING pathway to mitigate the host immune response.  
Recently, ICP27, an essential multifunctional protein for HSV-1 replication (Rice and 
Knipe 1990) and conserved among all herpesviruses (Sandri-Goldin 2011), has 
been shown to directly interfere with the TBK1 activated STING signalosome 
(Christensen, Jensen et al. 2016). They found that ICP27 translocated from the 
nucleus to the cytoplasm, where it interacts with the TBK1-STING activated complex 
resulting in a reduction in the phosphorylation and activation of IRF3 via the cGAS-
STING pathway. 
Viruses have co-evolved with their host developing mechanisms to overcome and 
evade host immune responses. The role of STING in host protection from HSV has 
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been clearly demonstrated by different studies indicating the essential role of this 
protein in IIR pathways.  
 
1.4.3. What is known about NET23/STING within the 
Nuclear Envelope? 
 
STING was originally identified and introduced as NET23 from a proteomic study to 
identify NETs in crude NE carried out in my supervisor´s lab (Schirmer, Florens et 
al. 2003). Since then, multiple studies have also located this protein in the ER and 
mitochondria where it has been described to play a pivotal role in innate immunity 
(Ishikawa and Barber 2008, Zhong, Yang et al. 2008, Sun, Li et al. 2009, Chen, Sun 
et al. 2011, Ishikawa and Barber 2011).  
Different studies have shown the accumulation of NET23/STING in perinuclear 
vesicles once innate immunity is activated by its interaction with TBK1. However, it 
is uncertain why this translocation takes place, and the authors of these studies 
have presumed it to stay in the ER and not enter the nucleus (Ishikawa, Ma et al. 
2009, Holm, Jensen et al. 2012, Tanaka and Chen 2012). Despite the distinct 
functions and localisations suggested for STING during innate immunity, the 
potential nuclear role for this protein has been largely unaddressed. 
 
1.4.3.1. NET23/STING and chromatin organization from the NE  
 
NET23/STING has been subjected to multiple studies carried out in our lab since it 
was first identified in a proteomic study in crude NE fractions. NET23/STING is 
resistant to detergent extraction from cells, suggesting association with the lamin 
polymer (Malik, Korfali et al. 2010).  
To determine whether NET23/STING is in the INM or ONM, three-dimensional 
structured illumination microscopy (OMX) studies were done. Interestingly, while 
other previously NETs tested with this method were exclusively detected in the INM 
or ONM, NET23/STING was found in some cells to be restricted to the INM and in 
other cells restricted to the ONM (Figure 9).  
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Figure 9. NET23/STING localises at the INM and ONM. Super resolution microscopy 
Nup153 colocalisation indicates INM localisation while Nup358 colocalisation indicates 
ONM localisation. Top panel images from control NETs. Lap2β is present in the INM and 
Sec61β in the ONM. Bottom panel shows images from NET23/STING presented in the INM 
in some cells and in the ONM in others. Taken from de las Heras et al, in preparation. 
 
 
Another study carried out in our lab aimed to identify NETs involved in chromatin 
organization, found NET23/STING as a strong promoter of chromatin compaction. 
In this study, different NETs identified in proteomic studies were tested by 
microscopy techniques to identify potential NETs that could promote chromatin 
compaction. Most of the analysed NETs showed little compacted chromatin. 
However, NET23/STING seemed to induce a very strong increase in the quantity of 
visually dense chromatin.  
 
NET23/STING expression promotes high levels of chromatin compaction 
 
Previous studies published by multiple groups have studied the role of 
NET23/STING as an ER and a mitochondria protein. Whether this population of 
NET23/STING is functional at the NE is also unclear. 
The identification of NET23/STING as a NET together with the strong chromatin 
compaction effect induced by this protein, opened the possibility of a potential new 
role of NET23/STING within the NE. But, how does NET23/STING promote 
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chromatin compaction from the NE? Is NET23/STING interacting with chromatin 
proteins?  
To our knowledge this was the first time where the function of NET23/STING within 
the NE was being addressed. This and another aspects regarding the role of 
NET23/STING in chromatin compaction from the NE will be addressed in chapter 3 
as a continuation of the study started in my supervisor´s lab. 
 
1.4.3.2. Some NET23 nuclear binding partners are highly involved in 
innate immunity 
 
Although NET23/STING was first discovered in a proteomic study for nuclear 
proteins in the Schirmer lab, different studies have shown the involvement of this 
protein in intracellular DNA-mediated and HSV-1-activated type I IFN production. 
However, its potential role in mediating IIR activation from the NE has been largely 
neglected.  
As previously mentioned, NET23/STING binds to the lamin polymer, resulting in a 
highly insoluble protein. Earlier studies aimed to identify NET23/STING binding 
partners might have missed NET23/STING specific binding partners at the NE due 
to the insolubility of this protein pool within the NE. Thus, in order to address the 
limitations of standard co-IPs, and with the aim of identifying NET23/STING specific 
binding partners at the NE that might be missed in earlier studies, a NET23-NE co-
IP was done in our lab.  To do so, NEs were isolated from cells previously 
transfected with NET23/STING-GFP and treated with reversible cross-linker (Figure 
10). After, cross-linked NEs were fragmented by sonication, immunoprecipitated, 
and crosslinks reversed with, then potential NET23/STING partners were identified 
by mass spectrometry.  
The NET23/STING-NE co-IP was highly enriched for proteins with Gene Ontology 
(GO) terms for chromatin and chromosome organisation and RNA/DNA binding 
factors. Specifically, they found that one of the most abundant NET23/STING-
binding partners were bromodomain proteins that might mediate the previously 
mentioned involvement of NET23/STING in chromatin compaction and other 
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epigenetic alterations associated with its role in IIR (Figure 10).  Interestingly, there 
was a pool of NET23/STING binding partners enriched for the GO term of proteins 







Figure 10. NET23/STING binding partner proteins identified by co-IP within the NE. 
Left panel shows the cross-linking of NEs with orthophenanthroline copper chasing 
NET23/STING to multimeric protein complexes while the treatment with DTT reversed the 
crosslinked protein into its expected molecular weight (NET23/STING-GFP 70 KDa). The 
right panel represents the Gene ontology (GO) classification for NET23 partners identified 
by mass spectrometry of cross-linking NE-co-IP proteins. Notably, chromatin, DNA binding 
and chromosome organization terms are enriched. Taken from de las Heras et al, in 
preparation. 
 
Predicting that the relationship between NET23/STING nuclear binding partners and 
its effect on gene expression might be interrelated, gene expression changes were 
analysed upon reduction or gain of NET23/STING. As previously shown for a 
NET23/STING knockout mouse, some of the genes that were affected upon 
NET23/STING silencing were targets of IRF3/7 transcription factors involved in IIR. 
Importantly, the NET23/STING nuclear partners and the genes affected by the 
manipulation of NET23/STING were highly represented for GO terms for nucleotide 
binding partners, specifically for ss and dsRNA binding partners, suggesting that 
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NET23/STING might be involved in sensing a wide variety of pathogen nucleic acids 
though these binding partners, consistent with what has been shown for its 
functioning in IIR to RNA viruses.  
Further analysis of the pool of NET23/STING NE-binding proteins using the HPRD 
interactome database and Cytoscape, revealed the presence of 17 direct binding 
partners that present interactions with six IRF3/7-binding partners, some of which 
are RNA-binding proteins. This suggested that NET23/STING might be indirectly 
affecting the regulation of the expression of genes involved in IIR by interactions 
with some of these 17 NE-binding partners (Figure11) suggesting a highly 





Figure 11. NET23/STING binding partners present connections with IRF3/7. 
Interactome analysis of NET23/STING NE binding partners showed indirect connections to 
IRF3/7 transcription factors involved in IIR. Taken from de las Heras et al, in preparation. 
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Based on all these observations, we postulated that NET23/STING might be acting 
as a nucleocytoplasmic transporter for some NET23/STING-NE co-IP partners 
facilitating the activation of IRF3/7 transcription factors to further activate IIR.  Many 
viruses are able to inhibit nuclear transport through the central channels of the NPC 
upon infection. NET23/STING, as a NET, might be able to navigate the peripheral 
channel of the NPC. Thus, the multiple NET23/NE binding partners that are linked 
with IRF3/7 transcription factors, and the potential ability of this protein to travel 
through the peripheral channels, opens the possibility of NET23/STING acting as a 
nucleocytoplasmic transporter for transcription factors and proteins involved in IIR.  
This would not exclude the activation of signalling cascades that navigate through 
the central channel of the NPC, but it would provide a backup mechanism for the 
host for activating IIR through the peripheral channels.    
 
NET23/STING could be acting as a nucleocytoplasmic transporter 
 
Additionally, the function of NET23/STING in sensing RNA nucleic acids is not well 
understood. Interestingly, in the study carried out in our lab, proteins involved in 
ssRNA and dsRNA were highly affected by the manipulation of NET23/STING. This 
opens the possibility of NET23/STING having an important role for sensing RNA 
nucleic acids in addition to DNA.   
Thus, the function of NET23/STING acting as a chromatin regulator together with 
its potential novel role in IIR activation from the NE will be investigated as part of my 
thesis project. Answering all these questions could have an important impact in 
human health as NET23/STING is known to be essential for host defence against 
pathogens and it could potentially facilitate the adjuvant activity of pathogen nucleic 
acid-based vaccines by enhancing immunization procedures through the production 







1.5. Outstanding questions 
 
One purpose of this research is to establish a more comprehensive understanding 
of the role of the NE during herpesvirus nuclear egress. The wide range of functions 
recently linked to the NE and the identification of hundreds of proteins associated 
with this cellular structure, indicates that it is a much more complex physical barrier 
to herpesvirus infection than previously thought, and it must be overcome to ensure 
infection and production of virus progeny.  
At the present, the most widely accepted model for herpesvirus egress at the NE is 
the envelopment/de-envelopment model in which it is thought that UL31/UL34 viral 
proteins are involved in the initial budding of herpesvirus nucleocapsids at the INM, 
resulting in the formation of PEP. Different studies have suggested that UL31/UL34 
are sufficient to drive the formation of perinuclear vesicles without the presence of 
other cellular proteins. However, all these experiments left the function of the NEC 
in membrane budding at the INM unclear. It is difficult to understand how these two 
viral proteins could directly drive membrane fusion events during primary 
envelopment without any other host protein interaction, as UL31 is not associated 
with the membrane and UL34 presents a short transmembrane domain attached to 
the INM with only three residues extending into the perinuclear space. Furthermore, 
there are a hundred of NETs in the INM and membrane fusion typically requires a 
close apposition of proteins that could be impeded by the presence of all these 
NETs.   
I postulate that NETs might be targeted during egress at the NE by either 
degradation or modification by the virus. For example, just as the UL31/34 complex 
recruits cellular kinases to depolymerise the lamin polymer it could also 
phosphorylate NETs to break their interactions with chromatin. (1) To test this 
hypothesis, different NETs were screened by immunofluorescence as tagged 
fusions to determine whether they are degraded or redistributed during HSV-1 
infection.  
As an alternative, host proteins might be recruited to the NE in where they could 
interact with viral proteins to enhance membrane association assisting viral fusion 
events during primary envelopment. During HSV-1 primary envelopment, 
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nucleocapsids acquire their envelope from the INM that contains potential host 
proteins that might be driving/contributing to membrane budding. During de-
envelopment at the ONM, nascent capsids are released into the cytoplasm while 
the primary envelope derived from the INM remains fused with the ONM. Thus, it 
might be expected that during de-envelopment, host proteins involved in membrane 
budding and other primary envelope proteins, would be released into the ONM and 
will diffuse into the ER, as it is continuous with the ONM. (2) To achieve the detection 
of host proteins that might be assisting viral fusion events during nuclear egress, 
microsomal membranes (MMs) and NEs from mock and HSV-1 infected cells were 
isolated to compare the relative distribution of associated proteins between the two 
fractions. 
If successful, this study will provide novel insights into herpesvirus life cycle, 
revealing proteins mediating herpesvirus egress at the NE that could be potentially 
targeted therapeutically. Furthermore, elucidating the protein composition of primary 
envelope particles will provide new insights into HSV-1 biology. 
The second purpose of this research is to continue the study started in my 
supervisor´s lab regarding the role of NET23/STING within the NE. NET23/STING 
was firstly identified in my lab as a NE integral membrane protein. Since then, 
different studies have linked this protein with an IIR function in the ER and 
mitochondria; however, whether this protein harbours a role within the NE was 
completely ignored.  
In a screen performed in our lab for NETs that promote chromatin compaction, 
NET23/STING was found to have a very strong effect indicating a potential novel 
nuclear function for this protein in IIR within the NE. Furthermore, the identification 
of NET23/STING NE-binding partners linked with a chromatin/chromosome 
organisation and IIR functions, supported the potential involvement of this protein in 
chromatin regulation and IIR signalling events within the NE.  
Our main hypothesis was that NET23/STING might have a separate role within the 
NE. To investigate some of these aspects, I used different approaches such as 
FRAP to study if the translocation of NET23/STING was being affected upon IIR 
within the NE. This will indicate a potential nucleocytoplasmic transport role of this 
protein. In addition, some NET23/STING NE-binding partners identified by co-IP 
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were observed by immunofluorescence staining to analyse if after NET23/STING 
depletion their redistribution fails to occur in IIR induced cells. This study allowed 































2.1.1. Bacterial strains and genotypes 
 
DH5alpha  
F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG Φ80dlacZΔM15 
Δ(lacZYA-argF) U169 hsdR17(rK- mK+) λ– 
StrataClone SoloPack 
F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG Φ80dlacZΔM15 
Δ(lacZYA-argF) U169 hsdR17(rK- mK+) λ–. (Stratagene, 240207) 
 
2.1.2. Buffers and solutions 
 
Table 5. Composition of Buffers used in this study. 
Name Composition 
LB 1% tryptone; 0.5% yeast extract; 10mM NaCl; pH7.4 
PBS 65mM Na2PO4; 8.8mM KH2PO4; 137mM NaCl; 2.7mM KCl; 
pH7.4 
TAE 40mM Tris-acetate; 1mM EDTA 
SDS PAGE buffer 25 mM Tris; 192 mM glycine; 0.1% SDS; pH 8.3 
Transfer buffer 80% SDS-page buffer; 20% methanol 
Denaturation buffer 
(FISH) 





50% formamide, 2xSSC, 1%Tween20,10% Dextran Sulphate 
SSC 20x 300mM Sodium Citrate pH 7.2, 3M NaCl 
ImmunoFISH blocking 
buffer 
2% BSA, 2xSSC 
FISH wash buffer 1 0.1% Tween20, 2X SSC 
FISH wash buffer 2 0.1% Tween20, 0.1X SSC 
Opti-MEM Opti-MEM® I Reduced Serum Medium (Gibco, 31985062) 
Hypotonic lysis buffer 10 mM HEPES pH 7.4, 1.5 mM MgCl2, 10 mM KCl, 2 mM 
DTT 
SHKM 50 mM HEPES pH 7.4, 25 mM KCl, 5 mM MgCl2, 1 mM DTT 
and 1.8M sucrose 
GMEM GMEM, Invitrogen, UK (51492C) 
DMEM Dulbecco's Modified Eagle's Medium (Lonza, 12-604F) 
 
 
2.1.3. Primary antibodies  
 
Table 6. Primary antibodies used in this study 





NET5 Rabbit 1:250 N/A Millipore (06-1013) 
α-tubulin Mouse 1:1000 N/A Sigma 
Tmem38A Rabbit 1:250 N/A Millipore (06-1005) 
Tmem214 Rabbit 1:250 N/A Proteintech (20125-1-A) 
WFS1 Rabbit 1:250 N/A Proteintech (11558-1-AP) 
Lamin A/C Rabbit 1:250 N/A (Schirmer et al, 2001) 
Emerin Rabbit 1:250 N/A Dr Glenn Morris 
Calnexin Rabbit 1:100 N/A Stressgen, SPA-860 
Rab11b Rabbit 1:100 N/A NBP2-15085 
Rab18 Rabbit 1:100 N/A IHC-plus TM LS-B9430 
VAPB Mouse N/A 1:400 ProteinTech 
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VAPB Rabbit 1:1000 N/A Dr Christopher C.J. Miller 
Rab24 Rabbit 1:200 N/A BD bioscience 
Rab1A Rabbit 1:200 N/A Santa Cruz Biotechnology 
Nup153 Rabbit N/A 1:200 Covance 
Nup358 Rabbit N/A 1:200 Dr. F. Melchior 
NET23/Tmem173 Rabbit 1:400 N/A ProteinTech 
gD Mouse 1:500 1:200 Abcam (ab41197) 
GM-130 Rabbit 1:1000 N/A Abcam (EP892Y) 
ICP27 Mouse 1:2,000 N/A Virusys Corp 
GADPH Rabbit 1:500 N/A E1C604-1 
US3 Rabbit 1:500 N/A Dr Thomas Mettenleiter and Dr 
Barbara Klup 
UL34 Rabbit 1:1000 1:500 Dr Richard Roller 
SUN1 Rabbit 1:100 1:200 HPA 008346 
H3K9me3 Rabbit 1:200 N/A Upstate (07-523) 
 
 
2.1.4. Secondary antibodies 
 
Table 7 summarised all the antigen targets, sources, and dilutions of secondary 
antibodies used in this study. Secondary antibodies used for immunofluorescence 
(IF) were raised in donkey against rabbit, mouse or chicken IgG and conjugated with 
a variety of Alexa Fluor® dyes (Molecular Probes, Invitrogen). By contrast, for ECL 
based Western blotting, horseradish peroxidase conjugated to highly cross-
absorbed goat anti-rabbit or anti-mouse antibodies were used. For fluorescence 
based Licor Western blotting, IRDye®-conjugated anti-mouse or anti-rabbit 










Table 7. Secondary antibodies used in this study 
Antibody Dye Application/Dilution Source 
Anti-mouse Alexa 568 IF 1:1000 Invitrogen (A11031) 
Anti-Rabbit Alexa 568 IF 1:1000 Invitrogen (A10042) 
Anti-chicken Alexa 488 IF 1:500 Invitrogen (A11039) 
Anti-chicken Alexa 568 IF 1:500 Invitrogen (A11041) 
Anti-mouse Alexa 647 IF 1:1000 Invitrogen (A31571) 
Anti-rabbit Alexa 647 IF 1:1000 Invitrogen (A31573) 
Anti-mouse Alexa 488 IF 1:1000 Invitrogen (A21202) 
Anti-rabbit Alexa 488 IF 1:1000 Invitrogen (A21206) 
Anti-mouse HRP WB 1:3000 Promega (W4021) 




IF 1:1000 Licor (926-32213) 
Anti-mouse IRDye® 
800CW 
IF 1:1000 Licor (926-32212) 
Anti-rabbit IRDye® 
680CW 
IF 1:1000 Licor (926-68073) 
Anti-mouse IRDye® 
680CW 
IF 1:1000 Licor (926-68070) 
 
 
2.1.5. Virus stocks 
 
The strain of wild-type HSV-1 used in this study was “herpes simplex virus type 2 
strain 17+ (HSV-1 17+ WT)”. HSV-1 strain expressing RFP fused to VP26 was kindly 
provided by Frazer Rixon, MRC Virology Unit, University of Glasgow, Glasgow, UK 
and it has been used previously used (Pasdeloup, Beilstein et al. 2010). The HSV-
1 strain vBSGFP27 expressing GFP fused to WT ICP27 under its own promoter was 
published in (Soliman, Sandri-Goldin et al. 1997). HSV-1 reporter virus expressing 
the enhanced green fluorescent protein (eGFP;HSV-1 strain C12) was used in one 
single experiment and it has been previously used (Griffiths, Koegl et al. 2013). 
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2.1.6. Lentiviral plasmids 
 
The lentiviral packaging plasmids psPAX2 and pMD2.G used to generate self-
inactivating lentiviral particles were a kind gift from Justina Cholewa-Waclaw (Adrian 
Bird Lab, Welcome Trust Centre for Cell Biology (WTCCB), Edinburgh) and were 
used as described previously with a variety of transfer plasmids (Zufferey, Dull et al. 
1998) 
 
2.1.7. Mammalian cells 
 
HeLa, HT1080, U2OS, BKH-21 cells were obtained from ATCC. 293FT cells were 
a gift from Justina Cholewa-Waclaw (Adrian Bird Lab, WTCCB, Edinburgh). These 
cells are derived from the 293FT fast growing clone of 293 embryonic kidney cells 
which have been made to stably express the SV40 large T antigen from the 
pCMVSPORT6TAg.neo plasmid.  
 
2.1.8. Commercial kits 
 
Table 8. Commercial Kits used in this study 
Kit Provider 
QIAprep Spin Miniprep Kit (27106) Qiagen 
QIAfilter Plasmid Midi Kit (12243) QIAquick Qiagen 
QIAquick Gel Extraction Kit (28704) Qiagen 
QIA DNeasy Blood&Tissue (69504) Qiagen 







2.2. Tissue culture methods 
 
2.2.1. Cell maintenance and counting of cells 
 
HeLa, HT1080, U20S and 293FT cells were grown in 1 X Growth Media (Dulbecco's 
modified Eagle's medium (DMEM) supplemented with 20% fetal calf serum (FBS), 
100 units/ml penicillin (Invitrogen, UK) and 100 μg/ml streptomycin (Invitrogen, UK) 
and passaged every 2 days in a 1:5 dilution by trypsinization. 293FT cells were 
treated with G418 final concentration 0.5 mg/ml to maintain drug selection.  
BHK-21 cells were maintained in Glasgow Modified Eagle’s Medium (GMEM, 
Invitrogen, UK), supplemented with 2 mM L-glutamine (Invitrogen, UK), 100 units/ml 
penicillin (Invitrogen, UK) and 100 μg/ml streptomycin (Invitrogen, UK), 10% (v/v) 
new born calf serum and 10% (v/v) tryptose phosphate broth (TPB, Invitrogen, UK). 
For quantification of the cell number, cells were 1:1 diluted (50 µl of cells were mixed 
with 50 µl 0.1% trypan blue (w/v)) or 1: 9 diluted (10 µl of cells were mixed with 90 
µl trypan blue) and the number of un-stained viable cells was counted using a 
haemocytometer under a microscope. The cell number was calculated by the 
following calculation:  
 
Cell number per ml= unstained cell count x the dilution factor ×10 
 
2.2.2. Transient plasmid transfection of Hela cells  
 
For the NETs screen, 50,000 Hela cells were plated onto 13 mm coverslips (VWR 
International) in 24-well plates the day before transfection. Cells were transfected 
with 0.5 µg of plasmid DNA in 50 µl of JetPRIME buffer using 1 ul of JetPRIME 
reagent (Polyplus transfection) per well as per manufacturer’s instructions. After 48 
h, cells were infected during 8 h with HSV-1 17+ WT strain, fixed in 4% 
paraformaldehyde (PFA) PBS for 10 min following a stringent wash in PBS and 
subsequently stained with 4,6-diamidino-2 phenylindole, dihydrochloride (DAPI). 
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Coverslips were extensively washed three times with PBS before mounting them in 
Vectashield (Vecta Labs). 
 
2.2.3. siRNA transient transfection in Hela and HT1080 
cells 
 
siRNA for Rab11b, Rab18, Rab1A and Rab24 were obtained from Dharmacon as 
SmartPools. siRNA for VAPB was ordered from SIGMA and it was used previously 
(De Vos, Morotz et al. 2012), sequence 5´ GCUCUUGGCUCUGGUGGUU 3´. The 
control siRNA was a random scrambled sequence (sense strand: 5’-
CGUACGCGGAAUACUUCGA-3’; antisense strand 5’-
UCGAAGUAUUCCGCGUACG-3’) which lacks homology to the human or mouse 
exome.  
 
Table 9. siRNA used in this study 
siRNA Product / Company 
Rab11B L-004727-00-0005 (Dharmacon) 
NET23 SIGMA 
Rab1A L-008283-00-0005 (Dharmacon) 
Rab24 L-010824-00-0005 (Dharmacon) 




55,000 Hela cells were plated in 12 well plates the day before the assay. 50 µM of 
each siRNA was transfected using 100 µl JetPRIME buffer and 3 µl of Jetprime 
reagent following manufacture´s introductions. At 48 h after transfection, the total 
final protein was extracted for Western blot analysis or cells were infected with HSV-
1 17+ WT virus strain for the described experiments.  
siRNA for NET23/STING was obtained from SIGMA. 1.5 x 106 HT1080 cells were 
plated in 6 well plates the day before transfection. In this case 100 µM of siRNA was 
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transfected using 200 µl JetPRIME buffer and 4 µl of Jetprime reagent for Western 
blot analysis or immunofluorescence experiments.    
 
2.2.4. Establishment of STING/NET23-GFP stable cell line 
 
To generate the inducible stable NET23/STING expressing cell line, lentiviruses 
encoding a doxycycline inducible NET23/STING fused to GFP at the C-terminus 
were prepared and transduced onto HT1080 cells. Transduced cells were selected 
with geneticin at 500 mg/ml. Inducible stable lines were induced with 1µg/ml 
doxycycline during 48 h. 
Non-replicating lentiviruses carrying the NET23/STING-GFP construct were 
generated in 293FT cells by joint transfection of the pMD2.G plasmid, expressing 
the vesicular stomatitis virus glycoprotein (VSV-G) coat protein, the psPAX2 
plasmid, expressing the viral proteins required to package, reverse transcribe and 
integrate the viral genome, and the transfer plasmid, containing the expression 
construct of interest, NET23/STING-GFP. Transfections were performed using 
lipofectamine 2000. Briefly, for the viral preparation, 4.6 µg psPAX2, 2.8 µg pMD2.G 
and 7.5 µg of the construct-specific transfer vector were mixed in 1.5 ml Opti-mEM. 
36 μl lipofectamine 2000 was then added to an additional 1.5 ml Opti-mEM in a 
separate tube. Both DNA and lipofectamine containing solutions were mixed briefly 
by vortexing and then left at room temperature for 5 min. Following this incubation, 
DNA-containing Opti-mEM and Lipofectamine 2000-containing Opti-mEM were 
combined, mixed briefly by vortexing and incubated at room temperature for 20 min. 
During this time, 6 million 293FT cells - approximately one confluent 8.5 cm diameter 
plate – were trypsinised, pelleted, resuspended in 6 ml 1X Growth Medium and 
plated onto a fresh 8.5 cm diameter plate. Following the incubation, DNA-
lipofectamine mixtures of Opti-MEM were added to the freshly plated 293FT cells. 
After 16 h 293FT media was replaced very gently with 10 ml 2X Growth Medium7. 
48 h later the virus containing supernatant was aspirated, cleared of cellular debris 
by centrifugation for 10 min at 3,500 rpm and further clarified by filtration through a 
0.45 μm2 low protein binding PES syringe filter (Millipore, SLHP003RS). The 
clarified supernatant was then loaded into a 30 ml Oak Ridge round bottomed tube, 
67 
 
topped up with PBS if necessary to adjust the total tube volume to 25 ml and spun 
at 55,000 x g for 75 min at 4ºC. Lentiviral particles appeared as a small semi-
transparent pellet on the side of the tube. The supernatant was then aspirated and 
the lentiviral particle pellet resuspended in the centrifuge tube by the addition of the 
desired volume of Opti-MEM or the required culture media followed by gentle 
shaking for 10 min at room temperature. If not used immediately aliquots were 
frozen at -80°C. Transduction was performed in a 6 well culture plates with 1 million 
HT1080 cells in the presence of 10 μg/ml protoamine sulphate (Sigma) for 16 h. 
 
2.2.4. Innate Immune Response Induction  
 
For FRAP experiments, a HT1080 cell line stably transfected with a doxycycline-
inducible NET23/STING construct was first induced 48 h prior to IIR induction with 
1µg/ml doxycycline. For immunofluorescence microscope experiments, HT1080 
cells were plated and transfected with either siRNA control or NET23/STING siRNA 
as previously described. 
IIR was induced by HSV-1 infection, poly I:C and plasmid DNA. Viral infection was 
performed with a MOI of 10 using HSV-1 17+ WT. Subsequently medium was added 
and the cells were incubated for additional 2 h before cell fixation for antibody 
staining or FRAP imaging. 
HT1080 cells were transfected either with 20 µg/ml polyI:C or 5µg pcDNA3.1 using 












2.3. Virology methods 
 
2.3.1. Preparation of virus stocks 
 
Stocks of HSV-1 were generated in BHK-21 cells. 1.5 x 106 cells were plated in a 
60 mm plate. The next day cells were infected with HSV-1 at a multiplicity of infection 
(MOI) of 0.001. Virus was adsorbed onto cells for 1h and incubated at 37 °C during 
2 or 3 days until medium turned yellow and there was extensive cytopathic effect 
(cpe) (Figure 12). CPE produced by HSV-1 infection could be recognised due to 
morphological changes in the infected cells that become rounded and detach from 
the monolayer. 
The cells were dislodged by scraping or gently tapping the plate and sonicated in a 
sonibath for 20-30 sec, centrifuged in 5,000 ×g at 4°C for 12 min and then the 
supernatant was transferred to 0.5 ml tubes. Samples were aliquoted, and stored at 






Figure 12. Cytopathic effect produced by HSV-1 infection in BHK21 cells. (A) mock 
BHK21 cells (B) BGK21 cells infected with MOI 0.01 during 3 days. CPE could be 
observed as cells become rounded and they are detached from the monolayer.   
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2.3.2. Titration of virus 
 
Plaque assays were used to measure the concentration of virus in a sample i.e. 
virus titre. Cellular culture supernatant was harvested after 16 hpi.  The samples 
were frozen at -80°C, thawed, and sonicated 3 times for 30 s each on a Branson 
450 sonifier at 40% of maximum output level and constant duty cycle. 2x105 U2OS 
cells were plated in 12 well plates the day before the infection. On the day of the 
assay, 10-fold serial dilutions usually (10-1 to 10-6) were made from these viral 
supernatants and 100μl of each dilution for each viral prep was added to duplicate 
wells and incubated on confluent U2OS cells for 1h at 37°C.  After 1h the virus was 
aspirated, cells were wash three times in PBS and overlaid with a 1:1 mixture of 1% 
(wt/vol) avicel (RC-591 NF) in sterile water–FBS-DMEM. The overlaid samples were 
cultured for 3 days before the avicel/medium overlay was removed. The cells then 
were fixed with methanol and stained with crystal violet solution (2% [wt/vol] crystal 
violet in 40% [vol/vol] methanol) in order to quantify viral plaque formation. Viral 
plaques were clearly observed under the microscope (Figure 13), counted and virus 
titre was calculated as plaque forming units (pfu/ml).  
 





Figure 13. Example image of viral plaques stained with crystal violet. Image of viral 
plaques produced by HSV-1 after three days of infection on a monolayer of Hela cells. Viral 
plaques were counted to calculate viral titres.  
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2.3.3. Infection of cells   
 
Once the titre of a given viral stock was known, the amount of virus from a viral stock 
with a desired MOI was calculated. The MOI corresponds to the number of PFUs 
delivered per cell. To infect cells, viral inoculum was prepared by mixing the required 
amount of viral stock with 3% serum supplemented media. Cells were incubated 
with the viral inoculum for an absorption period of 1 h at 5% CO2 atmosphere, 37°C. 
After 1h of adsorption either normal growth media was added without removing 
inoculum or monolayers were washed three times with PBS and replenished with 
normal growth media. Time zero (T0) or zero h post infection (0 hpi) corresponds to 
the end of the viral adsorption period. For mock infections the same medium used 
for preparation of viral inoculum was used only with no virus added.  
 
2.3.4. Rescue experiment 
 
Hela cells expressing the rescue constructs were plated in 12 well plates and 
transfected the next day with 50 nM of Rab1A, VAPB or Rab11b siRNA; 0.5 μg of 
pCDNA3.1 and 0.5 μg pCDNA3.1-GFP plasmid to check the efficiency of the 
transfection. After 48 h, cells were infected with HSV-1 WT at MOI 10. After 16 hpi, 
supernatants were collected for plaque assays. 
 
2.3.5. Viral growth kinetics in NET29 knockdown Hela cells 
 
100,000 Hela cells were plate in 24 well plates the day before transfection. Cells 
were transfected with either 20 µM of NET29 siRNA or control siRNA using 
Lipofectamine (2000) following manufacturer instructions. After two days 
postransfection, Hela cells were infected with eGFP; HSV-1 strain C12 during 1 h 
at 37ºC. After 1 h, cells were extensively washed with PBS and fresh medium was 
added to monitor virus growth kinetics as a measure of GFP-fluorescence. 
Replication was monitored at the indicated times post-infection using the POLAR- 
star OPTIMA plate reader (BMG Labtech).   
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2.4. Nucleic acid methods 
 
2.4.1. Plasmid construction 
 
NETs expression plasmids used in the screen were cloned from IMAGE collection 
cDNAs as previously described (Schirmer, Florens et al. 2003, Malik, Korfali et al. 
2010). NETs were fused to monomeric red fluorescent protein (mRFP) or to 
enhanced green fluorescent protein (EGFP) either at their C-terminus or N-terminus. 
All those used in the screen were under regulation of the CMV promoter.  
NET23/STING was additionally cloned into both the pEGFP-N2 and pEGFP-C2 
vectors for C- and N-terminal GFP fusions. The pEGFP-N2 fusion was further 
subcloned into pLVX- TRE3G using NheI and NotI as restriction sites for subsequent 
generation of lentiviruses for transduction to make stable inducible cell lines.  
 
2.4.2. Cloning of VAPB, RAB11b and Rab1A 
 
This experiment was performed by Andrew Stevensons at the University of 
Glasgow.   
Primers for PCR amplifying VAPB, RAB11B and RAB1A were designed for in 
Fusion cloning (Clontech) into pCDNA3.1 using the following software: 
(http://www.clontech.com/US/Products/Cloning_and_Competent_Cells/Cloning_R
es ources/Online_In-Fusion_Tools). The primers were designed to retain the EcoRI 
and BamHI sites in the multiple cloning site of pCDNA3.1. For initial cloning of 
VAPB, RAB11B and RAB1A PCR was carried out using the appropriate primer set 
(Eurofins) and CloneAmp HiFi PCR Premix (Clontech). The template was cDNA that 
had been synthesized (Maxima kit with dsDNAse -Thermofisher) from RNA that had 
been extracted from differentiated NIKS16 cells. PCR products were treated with 
cloning enhancer (Clontech) and mixed with pCDNA3.1 (which had been previously 
digested with EcoRI and BamHI (NEB) to linearize the vector) and cloned using the 
In-Fusion HD Cloning Kit (Clontech). Reactions were transformed into E. coli Stellar 
Competent Cells and selected on 100 μg/ml Ampicillin (Sigma). Plasmid DNA was 
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prepared (Qiagen QIAprep Spin Miniprep Kit) and plasmids digested EcoRI and 
BamHI to confirm insert. Clones were then verified by DNA sequencing (Eurofins). 
 
2.4.3. Mutagenesis of VAPB 
 
This experiment was performed with the assistance of Andrew Stevensons at the 
University of Glasgow. For site directed mutagenesis of VAPB ((DNA sequence 
CTTGGCTCTGGTGGTT change to GTTTGCACTTGTCGTG) an inverse PCR was 
carried out on pCDNA3.1VAPB using primer set VAPB SDMfw1 and VAPBSDMrv1 
with CloneAmp HiFi PCR Premix (Clontech). The PCR product was treated with 
cloning enhancer (Clontech) and the In-Fusion HD Cloning Kit (Clontech). Reactions 
were transformed into E. coli Stellar Competent Cells and selected on 100 μg/ml 
Ampicillin (Sigma). Plasmid DNA was prepared (Qiagen QIAprep Spin Mindiprep 
Kit) and the clone and mutation were verified by DNA sequencing (Eurofins). Note 
that mutagenesis was not required for Rab1A and Rab11b rescue constructs 
because their siRNAs targeted the 3' untranslated region. 
 
2.4.4. Sequencing of plasmid DNA 
 
The entire sequence of the cDNAs cloned into the expression vector was verified by 
sequencing. Sequencing was performed by the GenePool sequencing facility 
(University of Edinburgh). Provided chromatograms were analysed using the 
freeware program Gentle. 
 
2.4.5. Isolation of genomic DNA  
 
In order to isolate genomic DNA from HSV-1 infected Hela cells, the cells were 
trypsinised and centrifuged for 10 min at 200 X g. The supernatant was discarded 
and the pellet resuspended in 1ml of 1x PBS. After the pellet had been washed, 
DNA was isolated using the Qiagen DNeasy kit following the manufacter´s 
instructions. DNA was resuspended in 50µl of DNase/RNase free water. 
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2.4.6. qPCR  
 
Cells transfected with siRNA against Rab1a, Rab24, Rab11b, VAPB and Rab18 as 
described above were infected with HSV-1 WT at an MOI of 10. Supernatants or 
pellets were collected at 16 hpi.  DNA was purified from scraped pellet using the 
DNeasy Blood&Tissue Kit from Qiagen according to the manufacturer´s 
instructions. Viral DNA presence was analyzed by qPCR (Applied Biosystem 7500) 
with TakyonTM Low Rox Probe MasterMix dTTP Blue (Eurogentec) using primers 
detecting gD HSV-1 sequence (Weidmann, Meyer-Konig et al. 2003) (Forward: 5’-
CGGCCGTGTGACACTATCG-3’, Reverse:5’- CTCGTAAAATGGCCCCTCC-3’, 
Probe: FAMCCATACCGACCACACCGACGAACC- TAMRA) and primer pair 
specific for GAPDH (Forward: 5’-CGCTCTCTGCTCCTCCTGTT-3’, Reverse:5’- 
CCATGGTGTCTGAGCGATGT-3’, Probe: 5’-CAAGCTTCCCGTTCTCAGCC-3’). 
qPCR was performed using as template the supernatant media collected from 
infected plates and boiled for 5 min at 95°C. Serial dilutions of known-titre HSV-1 
solution were used as a standard curve to extrapolate the genomes/ml in the 
samples. Dilutions series of known standards were analysed in each plate. Standard 
curve was created comparing the known copies/reaction value with the mean of the 
Crossing threshold value (Ct value). Trendline was extrapolated by software, used 
to interpolate the genomes/ml of the analysed sample and data were compared with 
the control. When DNA extracted from pellet was analysed, both sets of primers 
where used in order to assess the cellularity of the sample. Values were calculated 
with ΔΔCT analysis and data are expressed in relative genome copy compare to the 
control.  
PCR conditions were: 50°C for 2 minutes, 95°C for 2 minute, 45 cycles of 95°C for 







2.5. Protein methods  
 
  Protein Extraction and Western blotting  
 
Cell lysates were resuspended in 2X Loading sample buffer (1M Tris-HCl pH 6.8, 
10% SDS, Glycerol, β-mercaptoethanol, 1% Bromophonol blue) and separated on 
8-12% Tris-glycine-SDS. Subsequently the gels were transferred onto nitrocellulose 
membranes (Odyssey 926-31092) by means of semidry transfer (BIO-RAD). After 
transfer the membrane was blocked in blocking buffer (5% milk powder in TBS with 
0.05% Tween-20) for 60 min. Subsequently, the membrane was incubated with the 
primary antibody diluted in blocking buffer at the dilutions indicated in Table 6 for 60 
min at room temperature or overnight at 4°C. Six washes in TBS, 0.05% Tween-20 
were then followed by incubation with the secondary antibody conjugated to 
horseradish peroxidase (HRP) or an IRDye® for 60 min at room temperature. After 
6 washes in PBS, 0.05% Tween20, the membrane was incubated with the ECL 
reagent (Amersham) to allow the HRP to react with hydrogen peroxide and luminol 
to generate a fluorescent signal that was measured on an X-Ray film (CP-BU NEW, 
Agfa). Alternatively, for Li-Cor visualisation of blots, membranes IRdye®-conjugated 
antibodies were detected on a Li-Cor Odyssey Quantitative Fluorescence Imager. 
 
 Proteomics methods 
 
2.5.2.1. NE and MMs fractions extraction 
 
NEs and MMs were isolated using well-established procedures previously 
established and described in the lab (Korfali, Wilkie et al. 2010, Wilkie, Korfali et al. 
2011). In brief, nuclei were first isolated from HeLa cells by hypotonic lysis in 10 mM 
HEPES pH 7.4, 1.5 mM MgCl2, 10 mM KCl, 2 mM DTT and protease inhibitors (1 
μM PMSF, 1 μg/ml aprotinin, 1 μM pepstatin A and 10 μM leupeptin hemisulphate) 
using a ‘tight’ dounce homogenizer (Wheaton, clearance between 0.1 and 0.15 
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mm). Cells were allowed to swell for 5-10 min and then nuclei were released by 
dounce homogenization with 20 vigorous strokes. Next, 1/10 volume of 1 M KCl was 
added to prevent nuclei themselves from lysing.  
Nuclei were then pelleted at 1,000 x g in a swinging bucket rotor (e.g. 4,000 rpm in 
a Beckman Coulter J6-MC floor model centrifuge) for 20 min at 4°C to separate 
them from small vesicles and mitochondria that require higher speeds to pellet. To 
float/remove contaminating membranes, nuclei were resuspended in SHKM (50 mM 
HEPES pH 7.4, 25 mM KCl, 5 mM MgCl2, 1 mM DTT and 1.8 M sucrose) and 
pelleted through a 5 ml 2.1 M sucrose cushion in a SW28 swinging bucket rotor 
(Beckman) at 4°C for 2 h at 82,000 x g. NEs were then prepared from isolated nuclei 
by two rounds of digestion with DNase and RNase in 0.3 M sucrose, 10 mM HEPES 
pH7.4, 2 mM MgCl2, 0.5 mM CaCl2, 2 mM DTT for 20 min followed by layering onto 
the same buffer with 0.9 M sucrose and centrifugation at 6,000 x g for 10 min at 4°C. 
MMs were isolated following similar established procedures. In brief, after removing 
nuclei as for NE preparations, 0.5 mM EDTA was added to inhibit 
metalloproteinases and mitochondria and other debris from post-nuclear 
supernatants were also removed by pelleting at 10,000 x g for 15 min. The 
supernatant was made to 2 M sucrose with SHKM and then overlaid with 1.86 M 
and 0.25 M sucrose layers. This was then subjected to centrifugation in a SW28 
swinging bucket rotor (Beckman) at 4°C for 4 h at 57,000 x g to float MMs. The 
material between the 1.86 and 0.25 M layers was then diluted 4-fold with 0.25 M 
SHKM and pelleted at 152,000 x g in a type 45 Ti rotor (Beckman) for 1h. 
NEs were extracted with 0.1 N NaOH, 10 mM DTT and pelleted by centrifugation at 
150,000 x g for 30 min and washed 3X in sterile H2O.  MMs samples were washed 
in sterile H2O without NaOH extraction. Samples were used for mass spectrometry 
analysis. HSV-1 infected MMs pellets were prepared and used for EM imaging. 
 
2.5.2.2. Mass Spectrometry 
 
Mass spectrometry analysis was performed by our collaborators Selene K. Swanson 
and Laurence Florens. Membrane pellets were resuspended in 30 μl of 100 mM 
Tris-HCl pH 8.5, 8 M Urea, then brought to 5 mM Tris(2-Carboxylethyl)-Phosphine 
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Hydrochloride (TCEP) and incubated 30 min at room temperature. Next this was 
reduced and alkylated with 10 mM chloroacetamide (CAM; Sigma) and incubated in 
the dark for 30 min followed by addition of Endoproteinase Lys-C (Roche) at 0.1 
mg/ml and incubated 6 h at 37°C. The solution was diluted for 2 M Urea with 100 
mM Tris-HCL pH 8.5 and 2 mM CaCl2 and 0.1 mg/ml Trypsin added and incubated 
at 37°C overnight. Formic acid was then added to 5% to quench reactions and 
samples were centrifuged to remove large undigested material (Florens, Korfali et 
al. 2008). Samples were then individually analysed by Multidimensional Protein 
Identification Technology (MudPIT) (Washburn, Wolters et al. 2001, Florens and 
Washburn 2006). Peptide mixtures were pressureloaded onto 250 μm fused silica 
microcapillary columns packed first with 3 cm of 5-μm Strong Cation Exchange 
material (Luna; Phenomenex), followed by 1 cm of 5-μm C18 reverse phase (Aqua; 
Phenomenex). Loaded 250 μm columns were connected using a filtered union 
(UpChurch) to 100 μm fused-silica columns pulled to a 5 μm tip using a P 2000 CO2 
laser puller (Sutter Instruments) and packed with 9 cm of reverse phase material. 
The loaded microcapillary columns were placed in-line with a Quaternary Agilent 
1100 series HPLC using a 10-step chromatography run over 20 h using a flow rate 
of 200–300 nl/min. The application of a 2.5 kV distal voltage electrosprayed the 
eluting peptides directly into a LTQ linear ion trap mass spectrometer (Thermo 
Scientific) equipped with a custom-made nano-LC electrospray ionization source 
and full MS spectra were recorded on the peptides over a 400 to 1,600 m/z range, 
followed by five tandem mass (MS/MS) events sequentially generated in a data-
dependent manner on the first to fifth most intense ions selected from the full MS 
spectrum (at 35% collision energy). Dynamic exclusion was enabled for 120sec. 
RAW files were extracted into ms2 file format (McDonald, Tabb et al. 2004) using 
RawDistiller v. 1.0  (Zhang, Wen et al. 2011)  MS/MS spectra were queried for 
peptide sequence information using SEQUEST v.27 (rev.9) (Eng, McCormack et al. 
1994) against 55,691 human proteins (non-redundant NCBI 2014-02-04 release), 
plus 162 sequences from usual contaminants (e.g. human keratins…) and 77 NCBI 
RefSeq HSV1 proteins. To estimate false discovery rates, each non-redundant 
protein entry was randomized and added to the database bringing the total search 
space to 111,524 sequences. MS/MS spectra were searched without specifying 
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differential modifications, but +57 Da were added statically to cysteine residues to 
account for carboxamidomethylation. No enzyme specificity was imposed during 
searches, setting a mass tolerance of 3 amu for precursor ions and of ±0.5 amu for 
fragment ions. 
Results from different runs were compared using DTASelect and CONTRAST 
(Tabb, McDonald et al. 2002)with criterion of DeltCn ≥ 0.08, XCorr ≥ 1.8 for singly, 
2.5 for doubly-, and 3.5 for triply-charged spectra, and a maximum Sp rank of 10. 
Peptide hits from all analyses were merged to establish a master list of proteins 
(Appendix). Identifications mapping to shuffled peptides were used to estimate false 
discovery rates. Under these criteria the final FDRs at the protein and peptide levels 
were on average 0.72% and 0.24%, respectively.   
To estimate relative protein levels, distributed normalized spectral abundance 
factors (dNSAFs) were calculated for each non-redundant protein (Appendix), as 
described in (Rice 1997). The complete MudPIT mass spectrometry dataset (raw 
files, peak files, search files, as well as DTASelect result files) can be obtained from 
the MassIVE database via ftp://MSV000079886@massive.ucsd.edu with a 
password NSR7095. The ProteomeXchange accession number for this dataset is 
PXD004519. 
 
2.6. Microscopy methods 
 
 Indirect Immunofluorescence  
 
Adherent cells were grown on coverslips and washed in PBS to remove cellular 
debris and remaining serum prior to fixation with either 4% para-formaldehyde (PFA) 
1X PBS or methanol, for 10 min at room temperature. If cells were fixed in 4% PFA, 
they were then permeabilised for 6 min with 0.2% Triton-X-100 in PBS and then 
washed 3 times in PBS.  
Coverslips were blocked in 3% bovine serum albumin (BSA), 10% human serum 
and 10% FBS, 1X PBS for 45 min at RT and subsequently incubated with the 
appropriate primary antibody (dilutions listed in Table 6). Following 3 washes in 
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PBS, coverslips were incubated with goat secondary antibodies conjugated with 
Alexa Fluor® dyes (summarised in Table 7) and DAPI at a final concentration of 2 
μg/ml (1: 2,000). Coverslips were then extensively washed in PBS multiple times 
over the course of 15 min and then mounted on cover slips with VectaShield (Vector 
Labs) and used for microscopy.  
For indirect immunofluorescence, images were acquired on a Nikon TE-2000 
microscope using a 1.45 NA 100x objective, Sedat quad filter set, PIFOC Z-axis 
focus drive (Physik Instruments) and a CoolSnapHQ High Speed Monochrome CCD 
camera (Photometrics) run by Metamorph image acquisition software. For 
deconvolution analysis, Z-stacks were acquired at intervals of 0.2 μm from the 1 μm 
above to 1 μm below the imaged nucleus. For super resolution microscopy, cells 
were prepared and stained similarly except that images were taken using a Zeiss 
880 confocal microscope with Airyscan and prepared for figures using Photoshop 
8.0. 
 
 Fluorescence recovery after photobleaching (FRAP) 
 
All fluorescence recovery after photobleaching (FRAP) experiments for regular 
STING/NET23-GFP and NET55-GFP constructs were performed on a Leica SP5 
microscope equipped with an Argon laser using the 488 nm laser line and a 60x 
HCX PLAPO NA 1.4 oil objective. Temperature was maintained at 37°C in an 
environmental chamber (Life Imaging Services, Switzerland), cells were gassed 
using 5% CO2 in air using a gas mixer (Life Imaging Services). Stably transfected 
inducible STING/NET23-GFP or NET55-GFP HT1080 cells were grown on 25 mm 
round coverslips mounted in an Attofluor incubation chamber (Life Technologies) 
were first induced for expression of the fusion protein during 48h with doxycycline. 
Coverslips were clamped into the chamber with 2 ml of preheated (37°C), phenol-
free complete DMEM containing 25 mM Hepes-KOH. Five pre-bleach images were 
taken followed by bleaching an area in either the NE or ER for 1 s at full laser 
intensity. Subsequent images were taken in 2 phases. The first rapid phase 
consisted of 25 frames every 0.65secs to observe the rapid initial recovery. The 
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second slow phase consisted of 75 frames every 2 s. Image data was processed 
using Image-Pro Premier (Media Cybernetics Inc., MD, USA). Background and 
photobleach corrections were engaged using an algorithm written by David Kelly 
according to (Phair and Misteli 2001). A macro was written in VB.Net within Image 
Pro Premier whereby a region of interest (ROI) was applied to the bleach spot, 
background and non-bleached area of a nearby cell and corrected for movement 
automatically compared to the 5 pre-bleach images. If the imaged cell moved, the 
measured region of the bleached area was adapted manually in XY position for each 
frame. Recovery halftimes were calculated from normalized fluorescence values, 
while the immediate post-bleach value was set to 0% and the average of the ten last 
points of recovery curve to 100%.  
For FRAP experiments, images were acquired on a Leica SP5 microscope.  
TIF files were generated using Metamorph (Molecular Devices) or SP5 application 
suite (Leica) and exported into ImageProPlus at 12 bit for further analysis. Images 
were also directly imported into Adobe Photoshop CS6 for figure preparation, 
reducing them to 8 bit. To determine differences and compared datasets the 
Kolmogorov-Smirnov test (KS-test) was applied. 
 
 Electron Microscopy 
 
MMs pellets were washed in sterile H2O. VAPB, Rab18, Rab11b, Rab1A or Rab24 
was depleted as previously described. Samples were fixed with 2.5% 
glutaraldehyde and 1% osmium tetroxide, then dehydrated through a graded alcohol 
series and embedded in Epon 812 resin. Thin sections were cut and examined in a 
JEOL 1200 EX II electron microscope. 
To test the localization of viral particles in cells with knockdowns of vesicle 
fusion proteins, monolayer cultures of HeLa cells were seeded in a 60 mm dish and 
transfected with siRNAs against VFPs as above. 48 hours later cells were infected 
with HSV for 16 hpi at an MOI of 10, and subsequently fixed with 2.5% 
glutaraldehyde in 2% sucrose, 0.05M Cacodylate buffer, pH 7.2 overnight at 4°C. 
Cells were thoroughly washed with PBS, scraped and pelleted by centrifugation 
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followed by fixation with 1% osmium tetroxide (TAAB Labs, UK) and staining with 
2% aqueous uranyl acetate for 1 h at room temperature. Cells were then harvested 
into PBS and pelleted through 3% low gelling temp agarose (Geneflow) at 45°C. 
The agarose was set at 4°C and cell pellets were cut into ~1 mm cubes, which were 
dehydrated through a graded alcohol series (30-100%) and embedded in Epon 812 
resin (TAAB Labs, UK) followed by polymerization for 3 days at 65°C. Thin sections 
of 120 nm were cut with a UC6 ultramicrotome (Leica Microsystems, Germany) and 
examined with a JEOL 1200 EX II electron microscope and images were recorded 
on a Gatan Orius CCD camera. 
 
 Immunoelectron Microscopy 
 
This experiment was performed at the University of Durham by our collaborators 
Christine A. Richardson and Martin W. Goldberg. Immuno-EM was performed on 
mock Hela and HSV-1 infected Hela for 16 h using the Tokuyasu (1973) method 
(Tokuyasu 1973). Cells were fixed in situ with 2% paraformaldehyde, 0.2% 
glutaraldehyde in PHEM buffer (60 mM Pipes, 25 mM Hepes, 2 mM MgCl2, 10 mM 
EGTA, pH 6.9) for 1 h, washed with PHEM buffer, then scraped off the culture dish. 
They were pelleted at 200 X g for 2 min and resuspended 0.1% glycine in PBS, 
pelleted at 400 x g for 2 min, resuspended 0.1% glycine in PBS for 15 min, pelleted 
at 400 x g for 2 min, resuspended in 1% gelatin (Dr Oetker) at 37°C for 10 min, 
pelleted at 400 x g for 2 min, resuspended in 10% gelatin for 10 min at 37°C, then 
replaced on ice. Gelatin embedded pellets were cut into ~5 mm cubes and 
immersed in 15% PVP (polyvinylpyrrolidone 10K molecular weight, Sigma), 0.17 M 
sucrose in PBS overnight. Samples were mounted and frozen in liquid nitrogen then 
sectioned on a cryo-ultramicrotome (UC6 with FC6 cryo-attachment; Leica). 
Cryosections were thawed, and the gelatin melted at 37°C, washed in 0.1% bovine 
serum albumin (BSA, Sigma) in PBS, then 1% BSA in PBS for 3 min, followed by 
overnight incubation with undiluted primary antibody, washed in PBS, incubated with 
secondary anti– mouse antibody conjugated to 10 nm colloidal gold (BBI solutions). 
Grids were then washed in PBS, transferred to 1% glutaraldehyde in PBS (5 min), 
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washed in water, and embedded in 2% methyl cellulose containing 0.4% uranyl 
acetate (Agar Scientific). A Hitachi H7600 TEM was used at 100 kV.  
 
 Fluorescence in situ hybridization 
 
For FISH experiments HeLa cells were cultured on coverslips that were washed in 
PBS prior to fixation in 4% para-formaldehyde in 1X PBS for 10 min at room 
temperature. Cells were permeabilized for 6 min with 0.2% Triton-X-100 in PBS, 
followed by 3 washes in PBS.  
(Next steps were developed and performed by Dr Rafal Czapiewski). Cells were 
next pre-equilibrated in 2X SCC and treated with RNase A (100μg/ml) at 37ºC for 1 
h. Following washing in 2X SCC, cells were dehydrated with a 70%, 85% and 100% 
ethanol series. Coverslips were then air dried, heated to 70ºC and submerged into 
85ºC preheated 70% formamide, 2X SSC (pH 7.0) for 18 min. A second ethanol 
dehydration series was then performed using -20ºC 70% ethanol for the first step. 
Coverslips were air dried and 150-300 ng biotin-labelled probe was added in 
hybridization buffer (50% formamide, 2X SSC, 1% Tween20, 10% Dextran 
Sulphate) containing 6 μg human Cot1 DNA (Invitrogen) and sheared salmon sperm 
DNA and incubated at 37°C for 24 h in a humidified chamber. Probes were 
generated from a plasmid encoding HSV-1 gene ICP27 by end labelling. After 
incubation, the coverslips were washed four times for 5 min each in 4X SSC at 50ºC 
followed by four times for 5 min each in 0.1X SSC at 65ºC. Coverslips were then 
preequilibrated in 4X SSC, 0.1% Tween-20 and blocked with 4% BSA before 
incubating for 30 min at room temperature with Alexa Fluor®conjugated-Steptavidin 
antibodies and DAPI at 2 μg/ml. Coverslips were subsequently washed 3 times in 
4X SSC, 0.1% Tween-20 at 37ºC and mounted on slides in Vectashield (Vector 
Labs). Images from the midplane of the nucleus were acquired on a Nikon TE-2000 
microscope using a 1.45 NA 100x objective, Sedat quad filter set, and a 
CoolSnapHQ High Speed Monochrome CCD camera (Photometrics) run by 
Metamorph image acquisition software. Images were analysed using ImageJ, using 
the DAPI stained image as a mask to determine nuclear area and the total 
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fluorescence intensity in the nucleus and in the whole cell were determined for over 
100 cells for each condition.  
 
 Image quantification of chromatin compaction  
 
Chromatin compaction images were captured using Metamorph acquisition 
software with identical settings after identical staining and fixing conditions. At least 
50 nuclei were analysed per condition. To distinguish individual nuclei in a field, 
nuclei were either thresholded or manually identified and segmented with individual 
masks. Pixel intensities were extracted from raw 16-bit images in TIFF format as a 
numerical matrix in Image J 1.33, and subsequent analysis performed in R 
(http://www.R-project.org). Raw pixel intensities were normalized to the sum of total 
number of pixel intensities in each nucleus, to account for possible differences in 
overall intensity between nuclei, and localized peaks of higher signal, corresponding 
to denser chromatin, were identified by taking the 15th percentile of the normalized 
pixel signals as a lower threshold. The resulting signal peaks were then filtered so 
that peaks smaller than 20 pixels were discarded, and peaks closer than 3 pixels 
were joined together. Images taken with the microscope configuration described in 
the Immunofluorescence microscopy section above correspond to 1 pixel equalling 
0.0645 mm. The distribution of numbers and areas of each individual peaks were 
then calculated and compared between samples using Kolmogorov-Smirnov tests 
for statistical significance (developed by Dr de las Heras). 
 
 Image quantification of vesicle fusion proteins NE 
versus ER 
 
To validate NE translocation of vesicle fusion proteins, the relative pixel intensities 
in ER and NE were quantified compared to ER controls. Pixel intensity was 
measured at a point in the nuclear rim (based on DAPI staining) and at a point 
approximately 2 µm distant into the ER, and the NE/ER ratio was calculated. Four 
such measurements were taken from each cell for VAPB and the control calnexin 
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and 20 different cells were analysed. Tukey’s boxplots for the ratios (NE/ER) for 
each protein in each cell line are shown in (Figure 47) with highlighting the median 
(central line), two quartiles above and below (box) and third quartile (error bars). We 
compared each sample to each control (mock infected) with the null hypothesis that 




To detect enriched proteins in HSV-1 infected MMs, the ratio of HSV-1 infected MMs 
versus mock-infected MMs was calculated according to relative abundance 
determined by dNSAF values. To choose only proteins present in the NE before 
infection, the ratio of mock-infected NE versus mock-infected MMs was similarly 
calculated. Only proteins with a HSV-1 infected MMs: mock-infected MMs ratio 
higher than 1.3 and detected in the mock infected NE were selected. 
Gene ontology (GO) analysis was performed in Ensembl BioMart and biologically 
interesting categories were represented either as a piechart or shown as bar plots 
in %. Biologically interesting GO-terms and their corresponding child terms were 
retrieved from the mySQL database http://amigo.geneontology.org (Carbon, Ireland 
et al. 2009). We used the following GO terms: “vesicle-mediated transport” 
(GO:0016192) “nucleocytoplasmic transport” (GO:0006913), “membrane 
organization” (GO:0061024), “regulation of protein phosphorylation” (GO:0001932) 
plus the one indicated in each table. To plot MS data pie charts, the relative 
proportions of the various classes were calculated from the relative abundances of 
the genes identified from each GO category, and this was compared to a pie chart 









Novel roles for 
NET23/STING within 
the Nuclear Envelope 
 
3.1. Introduction  
 
In the last few years, recent proteomic studies have identified tissue-specific NETs 
involved in multiple specific biological and cellular processes. (Schirmer, Florens et 
al. 2003, Korfali, Wilkie et al. 2010, Wilkie, Korfali et al. 2011). Interestingly, several 
of these proteins are linked to human diseases such as neuropathy and dystrophies 
(Ognibene, Sabatelli et al. 1999) (Fidzianska, Toniolo et al. 1998).  
NETs have been also linked to the regulation of specific spatial genome organization 
within the nucleus (Gordon, Pope et al. 2015, Czapiewski, Robson et al. 2016). 
Heterochromatin is dynamically associated with the NE and recently it has become 
increasingly apparent that the genome follows a non-random organisation of 
chromatin (Lanctot, Cheutin et al. 2007, Zuleger, Kelly et al. 2011, Bickmore and 
van Steensel 2013). Moreover, enrichment of heterochromatin at the NE varies 
significantly between different cell types (Fawcett, Doxsey et al. 1981).  
It is conceivable that mutations affecting lamin A, emerin and other NETs binding 
directly or indirectly with chromatin results in defective interactions of the NE with 
heterochromatin, impairing its correct localization at the nuclear periphery 
(Ognibene, Sabatelli et al. 1999). Thus, it is likely that other NETs might mediate 
heterochromatin changes observed in these NE-linked diseases 
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As an example, Emery-Dreifuss muscular dystrophy (EDMD) is linked to mutations 
in emerin and it presents alterations in the organization of chromatin with respect to 
the nuclear periphery (Bione, Maestrini et al. 1994, Bonne, Di Barletta et al. 1999). 
These defects in chromatin distribution were also observed in a mouse model 
presenting NE-linked cardiomyopathy (Wang, Herron et al. 2006). In addition to 
these alterations, modifications in the distribution of epigenetic silencing marks 
leading to changes in gene expression have been linked with patients presenting 
NE diseases. Indeed, alterations in gene expression patterns were found in NE-
linked muscular dystrophy patients and in a mouse model for this disease (Melcon, 
Kozlov et al. 2006).  
Altered patterns of heterochromatin distribution have been identified in several NE-
linked diseases in which lamin A is mutated (Goldman, Shumaker et al. 2004, 
Columbaro, Capanni et al. 2005, Shumaker, Dechat et al. 2006, Lattanzi, 
Columbaro et al. 2007). These diseases are also linked to mutations in several 
NETs such as emerin and LBR.  
Interestingly, a proteomic screen ran by Korfali et al. in NEs isolated from 
leukocytes, identified a NET named IAG2 which showed a strong chromatin 
compaction phenotype (Korfali, Wilkie et al. 2010). Additionally, the lab ran a screen 
for NETs identified in liver for potential roles in promoting chromatin compaction; 
NET23/STING was observed to promote a very strong increase in the amount of 
chromatin compaction compared with other tested NETs (Malik, Zuleger et al. 2014). 
This observation indicated the possibility of a previously uncharacterized nuclear 
role for NET23/STING in general chromatin architecture.  
Multiple reports have linked NET23/STING with a role in IIR within the ER and 
mitochondria (Ishikawa and Barber 2008, Ishikawa, Ma et al. 2009, Chen, Sun et al. 
2011). This protein has been shown to be translocated from the ER to perinuclear 
vesicles in the presence of dsDNA (Ishikawa, Ma et al. 2009, Holm, Jensen et al. 
2012, Tanaka and Chen 2012). Whether this population of NET23/STING is 
functional at the NE remains unclear.  Despite the translocation of this protein into 
perinuclear vesicles after IIR activation, and its identification as a NET in a 
proteomics screen carried out in Schirmer’s lab a few years ago, its role at the NE 
has been largely neglected.  
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Recent experiments carried out in our lab have identified multiple NET23/STING 
NE-binding proteins that link this protein with IIR cascades. These observations, 
together with the potential role of NET23/STING in the regulation of the compacted 
state of chromatin, led us to hypothesize that NET23/STING might have a separate 
role within the NE.  
This chapter aimed to test the hypothesis of NET23/STING being involved in 
chromatin compaction events. Furthermore, I aimed to investigate the contribution 
of this protein to IIR signalling within the NE. 
 
3.2. NETs screen to identify proteins involved in 
chromatin compaction 
 
In order to identify NE proteins that might be involved in chromatin compaction, a 
screen of multiple proteins previously identified in a NE proteomic analysis was 
performed in my supervisor´s lab to analyse the ability of these proteins to induce 
chromatin compaction when exogenously expressed. This study identified 
NET23/STING as a strong promoter for chromatin compaction.  
Different NETs identified in proteomic studies in our lab were cloned as mRFP 
and/or HA tag fusions and transfected into stable Hela cells expressing H2B-GFP. 
Results showed little compacted chromatin in untransfected cells, as well as in most 
of the cells in which different NETs were transfected. However, expression of 
NET23/STING after 72 h post-transfection seemed to induce a high compaction of 
H2B-GFP labelled chromatin in NET23/STING transfected cells (Figure 14). The 
increase of density observed in this experiment suggested that overexpression of 




















Figure 14. NETs screening for alterations in chromatin compaction. (A) 72 h post-
transfection Hela cells stably expressing H2B-GFP did not show changes in the distribution 
of H2B (green) when emerin-RFP or NET51-mRFP are transiently expressed (upper panel). 
However, cells overexpressing NET23/STING-mRFP (lower panel) exhibited a dramatic 
alteration in chromatin compaction. (B)  Zoom images of chromatin in untransfected cells 
and cells overexpressing NET23. Scale bars 10 µm. Taken from Malik et al. 2014. 
Experiment performed by Nikolaj Zuleger and Vassiliki Lazou. 
 
 
Moreover, Nikolaj Zuleger observed an increased in the chromatin compaction 
levels in the DAPI staining of multiple cells overexpressing NET23/STING tagged 
with mRFP, but lacking the expression of H2B tagged with GFP. This experiment 
supported that the chromatin compaction phenotype observed in cells transfected 
with NET23/STING was not due to a potential artificial interaction with the GFP 
labelled H2B molecules. In this case, the compaction was visualized using DAPI to 
stain the DNA. These results indicated that the observed chromatin compaction 
indeed was produced by the expression of NET23/STING (Figure 15A). 
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Moreover, he confirmed that the NET23/STING chromatin compaction phenotype 
was not cell-type dependent as it could be observed in multiple cell lines (Figure 
15B). Interestingly, it is known that some of the cell lines tested in this experiment 
presented different visual levels of chromatin compaction. For instance, 
lymphocytes and mouse cells presented a higher level of chromatin compaction 
than the rest of the cell lines tested. Furthermore, NET23/STING is known to be 
highly expressed in these two cell lines. This observation raised the question 
whether there was a link between endogenous expression levels of NET23/STING 





Figure 15. The NET23/STING chromatin compaction effect is independent of H2B-
GFP construct or the epitope tag used and occurs in different cell types. (A) Chromatin 
compaction was observed at the nuclear periphery of cells transfected with NET23/STING-
mRFP but without the H2B-GFP transfected. The compaction was visualized using DAPI to 
stain the DNA. (B) Chromatin compaction was not cell dependent as it was observed in 
multiple cell lines not expressing H2B-GFP.  MRC5 primary human lung fibroblasts, 216 -/- 
lamin A knockout mouse embryonic fibroblasts, U2OS human osteocarcinoma cells, HepG2 
human liver cancer cells, HEK/293T human embryonic kidney cells, and NIH3T3 mouse 
fibroblasts. NIH3T3 showed higher levels of chromatin compaction. NET23/STING was 
shown in red and the DAPI staining for DNA in grey. Scale bars, 10 µm. Taken from Malik 
et al. 2014. Experiment performed by Nikolaj Zuleger.  
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3.3. NET23 expression correlates with levels of 
chromatin compaction in different cell types  
 
To be able to objectively measure the level of chromatin compaction observed in 
different cell lines, an algorithm was developed by Dr de las Heras to quantify this 
phenotype.  
HT1080 cells were used to set up this experiment as they present lower basal level 
of epigenetic silencing marks and chromatin compaction (Ohzeki, Bergmann et al. 
2012). DAPI was used to visualize nuclear DNA and imaging was done using an 
identical microscope and camera settings. High-density clusters were observed and 
multiple parameters such as number of clusters and size were calculated for these 
clusters (Figure 16, A). 
Generally, the presence of a higher number of clusters in the nuclei of certain cells 
indicates a more heterogeneous nucleus due to the presence of chromatin clusters 
distributed within it. On the other hand, the observation of less number of clusters 
represents a more uniform and homogenous nucleus. Larger number of smaller 
individual clusters of dense chromatin could be observed in the nuclei of 
NET23/STING transfected cells based on the intensity of the DAPI signal compared 
with untransfected cells (Figure 16, B). 
The algorithm used three basic parameters to detect chromatin compaction clusters. 
The main parameter was a signal threshold based on the DAPI staining to select 
pixels above a certain level with respect to the normalised DAPI pixel signal 
intensity. Minimum cluster size parameter was used to avoid the selection of 
spurious isolated specks and a merge parameter to control how close two separate 
clusters are before they are merged into one.  
Multiple thresholds assigned to these parameters were tested to confirm that the 
algorithm was able to distinguish between the two conditions; NET23/STING 
overexpression and untransfected cells (Figure 16, C). Some of the tested 
thresholds included values between 5 to 20% of the normalised pixel DAPI signals 
(pixel intensities were normalized to the sum of total number of pixel intensities in 
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each nucleus), and a huge range of merge and minimum cluster size parameters 
(Figure 16, C).  
Across the entire range of tested values, strong differences and confidence p-values 
could be observed for 15% DAPI signal intensity, 20-pixel minimum cluster size and 
3 connecting pixels required for merging. Thus, to localize higher intensity peaks 
corresponding to denser chromatin regions, the 15% DAPI signal intensity of the 
normalised pixel signal was assigned as the lower threshold. Pixel peaks smaller 
than 20 pixels were discarded and those peaks that were closer than 3 pixels were 





Figure 16. Different parameters tested to validate the algorithm used for measuring 
chromatin compaction. (A) Topographic representation of pixel intensities from DAPI 
images from NET23/STING transfected and untransfected cells obtained using identical 
microscope and camera settings. The presence of high intensity pixel clusters can be 
observed in NET23/STING transfected cells compared with only a small number of high 
intensity pixel clusters detected in untransfected cells. (B) Colour representation of each 
high intensity pixel cluster for a particular plane in the cells shown in A. This indicates how 
accurately the algorithm distinguishes individual cluster in different planes. (C) Multiple 
thresholds assigned to different parameters to distinguish between untransfected and 
NET23/STING transfected cells. Pixel intensity cutoffs were tested from 5% to 20% total 
DAPI pixel intensity of the normalised pixel signal. Additionally, the number of pixels 
connecting clusters before merging them (m) and the minimum cluster size in pixels (s) 
were varied. This experiment confirmed that the algorithm is robust as significant 
differences for mostly all parameters tested were observed between untransfected and 




To further test that the method was able to distinguish the chromatin clusters 
observed by microscopy, NET23/STING was overexpressed in HT1080 cells, and 
among other parameters, the distribution of the number of chromatin clusters in 
DAPI images was analysed and compared with images from control cells (Figure 
17, A). The differences in the number of chromatin clusters between the two 
conditions could be clearly observed (Figure 17, B). Size of these chromatin clusters 
also showed a significance difference between control and cells overexpressing 
NET23/STING (Figure 17, C). In summary, cells overexpressing NET23/STING 
presented a higher number of clusters with smaller size compared with smaller 
numbers of clusters with a bigger individual area observed in control cells. 
The chromatin compaction induced by NET23/STING could be due to a decrease 
in the nuclear area of the cells that were analysed. Thus, to be sure that the 
observed differences in chromatin compaction were produced by the presence of 
NET23/STING and they were not an artefact, the nuclear size was calculated 
showing no differences between the NET23/STING-transfected and control cells. 
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Indeed, no differences in nuclear area were observed between cells overexpressing 

































Figure 17. Characterization of the algorithm for measuring chromatin compaction. 
(A) Histogram representation showing the distribution of the number of clusters in 
untransfected and NET23/STING transfected cells following the final parameters chosen as 
referred above (B) Box plots showing the number of clusters presented in DAPI images 
from cells exogenously expressing NET23/STING and control cells. The distributions were 
compared using a Kolmogorov-Smirnov (KS) test. (C) Box plot showing the distribution of 
data representing cluster size. Red bars represent the median of the distribution. The 
median cluster size of cells expressing NET23/STING is significantly smaller compared with 
control cells indicating a higher degree of chromatin compaction. (D) Nuclear size was also 
quantified for the cells analysed showing no changes between control and NET23/STING 
transfected cells. More than 100 cells were analysed per condition. Taken from Malik et al. 
2014. (All measurements performed by myself). 
 
To test the hypothesis that chromatin compaction differences observed in multiple 
cell types were due to the endogenous NET23/STING function, and to further test 
that the chromatin compaction phenotype reflects the function of the endogenous 
NET23/STING rather than being an overexpression artefact, I measured the protein 
levels of NET23/STING and the degree of chromatin compaction based on the DAPI 
staining in a variety of cell lines.   
NET23/STING endogenous levels were quantified by Western blot in five different 
immortalised cancer cell lines: HT1080, fibrosarcoma cells; Jurkat, human 
immortalized T-lymphocytes; EL4, mouse lymphoma cells; LNCaP, human prostate 
adenocarcinoma cells; and HEK293, human embryonic kidney cells. The levels of 
NET23/STING were normalised against alpha-tubulin levels (Figure 18, A). Results 
indicate that there is a clear correlation between endogenous levels of 
NET23/STING and number of clusters measured in each cell type using the cluster 
algorithm as a readout for chromatin compaction. Jurkat cells as well as EL4 cells 
presented high NET23/STING endogenous levels (22,000 and 14,000 arbitrary 
protein units respectively) correlating with a high number of clusters measured (5 
and 4 respectively) (Figure 18, B, C).  
Significant p-values showed the correlation between the higher level of chromatin 
condensation and the increase of NET23/STING endogenous levels (Figure 18, D).  
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Also, the nuclear size measurement of each cell line indicated similar values 
between all of them, arguing that the differences observed in chromatin compaction 
are not being affected by changes in the size of the nucleus (Figure 18, E).  
Therefore, these results, together with the previous data, indicated that higher levels 








Figure 18. NET23/STING endogenous levels correlates with the degree of chromatin 
compaction in different observed cell lines. (A) Western blot comparing endogenous 
expression levels of NET23/STING in five different cell lines using α-tubulin as a loading 
control. Jurkat cells presented the highest levels of endogenous NET23/STING expression. 
(B) NET23/STING quantification from 3 independent blots. Protein expression values are 
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represented as arbitrary protein units and are normalised for α-tubulin. (C) Using the 
algorithm described above, the number of clusters was measured in these five cell lines. 
Values are represented in box plots and the black bar represents the median of the number 
of clusters of each cell line. Results reveal a general trend that cells presenting a higher 
number of clusters have higher endogenous expression levels of NET23/STING. (D) Table 
showing the p-values (calculated using KS test) for all possible combinations from data 
represented in panel C. (E) Nuclear size measurements of each cell line showing no 
significant differences. P-values were calculated using the KS test and all of them were > 
0.05 with the exception of HT1080 and EL-4 (p=0.039) and HT1080 and Jurkat cells 
(p=0.003). Taken from Malik et al. 2014. (All measurements performed by myself).  
 
To determine if the relationship between NET23/STING expression levels and 
chromatin compaction also pertains to primary cells (all cells tested in Figure 18 
above were immortalised cancer lines), I analysed several primary human cells. 
Similarly, the amount of endogenous NET23/STING levels was quantified by 
Western blot in three primary cell lines presenting similar nuclear size; MRC5 lung 
fibroblasts, BJ foreskin fibroblasts, and AG dermal fibroblasts and the number of 
clusters representing chromatin compaction was measured (Figure 19). 
This data showed a rough correlation between the degree of chromatin compaction 
measured using the cluster algorithm on DAPI-stained chromatin, and the 
endogenous levels of NET23/STING expressed in these three primary cell lines. 
MRC5 lung fibroblasts presented the smallest NET23/STING expression levels 
compared with AG and BJ cell lines, correlating with the smallest number of clusters 
among the three cell lines. Thus, NET23/STING appears to be playing a role in the 








Figure 19. Endogenous NET23/STING expression correlates with chromatin 
compaction levels in three primary cell lines confirming the relationship between 
NET23/STING levels and the degree of chromatin compaction. (A) Western blot 
showing endogenous NET23/STING expression in three primary cell lines with α-tubulin as 
a loading control. BJ cells reveal the highest levels of NET23/STING protein expression (B) 
NET23/STING quantification from three independent blots. (C) Number of clusters from 
MRC5, AG and BJ cells quantified with the algorithm. A clear correlation between NET23 
expression and the number of chromatin clusters was observed. (D) P-values for comparing 
cluster number between the different primary cell lines. P-values were calculated with the 
KS test. (E) Nuclear size was quantified to exclude that this parameter could be affecting 
the quantification of chromatin compaction. Results show no notable difference in nuclear 
size among the three analysed primary cell lines. Taken from Malik et al. 2014. (All 






To test that the readout of the algorithm reflects the classically defined denser 
chromatin observed in some cell types by EM studies, EM was performed on wild 
type HT1080 cells and cells expressing NET23/STING to visualize chromatin 
compaction levels. To regulate the expression levels of NET23/STING and avoid 
the induction of apoptosis produced by transient transfection of NET23/STING in 
cells analysed by EM, I made an inducible stable cell line expressing NET23/STING-
GFP upon the addition of doxycycline.   
EM analyses enabled visualization of the degree of chromatin compaction as denser 
stained areas of the nucleus using osmium tetroxide. This analysis revealed that 
wild type HT1080 and uninduced NET23/STING stable cells (no doxycycline) 
presented similar levels of chromatin compaction observed by density staining in 
the nucleus. However, HT1080 cells in which NET23/STING was stably induced 
upon the addition of doxycycline presented a higher denser stained areas of 
chromatin in the nuclear periphery and also in the nuclear interior (Figure 20). This 




















Figure 20. Electron microscopy reveals an increase in chromatin compaction in 
NET23/STING overexpressing cells as measured by electron densities. The panel on 
the right shows EM images from HT1080 cells stably expressing NET23/STING upon the 
addition of doxycycline. They presented higher electron density staining areas in the 
nucleus using osmium tetroxide, suggesting higher degree of chromatin compaction. Panels 
on the left are the HT1080 parent cell line and the uninduced HT1080 stable cell line 
carrying the NET23/STING-GFP construct showing less electron dense staining in the 
nucleus. Scale bar 0.5 µm. Taken from Malik et al. 2014. (Experiment performed by myself 
with assistance from Alexander Makarov). 
 
3.5. NET23/STING alters levels of H3K9Me3 epigenetic 
mark 
 
Giving the involvement of NET23/STING in IIR and that immune signalling cascades 
are often accompanied by epigenetic modifications, the observed chromatin 
compaction induced by NET23/STING might be mediated by epigenetic silencing 
mechanisms.  
It is known that epigenetic marks such as histone acetylation and methylation 
regulate the expression of genes involved in inflammation and other innate immunity 
processes (De Santa, Totaro et al. 2007, De Santa, Narang et al. 2009). Multiple 
inflammatory genes suffer epigenetic modifications including DNA methylation and 
covalent histone modifications in order to regulate their expression. For example, 
Toll-like receptors (TLRs), that are key factors involved in the activation of the innate 
immunity via the recognition of pathogen-associated molecular patterns (PAMPs), 
activates signalling cascades leading to the modification of histones to regulate 
genes involved in innate immunity as NF-KB or IRF (Stender and Glass 2013). 
To test if NET23/STING could promote chromatin compaction by the modification of 
epigenetic marks, Dr Malik tested if there was a correlation between the histone 
mark H3K9me3 and the expression of NET23/STING by immunofluorescence. 
HT1080 cells were transfected with NET23/STING-mRFP plasmid and stained with 
specific antibodies to epigenetic marks at 21 and 85 h post-transfection. Antibodies 
were against H3K18ac, a standard histone mark for activation of gene expression, 
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and H3K9me3, a classical histone mark for repressing and silencing gene 
expression. At 21 h post-transfection no change in the H3K18ac mark was observed 
while there was a small increase in H3K9me3 (Figure 21, A, B).  
At 85 h post-transfection a strong decrease in acetylation at K18 along with another 
mark of active chromatin H3K4me2 was observed (Figure 21, C). The epigenetic 
mark H3K9me3 and S10 phosphorylation associated with polycomb repressed 
genes was also tested. This epigenetic mark is quite interesting as it adds a higher 
level of repression at polycomb marked genes. Polycomb proteins are involved in 
gene silencing through the regulation of histone methylation profiles of multiple 
genes involved in various cellular pathways (Sabbattini, Sjoberg et al. 2014). Cells 
expressing NET23/STING showed a reduction of this epigenetic mark indicating a 
loss of repression at polycomb marked genes (Figure 21, C).  
Thus, the expression of NET23/STING is associated with changes in epigenetic 
marks, specifically a general increase in H3K9me3 mark linked with silencing genes 
and a decrease in the active histone marks H3K18Ac and H3K4me3 associated with 
gene activation. Interestingly, some genes are being loosened from particularly 
strong repression (polycomb marked genes).  
This experiment was performed in transiently transfected cells in which the 
transfection of foreign DNA could induce IIR and complicate distinguishing a real 
effect produced by NET23/STING-induced chromatin compaction from downstream 






Figure 21. Epigenetic marks are associated with compacted chromatin induced by 
NET23/STING. Cells were transfected with NET23/STING-mRFP and stained for 
epigenetic marks H3K9me3, H3K9m2, and H3K18ac (A) H3K9me3 was slightly increased 
after 21 h post-transfection however no change was observed in the H3K18ac mark. (B) 
Chromatin compaction induced by NET23/STING at this early timepoint is observed in the 
nuclear periphery correlating with an increase in HSK9me3 (white arrows). Higher 
magnification image from panel A. (C) At 85 h post-transfection a decrease of H3K18ac and 
H3K4me2 was observed indicating a general loss of active marks. At the same time, a 
strong increase in H3K9me3 was observed consistent with an increase in silencing marks. 
However, the stronger repression mark H3K9me3 combined with S10ph was reduced in 
cells transfected with NET23/STING. Scale bars 10 µm. Taken from Malik et al,2014. 





To determine if the increase in H3K9me3 silencing mark observed by 
immunofluorescence reflects absolute levels of this mark or is limited by epitope 
accessibility issues in the fixed cells, I performed a Western blot analysis in control 
cells and cells overexpressing NET23/STING tagged with GFP under the addition 
to quantify the protein expression levels in H3K9me3. To avoid the potential 
problems of IIR activation that could be generated by the transient transfection of a 
DNA plasmid due to a cell response to foreign DNA, I performed this experiment 
using the previously mentioned stable doxycycline-inducible cell line expressing 
NET23/STING fused with GFP that I generated.   H3K9me3 levels were quantified 
by Western blot in lysates from this stable cell line and also, from the parent cell line 
with a NET23/STING knockdown and a control siRNA. Interestingly, protein levels 
of H3K9me3 were 4-fold increased in the stable cell lines overexpressing 
NET23/STING and slightly reduced in the siRNA NET23/STING parental line 
compared with the siRNA control (Figure 22). Thus, this indicates there is a general 
increase in the H3K9me3 repression mark associated with NET23/STING 









Figure 22. Levels of H3K9Me3 epigenetic mark correlates with NET23/STING protein 
expression. (A) HT1080 cells were transfected with either siRNA oligos for siRNA control 
or for NET23/STING for 3 days. Lysate cells were analysed by Western blot showing a 30% 
reduction of NET23 levels compared with initial levels. Values were normalized against α-
tubulin. (B) Cell lysates from HT1080 cells either treated with siRNA control or 
NET23/STING or the stably NET23/STING HT1080 cell line were analysed by western blot 
for H3K9me3 histone mark. Box plot representing H3K9me3 quantification from three 
independent blots with standard deviation. Staining and quantification revealed that 
H3K9me3 levels were increased by 4-fold in cells overexpressing NET23/STING upon the 
addition of doxycycline. However, H3K9me3 levels were slightly reduced when 
NET23/STING was depleted in HT1080 cells compared with siRNA control cells. Taken 
from Malik et al,.2014 Experiment performed by myself. 
 
3.6. Chromatin compaction is affected by 
NET23/STING depletion in HSV-1 infected cells 
 
As previously mentioned, different studies have identified NET23/STING as a critical 
signalling molecule in the innate response to many bacterial, viral and eukaryotic 
pathogens (Ishikawa and Barber 2008, Ishikawa, Ma et al. 2009, Chen, Sun et al. 
2011). 
Cells infected with HSV-1 undergo a variety of changes in nuclear architecture 
(Bosse, Hogue et al. 2015). Herpesviruses, as well as many other DNA viruses, 
disturb the spatial organization of the host cell chromatin due to the formation of 
viral DNA replication compartments (VRC), which are the sites of replication, 
transcription and encapsidation of HSV-1 genomes (Placek and Berger 2010, Conn 
and Schang 2013). Nuclei of infected cells start to be expanded at early times post-
infection during viral replication and host chromatin is marginalized to a thin intact 
layer at the nuclear boundary due to the expansion of the VRC. Drastic modification 
of the nucleolar morphology is also observed within the nucleus of infected cells. 
HSV-1 leads to a nucleoli increase in size that soon after infection localize close to 
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the NE and finally becomes fragmented into small pieces (Calle, Ugrinova et al. 
2008, Sagou, Uema et al. 2010).  
The host chromatin regulation of herpesvirus is a key regulatory step involving the 
suppression and the activation of different types of viral genes to ensure a 
successful viral infection. Immediately after infection, the genome of host cells 
exhibits an increase of repressive histone marks (H3K9me3) and a compacted 
heterochromatin as a rapid antiviral defence strategy (Conn and Schang 2013). The 
assembly of heterochromatin in a high compacted state limits the viral genome 
access for transcription and DNA viral replication and it appears as a cellular 
defence to infection. The increase of repressive histone signatures observed in the 
genome of host infected cells at early times post-infection initially suppresses the 
expression of the viral immediate early genes and the progression of the infection 
(Arbuckle and Kristie 2014). 
To test whether the chromatin compaction associated with the initial stages of viral 
infection depends on the function of NET23/STING, I depleted this protein in HSV-
1 infected cells to check if chromatin compaction fails to occur upon viral infection. 
To do so, HT1080 cells were treated with either siNET23/STING or scramble siRNA 
prior to HSV-1 infection. As previously reported, chromatin compaction was 
expected to increase at early times post-infection as a mechanism to avoid the 
access of binding factors and coactivators that ultimately activate viral gene 
expression. Unexpectedly, the levels of chromatin compaction in scramble siRNA 
infected cells were showing a reduction rather than an increase in the number of 
clusters measured by the cluster algorithm (Figure 23A). However, there was a clear 
difference in the amount of chromatin compaction observed in NET23/STING 
knockdown cells infected with HSV-1 for 2 hours. These cells showed the same 
level of chromatin compaction as non-infected cells (scramble and siNET23). This 
result suggested that the depletion of NET23/STING prevented the increase of the 
compaction state of chromatin that generally occurs at early stages upon HSV-1 
infection (Figure 23, A).  
It is important to mention, that the output of the algorithm might be affected by the 
differences observed in the nuclear size of infected and uninfected cells. As it is 
known that HSV-1 infection alters nuclear size, this parameter was analysed in the 
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same population of cells. Results showed a slightly difference in the nuclear size of 
infected and uninfected cells (Figure 23, B).  Although the observed change in 
nuclear size might alter the final output of the algorithm, there is a clear effect in 
HSV-1 infected cells no longer expressing NET23/STING, in which levels of 
chromatin compaction that normally occur upon infection are mitigated.  
Taken together these results and the alteration in the nuclear size observed 
between infected and non-infected cells, I can not unequivocally state that the 
changes in chromatin compaction observed in infected cells no longer expressing 
NET23/STING are an effect directly produced by NET23/STING. It also remains 
unclear why the number of clusters (used as a measure of chromatin compaction) 
were reduced in HSV-1 infected scramble siRNA control HT1080 cells. 
Observation of chromatin by EM in wild type HSV-1 infected cells will allow us to 
determine whether chromatin compaction is increased in these cells compared with 
infected cells no longer expressing NET23/STING. Although the effect of the virus 
appeared to be mitigated by NET23/STING knockdown, future experiments will 
need to support this observation. For instance, reduced viral titers in cells no longer 
expressing NET23/STING might confirm this hypothesis.  
It is important to point out that as I previously showed, the parental cell line HT1080 
presented low NET23/STING expression levels compared with other cell lines. 
Therefore, it is not surprising that the levels of chromatin compaction upon 
NET23/STING silencing in non-infected HT1080 cells were not showing large 




















Figure 23. Effect of NET23/STING on chromatin compaction in HSV1 infected cells. 
(A) HT1080 cells were transfected with either siRNA for control or NET23/STING during 3 
days. After this cells were infected with HSV-1 during 2h with a MOI 5 to induce the IIR. 
Cells were fixed and stained with DAPI to quantify chromatin compaction using the cluster 
algorithm previously described. P-values were calculated using the KS-test to compare the 
HSV-1 infected cells between the different NET23/sting conditions (B) Nuclear size was 
analysed in the same population of cells indicating a notable difference when cells were 
infected with HSV-1. More than 100 cells were analysed per condition. Taken from Malik et 









3.7. NET23/STING drives nucleo-cytoplasmatic 
shuttling of Syncrip and MEN1, potential innate 
immunity regulators 
 
We have shown that NET23/STING is a nuclear protein capable of mediating 
chromatin distribution patterns associated with histone mark changes. Although this 
protein was first discovered in a proteomic study for nuclear proteins by Dr Schirmer 
in his post-doctoral work at Gerace’s lab (Schirmer, Florens et al. 2003), different 
studies have shown the importance of NET23/STING in intracellular DNA-mediated 
and HSV-1-activated type I IFN production (Ishikawa and Barber 2011, Burdette and 
Vance 2013, Shu and Wang 2014). Additional studies have reported a role of 
NET23/STING in response to RNA, but its function is much less clear (Chen, Sun 
et al. 2011). All previous studies have ignored a potential additional or related NE 
role for NET23/STING in mediating the activation of IIR.    
As mentioned in chapter 1, the lab found a striking number of indirect relationships 
between NET23/STING-NE binding partners and the transcription factors IRF3/7. 
17 of these partners identified by co-IP interacted with six known IRF3/7 binding 
partners, some of which were RNA-binding partners among others, suggesting a 
highly redundant network by which NET23/STING could influence IIR signalling 
pathways. Additionally, NET23/STING was observed to be present in the INM in 
some cells and restricted to the INM in others, suggesting the potential redistribution 
of this protein into different nuclear locations under certain cell-specific conditions 
(refer to chapter 1, 1.4 for further details). 
We postulated that these NET23/STING-NE binding partners might be novel IIR 
mediators because of their indirect relationship with IRF3/7 transcription factors and 
as NET23/STING is found in both the ONM and INM, it might be able to carry these 
binding partners between the two compartments for a function in activating IRF3/7 
leading to type I-IFN production.  
Syncrip and MEN1 were two of the 17 NET23/STING NE-binding partners identified 
that have been reported to interact with six IRF3/7 binding partners we propose to 
effect IIR activation.  
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Syncrip (synaptotagmin-binding, cytoplasmic RNA-interacting protein) is a member 
of the cellular heterogeneous nuclear ribonucleoprotein (hnRNP) family, known for 
their ability to interact with cellular proteins and RNAs facilitating many biological 
processes such as mRNA processing mechanisms (Mizutani, Fukuda et al. 2000, 
Bannai, Fukatsu et al. 2004). Interestingly, in addition to cellular functions, Syncrip 
was shown to be involved in viral RNA synthesis (Choi, Mizutani et al. 2004). 
Different studies have observed an interaction between Syncrip and RNA from 
different viruses. Syncrip binds to Hepatitis C Virus (HCV) RNA (Liu, Aizaki et al. 
2009, Wang, Jeng et al. 2011) and to the Transmissible Gastroenteritis Coronavirus 
(TGEV) RNA, affecting the RNA replication of these viruses (Sola, Galan et al. 
2011). Additionally, Syncrip has been associated with the GO term for “cellular 
response to type II IFN”, linking this protein with downstream cascade signals. 
Despite the role of Syncrip in viral replication processes and its downstream activity, 
nobody has shown a specific mechanism of this protein within the activation of the 
IIR.  
On the other hand, MEN1 (Multiple endocrine neoplasia type 1) is a tumour 
suppressor gene that encodes a protein called menin. This protein contains two 
nuclear localization signals and localizes predominantly to the nucleus (Gracanin, 
Dreijerink et al. 2009) (Sato, Matsubara et al. 1998). Previous studies observed a 
direct interaction between MEN1 and JunD, an AP-1 transcription factor involved in 
the regulation of a range of cellular processes including cell proliferation, death and 
differentiation (Agarwal, Guru et al. 1999, Ikeo, Yumita et al. 2004). This interaction 
results in the inhibiting of JunD´s activation of transcription. Also, MEN1 was shown 
to interact with NF-кB and repress NF-кB mediated transactivation (Heppner, 
Bilimoria et al. 2001). 
To test if there was a NET23/STING-dependent redistribution of some of the 
identified NET23/STING-NE binding partners upon the induction of the IIR, and to 
test the potential involvement of NET23/STING in carrying IIR proteins between the 
nucleus and the cytoplasm, I analysed the redistribution pattern of Syncrip and 
MEN1 in cells treated with a control siRNA or NET23/STING siRNA.  
Silencing of NET23/STING was confirmed by Western blot analysis of protein 
lysates from HT1080 cells treated with siRNA against NET23/STING for three days. 
109 
 
NET23/STING levels were clearly reduced in siNET23/STING treated cells 
compared with control cells (Figure 24, A). 
HT1080 cells treated with NET23/STING siRNA or control siRNA were transfected 
with either plasmid DNA or poly I:C (synthetic RNA analogue to dsRNA) or infected 
with HSV-1 in order to induce the IIR.  
Once STING is activated by an external stimuli, TBK1 is recruited  producing the 
phosphorylation of IRF3 that results in its translocation into the nucleus for type I 
IFN production. IRF3 is a protein that has an active nuclear localization signal (NLS) 
which is recognized by importin-α receptors and transported to the nucleus through 
the NPC central channel (Kumar, McBride et al. 2000, Zhu, Fang et al. 2015).  
On the other hand, poly I:C, a mimetic form of dsRNA is recognized by RIG-I or 
MDA5, specific sensor for RNA. This recognition allows MAVS aggregation in the 
mitochondria leading to the phosphorylation of IRF3 by the activation of TBK1 
(Burdette and Vance 2013).  Thus, IRF3 staining was used as a control to confirm 
that IIR was activated. As expected, accumulation of IRF3 was observed in the 
nucleus of control siRNA cells treated with poly I:C or plasmid DNA confirming the 
activation of the IIR. (Figure 24, B left panels). Same effect was observed in HSV-1 
infected cells (Figure 26). It is important to mention that the phosphorylation of IRF3 
and its translocation into the nucleus might be promoted by some of the identified 
NE-NET23/STING binding partners rather than by TBK1, something that will need 




Figure 24. IRF3 translocates into the nucleus upon IIR activation by either poly I:C or DNA plasmid. 
(A) NET23/STING knockdown. HT1080 cells were transfected with siRNA for either control or 
NET23/STING. Protein lysates from control and NET23/STING depleted cells were analysed by western 
blot for NET23/STING and α-tubulin. (B) HT1080 cells were transfected with siRNA for either control or 
NET23/STING for 3 days. After this, the IIR was activated by either poly I:C (top panel) or DNA plasmid 
(bottom panel) during 2 h. IRF3 is being translocated into the nucleus in either control or NET23/STING 
depleted cells upon IIR induction by poly I:C. However, IRF3 fails to redistribute when the IIR is activated 
by DNA plasmid in cells no longer expressing NET23/STING. Scale bar= 10 µm 
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In siRNA control cells which the IIR was induced by either poly I:C or plasmid DNA, 
Syncrip and MEN1 proteins showed a clear redistribution from the nucleus to the 
cytoplasm (Figure 25, left panel) (Figure 26). However, in cells where NET23/STING 
was depleted, Syncrip and MEN1 redistribution failed to occur (Figure 25, right 
panel) (Figure 26). The amount of IRF3, Syncrip and MEN1 was quantified in the 
nucleus and in the cytoplasm of 100 siRNA control cells and 100 NET23/STING 
knocked down cells with and without the activation of the IIR by poly I:C, plasmid 
DNA or HSV-1 (Figure 26). Interestingly, when the IIR was induced by HSV-1 
infection, the directionality of Syncrip and MEN1 translocation in control cells is the 
opposite than the one observed with plasmid DNA or poly I:C, but again, the 
redistribution of Syncrip is mitigated when NET23/STING is knocked down while 
MEN1 seemed not be affected (Figure 26). 
This quantification confirmed the redistribution of MEN1 and Syncrip upon IIR 
activation by either poly I:C or plasmid DNA in the siRNA control (p-value<0.001). 
However, in cells where NET23/STING was depleted there was no significant 
difference observed in the MEN1 and Syncrip redistribution.  
In addition, as previously was described, I observed that IRF3 failed to redistribute 
normally in NET23/STING knockdown cells upon IIR activation with plasmid DNA 
(Figure 24, B) (Ishikawa, Ma et al. 2009). This result suggested that NET23/STING 
probably functions in mediating intracellular DNA-triggered IFN production upstream 
of TBK1 as IRF3 is not phosphorylated and therefore translocated into the nucleus. 
However, IIR activation by HSV-1 or poly I:C upon NET23/STING knockdown did 
not produce any defect in IRF3 redistribution leading to a normal translocation of 
this protein into the nucleus (Figure 24, B).  
Thus, the unaffected redistribution of IRF3 in NET23/STING knock down cells where 
the IIR has been activated upon HSV-1 infection or poly I:C argues that the Syncrip 
and MEN1 effects are not a downstream effect of NET23/STING IIR signalling 
defect produced by its depletion, suggesting the possibility of NET23/STING being 














Figure 25. NET23/STING binding partners SYNCRIP and MEN1 normally redistribute 
during IIR and fail to redistribute in NET23/STING knockdown cells. SYNCRIP and 
MEN1 are translocated from the nucleus to the cytoplasm after IIR by poly I:C in siRNA 
control cells (left panel). This translocation fails to occur when NET23/STING is depleted 





























Figure 26. SYNCRIP and MEN1 shuttling upon IIR activation is dependent on 
NET23/STING. Quantification of nucleo-cytoplasmic redistribution of NET23 binding 
partners with or without NET23/STING knockout upon activation of IIR with poly I:C, plasmid 
DNA (dsDNA) or HSV1 infection. P-values were calculated with KS test (* p < 0.05, ** 





3.8. NET23/STING shuttling is increased upon IIR 
activation in the ER and in the NE 
 
To further investigate the hypothesis of NET23/STING acting as a transporter for 
proteins involved in IIR, I used FRAP to quantify the mobility of this protein within 
the NE and the ER after the induction of the IIR. I postulated that NET23/STING 
might promote the shuttling of factors involved in IIR between the nucleus and 
cytoplasm, thus its mobility could change upon IIR activation.  
It has been shown that FRAP in the NE predominantly measures NETs translocation 
from the ER to the NE rather than movement of NETs within the NE. NETs, as the 
rest of membrane proteins, are synthetized in the ER and need to reach their final 
destination, the INM. To do so, NETs need to travel from the ER to the ONM to 
finally translocate into the INM via the peripheral channels of the NPCs.  
PA and FRAP studies performed by Nikolaj Zuleger showed the presence of 
different NET pools due to an exchange of these proteins between ER, ONM and 
INM.  FRAP studies in NETs showed that the recovery of fluorescence within the 
NE was not due to protein movement within the NE but rather translocation from the 
ER to the NE. Generally, NETs in the NE present interactions with nuclear 
components resulting in NETs tethered to the NE after their translocation from the 
ER. Thus, the mobility of NETs within the NE was observed to be slower when 
compared with the mobility of NETs within the ER, in where proteins are completely 
mobile and present free membrane diffusion, resulting in a faster mobility. 
This was further confirmed by PA-GFP studies which allow to detect the movement 
of a particular pool of proteins in living cells. This experiment showed that NET 
binding in the NE is really tight as photoactivated NETs in the NE were relatively 
immobile, confirming that the NE fluorescence recovery of FRAP experiments 
depended on the exchange of NETs between the ER and the INM rather than on 
the movement of NETs within the NE.  Additionally, PA studies performed in the ER 
showed that photoactivated NETs were quickly accumulated in the NE rather than 
stay in the ER, confirming the previous observations. Furthermore, FRAP 
experiments of NETs in the ER showed higher mobility than those proteins bleached 
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in the NE.  In conclusion, these observations clearly support that FRAP in the NE is 
predominantly measuring ER- INM translocation (Zuleger, Kelly et al. 2011).  
 
Based on these studies, the term “translocation” will be used in this thesis 
for movement of NETs from the ER into the INM of the NE 
 
If NET23/STING was acting as a transport receptor for IIR proteins in and out of the 
nucleus to activate transcription factors IRF3/7, we expected its translocation from 
the ER to the NE to be increased upon the activation of the IIR. For this propose, 
NET23/STING mobility within the NE and ER was quantified by FRAP upon the 
activation of the IIR by HSV-1 (Figure 27).  
To avoid the activation of the IIR due to the transfection of plasmid DNA, I used the 
NET23/STING-GFP inducible cell line previously generated in which the expression 
of this protein was controlled by the addition of doxycycline to the medium. As a 
control, a stable cell line expressing the nuclear protein NET55 fused with GFP was 
used to test whether other NETs lose NE tethering connections and thus, might 
shuttle in and out of the nucleus upon the HSV-1 induced IIR activation. FRAP was 
performed in these two stable cell lines under normal conditions and upon the 





Figure 27. Schematic of the FRAP experiment to study NET23/STING dynamics upon 
IIR activation. After NE photobleaching, fluorescence recovery of NET23/STING within the 
NE is mainly due to translocation of this protein from the ER into the NE (blue) rather than 
from diffusion of unbleached NET23/STING protein in the NE (green). After ER 
photobleaching, fluorescence recovery of NET23/STING in the ER is due to the diffusion of 
NET23/STING within the ER (blue). 
 
The t½ is the parameter that indicates the time in which 50% of the maximal 
recovery achievable from the bleached fluorescence has been recovered and in this 
case it is used as a relative measure for protein translocation; the lower the t½ is, 
the faster the translocation of the studied protein occurs.   
For FRAP experiments, five pre-bleach images were taken followed by bleaching a 
spot of 1µm in the ER and NE for 1 s at full laser intensity. The fluorescence recovery 
was measured before, during and after the bleach in either the NE or the ER to 
generate fluorescence recovery curves. The t½ was calculated from normalized 
fluorescence values while the immediate post-bleach value was set to 20-30% of 
the starting fluorescence signal (0.2-0.3 normalized values in the graphic) and the 
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average of the ten last points of the recovery curve to 100% (1 normalized value in 
the graphic) (for further details refer to Materials and Methods chapter).  
To circumvent variability due to imaging and to objectively optimize the best 
experimental parameters to perform FRAP, different validations were done. Various 
parameterizations were tested such as laser intensity and post-bleach time 
recovery. 
Photobleaching of NET23/STING tagged with GFP was performed in the NE and 
ER of mock and HSV-1 infected inducible stable cell lines. I conducted three 
independent experiments in each of which FRAP was performed within the NE and 
ER on 5-6 individual cells per condition; mock and HSV-1 infected cells.   
Fluorescence recovery was measured at the indicated times. As observed in Figure 
15, for experiments performed in the NE, the fluorescence recovery of each 
individual experiment was roughly similar between them. The mean of the t½ and 
the SD from the means of each experiment showed robust values, confirming the 























Figure 28. Fluorescence recovery curves from three independent experiments to calculate t½. 
NET23/STING translocation within the NE was quantified in three independent experiments for mock and 
HSV-1 infected cells to validate the reproducibility of the technique. Representation of three fluorescence 
recovery curves from three independent experiments in which NET23/STING translocation was measured 
in 5 or 6 mock or HSV-1 infected cells, showed a clear reproducibility of NET23/STING translocation in the 





Induction of the IIR with HSV-1 infection increased the mobility of NET23/STING in 
the NE compared with mock infected cells. The t½ of NET23/STING in the NE is 
significantly decreased by 1/3 from 11.1 s to 6.7 s. In contrast for the control NET55 
the t½ was unaffected (Figure 29).  
In addition, I also assessed the fluorescence recovery of NET23/STING and NET55 
after IIR induction in the ER. NET23/STING mobility was significantly increased by 
8 s in HSV-1 infected cells compared with uninfected cells while NET55 was 
unaffected upon IIR activation (Figure 29) (Figure 30). A faster mobility of 
NET23/STING in the ER is consistent with a redistribution of NET23/STING from 
the ER to the Golgi in where it assembles into punctuate structures containing TBK1, 
a kinase needed for the phosphorylation of IRF3.  
Table 10 summarizes the mean of the recovery times (t1/2) for NET23/STING and 
NET55 within the NE and ER in control and HSV-1 infected cells. It also includes 
SD from the means of each experiment and the p-values calculated with one-way 
Anova test.  
In addition, as previously shown for other NETs by Nikolaj Zuleger, the faster 
mobility of NET23/STING observed in the ER of HSV-1 infected cells, is reflecting a 
faster translocation of this protein from the ER to the NE, possibly acting as a 
transport receptor for different proteins involved in IIR that provide directionality to 
NET23/STING forcing the movement within the ER towards the NE.  
Based on previous PA studies performed for other NETs in which photoactivated 
NETs within the ER were quickly accumulated in the NE rather than stay in the ER, 
together with the faster ER mobility that NET23/STING showed upon IIR activation, 
it is extremely likely that NET23/STING shuttling is being increased upon IIR 
activation from the ER to the NE. These results suggested that the increase in 
NET23/STING mobility upon IIR is associate with the redistribution of 
NET23/STING-NE binding partners in and out the nucleus that ultimately will lead 
to the activation of transcription factors involved in IIR. 
Altogether, this data supports that NET23/STING is not just acting as an upstream 
activator of the IIR. But it also shuttles between the nucleus and the cytoplasm likely 
acting as a carrier for proteins involved in IIR in either direction. NET23/STING 
binding partners, as Syncrip and MEN1, can redistribute and might be activating IIR 
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factors by its translocation, probably, through the peripheral channels. Further 
experiments will need to confirm the use of peripheral channels by NET23/STING 









Table 10. NE and ER FRAP recovery times (t½) s for NET23/STING and NET55 
mobility in control and HSV1 infected cells. 
   









CTL 12.9 11.3 14.5 1.59 
0.002 
HSV1 5.1 4.2 5.9 0.87 
ER 
CTL 16.1 14.4 17.8 1.71 
0.011 







CTL 14.4 13.3 15.5 1.11 
0.261 
HSV1 13.5 13.3 13.8 0.27 
ER 
CTL 15.3 10.3 20.2 4.95 
0.168 
HSV1 10.1 8.1 12.1 2.01 
 
a NET23/STING and NET55 t½ recovery times within the NE and ER are presented together 
with the standard deviation (sd). P-values were calculated with one-way Anova test. 
Comparison of the recovery times (t½) between the control and HSV-1 infected cells 






Figure 29. NET23/STING mobility in the NE and ER increases upon IIR activation. Stably-
transfected HT1080 cells expressing NET23/STING-GFP were bleached in the NE (top panel) and 
in the ER (lower panel). Fluorescence recovery in the bleached area is monitored (red box represent 
the beached area). NET23/STING recovery within the NE or ER was very slow in control cells 
compared with HSV-1 infected cells. The recovery curves for ER and NE FRAP for NET23/STING 































Figure 30. NET23/STING mobility is significantly increased upon HSV-1 infection in HSV-1 
infected cells Comparison of the recovery half times (t½) for NET23/STING and NET55 in either 




3.9. Summary of Chapter 3 
 
In this chapter, two novel nuclear functions for NET23/STING have been identified; 
its role in chromatin remodelling together with its ability of acting as a transport 
receptor directing the nucleo-cytoplasmic redistribution of proteins contributing to 
IIR.  
STING was originally introduced as NET23 from a proteomic study of NETs in my 
supervisor´s lab (Schirmer, Florens et al. 2003). Since then, this protein has been 
shown to be localized also at the ER and mitochondria playing a role in the activation 
of IIR signalling cascades that stimulate IRF3/7 transcription factors (Ishikawa and 
Barber 2008, Ishikawa, Ma et al. 2009, Barber 2011, Chen, Sun et al. 2011, Ishikawa 
and Barber 2011). However, its function within the NE has been completely ignored.  
This chapter has been focused on the experiments I performed to test the 
hypothesis of NET23 being involved in chromatin compaction and in IIR signalling 
within the NE.  
Firstly, I confirmed the correlation between NET23/STING and the chromatin 
compaction phenotype observed in cells overexpressing this protein. Moreover, I 
showed that the chromatin compaction phenotype dependant on NET23/STING  
expression is linked with an increase in certain epigenetic marks. I demonstrated 
that the chromatin compaction levels of eight cell lines correlated with their 
endogenous NET23/STING expression levels confirming the involvement of this 
protein in regulating levels of chromatin compaction.   
Furthermore, I showed by EM that cells overexpressing NET23/STING presented 
higher levels of chromatin compaction when compared with control cells. In addition, 
I showed that HSV-1 infection is mitigated by the depletion of NET23/STING and 
how the silencing of this protein is preventing the chromatin compaction phenotype 
that is generally observed in host cells at early times post infection. 
Additionally, I used FRAP as a method to study the behaviour of NET23/STING 
within the NE and ER upon the induction of the IIR. I clearly confirmed an increase 
in the translocation of NET23 from the ER to the NE in HSV-1 infected cells. This 
result, together with immunofluorescent microscopy studies in which I showed that 
Syncrip and MEN1, two NET23/STING NE-binding partners, failed to redistribute in 
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NET23/STING knockdown cells, strongly argues for NET23/STING acting as a 
transporter for IIR proteins. Thus, this supports our hypothesis in which 
NET23/STING might be involved in the shuttling of proteins between the nucleus 
and cytoplasm in order to activate the IIR. Although future experiments need to 
confirm this hypothesis, I can clearly state that in this chapter I confirmed a novel 




























Chapter 4  
NETs redistribution 





Viruses are experts at remodelling cellular membranes, breaching them during cell 
entry or deforming them during the course of infections for budding. Herpesviruses 
represent an unusual case of viral budding. This family of virus starts in the nucleus 
by the assembly of new DNA viral capsids that leave the nucleus to reach the 
cytoplasm in which they acquire the tegument proteins and the final envelope. The 
viral nucleocapsids are around 125 nm of diameter, too large to pass through the 
NPCs. It is for this reason that herpesviruses have developed different strategies to 
break through the NE and reach the cytoplasm to complete its lifecycle.  
During budding at the NE, capsids become enveloped at the INM (primary 
envelopment), which results in the formation of PEP inside the perinuclear space. 
These particles then fuse with the ONM (de-envelopment) releasing naked capsids 
into the cytosol. However, the viral capsids do not have unimpeded access to the 
INM (Bigalke and Heldwein 2016).  
The NE presents a unique set of NETs that theoretically should hamper the ability 
of nucleocapsids to get access to this membrane (Florens, Korfali et al. 2008, 
Korfali, Wilkie et al. 2010, Malik, Korfali et al. 2010). The majority of these proteins 
are thought to localize to the INM by a diffusion and retention mechanism. As the 
ER is continuous with the ONM, NETs diffuse in these two membrane systems after 
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synthesis using their transmembrane domains. They can subsequently diffuse from 
the ONM laterally through the peripheral channels of the NPC to reach the INM 
where they are retained by interactions with the lamina and / or chromatin (Zuleger, 
Kerr et al. 2012, Zuleger, Boyle et al. 2013, Laba, Steen et al. 2014, Ungricht, Klann 
et al. 2015).  
The nuclear lamina, a dense meshwork of filaments and lamin binding proteins is 
underlying the INM also hampering the budding of nucleocapsids at this membrane. 
The lamina meshwork is made up of intermediate filaments proteins that polymerize 
to form 10 nm diameter filaments of sufficient density to block the large viral capsids. 
The binding between lamins, chromatin and NETs form a complex web of links 
resulting in a tightly entwined protein meshwork for nucleocapsids to bypass 
(Gruenbaum, Margalit et al. 2005).  
Herpesviruses have developed different strategies to locally disassemble the 
nuclear lamina that are critical for the viral capsids to gain access to the INM to 
achieve primary envelopment. Total dismantling of the NE takes place during 
processes normally involved in cellular dynamics such as in mitosis. 
During mitosis, the lamina meshwork disassembles between prophase and 
metaphase and reassembles during interphase (Gerace and Blobel 1980). Lamins 
and NETs like emerin are phosphorylated by cellular kinases to break down the 
nuclear lamina and dissociate lamina components. Nuclear lamina is completely 
disassembled by site-specific, reversible phosphorylation of lamins by multiple 
cellular kinases such as PKA, PKC, MAPK and Cdc2 (Peter, Sanghera et al. 1992, 
Fields and Thompson 1995, Likhacheva and Bogachev 2001). During herpesvirus 
infection nuclear lamina is only partially dissolved in areas with high concentrations 
of the NEC (Reynolds, Liang et al. 2004, Bjerke and Roller 2006, Leach and Roller 
2010). It is thought that herpesviruses partially mimic some of these cellular 
processes by the activation of viral and cellular kinases in these sites, resulting in 
the phosphorylation of lamins and the disruption of the lamin polymer and lamin 
interactions with other proteins and DNA facilitating access of nucleocapsids to the 
INM (Simpson-Holley, Colgrove et al. 2005, Leach and Roller 2010). However, there 




It seems likely that in order to achieve budding at the INM for the formation of PEP, 
herpesviruses must disrupt not only the lamin polymer, but also the many NETs that 
interact with both lamins and chromatin. Recent studies have shown that the 
localization of emerin and LBR is altered during viral nuclear egress resulting in an 
increase of the mobility of these proteins and their redistribution into a cytoplasmic 
compartment (Scott and O'Hare 2001, Leach, Bjerke et al. 2007, Morris, 
Hofemeister et al. 2007). These observations suggested that with lamin dissociation 
the tethering of these proteins is disrupted resulting in their release from the INM. 
However, both proteins bind not only to lamins, but also to chromatin. Thus, these 
proteins could also be direct targets of the virus and be phosphorylated similarly to 
lamins by viral and cellular kinases to break their interactions with chromatin. 
As the INM has hundred of NETs, it is a formidable barrier for viruses to bypass 
beyond just the lamins, emerin and LBR and thus, it is reasonable to postulate that 
HSV-1 is targeting some other NETs to facilitate its access to the NE. NETs present 
at the INM could be targeted for degradation or could lose their interaction with the 
nuclear lamina and / or with chromatin to allow their redistribution so that the 
membrane becomes accessible for primary envelopment of nucleocapsids.  At the 
same time, it is also possible that some NETs might interact with capsid or primary 
tegument proteins to actually facilitate nuclear egress. 
I hypothesized that INM proteins could be targeted and redistributed during viral 
infection into cytoplasmic compartments to allow an efficient access of HSV-1 
nucleocapsids to the INM and thereby facilitating nuclear egress.  
In this chapter I will describe a screening for NETs that I performed in order to study 
by immunofluorescence microscopy the involvement of some NETs during HSV 
egress at the NE. 
 
4.2. Screening of NETs during HSV-1 infection 
 
In order to determine whether the localization of NETs changes in response to HSV-




Hela cells were infected with HSV-1 for 8 h after being transiently transfected with 
different NETs tagged with either RFP or GFP. The infected cells were fixed and 
subcellular distribution of NETs was then studied by immunofluorescence 
microscopy. I made use of HSV-1 strains in which a viral protein was fused with 
either RFP or GFP (complementing the fluorophore of the transfected NET) to 
identify infected cells. In the case of transfecting NETs fused with GFP I used a viral 
strain in where the capsid protein VP26 was tagged with RFP. On the other hand, if 
the NET was tagged to RFP the viral strain used contained ICP27 fused with GFP 











Figure 31. NETs redistribution upon HSV-1 infection. Hela cells were transfected with 
different NETs tagged with either RFP or GFP. HSV-1 strain containing either ICP27-GFP 
or VP26-RFP was used to infect the transfected cells depending on the tag fused with each 
NET. After 8 hpi cells were fixed and observed by immunofluorescence microscopy. Three 
phenotypes in the localization of NETs can be observed: (1) NETs showing a redistribution 
to the ER upon viral infection including LBR, NET20 and NET29A proteins. (2) NETs 
changing from a smooth NE distribution to a punctuate pattern around the NE and ER 
including NET39 and NET92, and (3) NETs that are not notably different in distribution upon 
viral infection compared with mock cells including NET34, WFS1, NET51, TAPBPL, NET97, 
NET33, NET37 NET34 and METTL7A. Scale bars: 10 µm 
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As expected, in mock cells NETs localized at the nuclear rim with a roughly uniform 
distribution on the membrane. NETs are also detected in the ER in a homogenous 
distribution pattern. Note that absent available antibodies it remains uncertain for 
most NETs whether the ER pool is normal or an overexpression artefact due to 
saturation of binding sites at the NE. Infection with wild-type virus altered the 
localization of some NETs resulting in three different scenarios: NETs translocated 
into the ER, NETs becoming punctuate within the NE, and NETs showing no 
changes (Figure 31). 
As has been previously shown, in cells infected with HSV-1 the nuclear-rim signal 
of LBR became distorted and redistributed to a membranous cytoplasmic 
compartment (Scott and O'Hare 2001). In addition, small intranuclear domains could 
be observed. Previous studies identified the cytoplasmic compartment to which LBR 
translocated upon infection as the ER. Interestingly, NET20 and NET29A showed a 
similar phenotype to that of LBR upon viral infection. In cells infected with HSV-1, 
the signal of these two NETs within the NE strongly decreases while starting to 
accumulate at the ER at 8 hpi.  
Two other tested NETs, NET39 and NET92 presented a different phenotype to that 
described for LBR, NET20 and NET29A. After infection, NET39 and NET92 still 
accumulated at the NE of infected cells but showing a patchier distribution. In 
addition, punctuate structures around the NE and ER could be observed. Notably, 
the presence of intranuclear granular structures with the appearance of protein 
conglomerations could be detected in some cases (Figure 31)  
The rest of the NETs screened in this analysis including NET34, WFS1, NET51, 
TAPBPL, NET97, NET33, NET37 NET34 and METTL7A did not show any clear 
alteration in distribution after infection with HSV-1. All NETs tested are listed in Table 
11. The two redistribution phenotypes observed for some of the tested NETs 
suggest a potential direct or indirect involvement of these proteins during viral 
egress as their localization is being affected during viral infection. Interestingly, LBR, 
NET29A and NET39 have been previously described as playing a role in 
chromosome organization. Therefore, the virus might be targeting these proteins to 
release their tethering at the INM of chromatin creating a more flexible environment 










Phenotype upon HSV1 
LBR LBR 8 YES ER accumulation 
METTL7A NKP2 1 NO N/E 
FAM105A NET20 1 NO ER accumulation 
TMEM120A NET29 5 YES ER accumulation 
SLC39A14 NET34 7 NO N/E 
WFS1 mNET2 9 YES N/E 
PPAPDC3 NET39 3 YES Punctuate struct. 
ATLA3 NET92 2 ? Punctuate struct. 
C14orf1 NET51 4 NO N/E 
TAPBPL NKP39 1 YES N/E 
AADACL1 NET97 1 ? N/E 
SCARA5 NET33 1 NO N/E 
KIAA1161 NET37 1 NO N/E 
 
 
Based on the results obtained by immunofluorescence microscopy I could conclude 
that certain types of NETs are being affected by HSV-1 infection. If a NET is 
localised to the NE by only its interaction with lamin, the redistribution observed 
upon viral infection could be an indirect effect of lamin disassembly. However, if a 
NET in addition is interacting with chromatin, either the chromatin or the NET has to 
be directly targeted by the virus in order to break the tethering of the NET to the NE 
and produce its redistribution. Thus, it still remains unclear whether the redistribution 
observed for some upon viral infection is a direct or indirect aid for the virus.  
Additionally, based on the availability of antibodies present in the lab, I decided to 
test whether some NETs are being degraded during viral infection. For this, Western 
blot analyses were performed in HSV-1 infected Hela cells. Cells were either mock 
infected or infected for 8 h with a MOI of 10 with 17+ wt strain of HSV-1. The cell 
Table 11. Phenotype of screened NETs upon HSV-1 infection 






lysate was extracted and analysed by Western blot for different NETs including 
NET5, LAP2B, WFS1, Tmem214 and emerin. I observed that multiple lower 
molecular weight bands resulting from protein degradation were not present in any 
of the tested NETs indicating that NET degradation by HSV-1 infection is unlikely to 





Figure 32. NETs are not being degraded upon HSV-1 infection. Lysates from Hela cells 
infected for 8 h with w+ HSV-1 were analysed by Western blot for NETs degradation. Emerin 
Lamin A/C, NET5, Tmem38A, Tmem214 and WFS1 are not suffering degradation upon 
HSV-1 infection. α-tubulin was used as an internal control. 
 
4.3. HSV-1 production is decreased in NET29 depleted 
cells 
 
In the previous section I have shown that NET29, a INM protein known to affect 
chromosome organization, accumulates in the ER after HSV-1 infection. A single 
preliminary study was performed in order to investigate if NET29 is implicated in 
HSV-1 growth. This experiment was done in Dr Finn Gray´s lab as part of one 
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collaboration aimed to identify potential host proteins that could affect HSV-1 viral 
growth (this data is not shown in this thesis).  
To do so, I used a single-step viral growth assay and directly compared WT and 
NET29 knockdown cells. Hela cells were transfected with siRNA against NET29 
during three days before being infected with a HSV-1 strain that expressed a GFP 
protein to monitor virus growth kinetics as a measure of GFP fluorescence. I found 
that viral production already was decreased in NET29 knockdown cells at 10 hpi 
and a more than 2-fold difference was observed at 30 hpi compared with siRNA 
control cells (Figure 33).  
Importantly, the defect in viral infectivity resulting from NET29 depletion suggested 
the potential role of this NET during HSV-1 viral growth. However, further 




Figure 33. NET29 depletion inhibits HSV-1 production by 2-fold. Hela cells were 
transfected with either siRNA against NET29 or siRNA control. After 3 days, the siRNA 
transfected cells were tested for the capacity to influence replication of the HSV-1 GFP 
reporter virus from 5 to 60 h post-infection. Virus replication slopes during the linear phase 
were calculated and normalized to mock-transfected cells. Replication slopes were then 
compared to replication upon knockdown of NET29 and control siRNA cells. 
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4.4. Summary of chapter 4 
 
In this chapter I conducted a screen for NETs that can be redistributed during HSV-
1 infection. For this, I initially transfected Hela cells with multiple NETs tagged with 
either RFP or GFP. After, cells were infected with HSV-1 and the position of the 
NETs was analysed by fluorescence microscopy. This identified three categories: 
NETs redistributing to the ER, NETs that become punctate at the NE, and NETs 
that are unchanged. Further study may identify the contributions of these different 
groups to infection. 
NET20 and NET29 with the already described protein LBR underwent a partial 
redistribution from INM to a significant accumulation observed in the ER of infected 
cells at 8 hpi. In addition, the localization of other NETs is changing from a uniform 
pattern lining the nuclear membrane to an uneven distribution with concentrations 
of dots that appear to be in the outer surface of the ER and nuclear membrane  
The redistribution of some NETs during HSV-1 infection suggests a potential direct 
or indirect involvement of these proteins during viral egress. Furthermore, I 
observed that some of these NETs seem not to be degraded after HSV-1 infection, 
suggesting that the observed phenotype is not a consequence of the degradation of 
the NET that could lead into the partial redistribution of the protein within the ER but 
rather of a total redistribution of the protein during viral egress at the NE.  
Together with the finding that the depletion of NET29 in HSV-1 infected cells 
produced a reduction in HSV-1 viral growth, these observations open the possibility 
of the involvement of NETs during HSV-1 infection in addition to the already 









Chapter 5  
Identification of host 
cellular proteins 





Both, the NETs that became punctate at the NE and those that remained distributed 
throughout the NE in the previous chapter are physically poised such that they could 
in theory functionally participate in the mechanism of egress.  As an example, they 
could potentially interact with capsid or tegument proteins increasing the affinity of 
viral particles for the NE or help wrap the INM around the new virus particles 
synthesized within the nucleus facilitating nuclear egress. Alternatively, just by not 
being redistributed away from sites of egress, those that remained unchanged might 
be captured in primary envelopes even if they have no functional role. More steps 
of the herpesvirus lifecycle are known to involve the commandeering of host cell 
proteins (Li, Zhang et al. 2006, Ni, Wang et al. 2012, Christensen, Jensen et al. 
2016); thus it is not surprising that HSV-1 might co-opt host machinery during 
nuclear egress. 
Nuclear membrane proteins enter the nucleus after synthesis in the ER by lateral 
diffusion through the peripheral channels of the NPC. According to the lateral 
diffusion hypothesis, described in the introduction, once NETs are inside the 
nucleus, interactions with the nuclear lamina largely immobilize proteins in the INM. 
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However, if these interactions are broken, proteins become free to diffuse laterally 
and are able to diffuse back into the ONM and throughout the ER (Ohba, Schirmer 
et al. 2004, Zuleger, Korfali et al. 2008, Zuleger, Kelly et al. 2011, Ungricht and 
Kutay 2015). Thus, it might be expected that during the process of de-envelopment 
in which the PEP fuse with the ONM, the host proteins facilitating the budding at the 
INM presented in the primary envelope would release and diffuse into the ER. 
With this idea in mind and with the purpose of capturing host proteins involved in 
HSV-1 primary envelopment, I used a well characterised method originally 
developed by Peter Walter for isolating microsomes (MMs), lipid vesicles coming 
principally from the ER. Based on the hypothesis that proteins involved or captured 
in PEP would partially distribute to the ER, I applied this already developed method 
to isolate MMs from mock and HSV-1 infected cells and searched for proteins that 
changed abundance in the ER after infection. Important to note that a potential 
caveat to this method is the capture of later proteins already synthesized in the ER.  
In this chapter I will describe the optimization and development of the isolation of 
MMs from HSV-1 infected cells for the identification of cellular proteins involved in 
herpesvirus egress at the NE. Subsequently, this chapter will show the mass 
spectrometry analysis of the HSV-1 MMs compared with the mock MMs and the 
identification of a group of vesicle fusion host proteins that might be co-opt HSV-1 
machinery during egress at the NE.  
 
5.2. Isolation of MMs from HSV-1 infected cells: a novel 
approach to identify host proteins involved in viral 
egress at the NE. 
 
In order to identify potential host proteins involved in the process of primary 
envelopment, I considered the possibility of performing mass spectrometry analysis 
on NEs from HSV-1 infected cells and comparing the protein content with mock NEs. 
However, during infection HSV-1 weakens the lamin polymer making the NE weak 
and prone to rupture. Since NE isolation procedures depend on a strong intact NE 
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isolating, isolation of NEs from infected cells will necessarily result in fragmentation 
and high contamination. To get around this problem and detect host proteins 
involved in HSV-1 egress, I performed the isolation of MMs from HSV-1 infected 
cells.  
MMs are in vitro spherical lipid vesicles derived principally from the ER that were 
firstly obtained by Claude in 1943. To study the functions and biochemistry of the 
ER, it was necessary to isolate the ER membrane and separate it from other 
components of the cytoplasm. When cells or tissues are disrupted, the ER breaks 
into small fragments and creates many small closed vesicles called MMs (˜200-400 
nm in diameter). The general structure of the membranous compartment of the ER 
is transformed from a tubular to vesicle structure while the protein content remains 
consistent through the fractionation.  
I postulated that host proteins on the INM that either participate in the process of 
primary envelopment or get captured in the envelope of PEP, will become part of 
the ONM when egress yields their fusion with the ONM for release of non-enveloped 
particles into the cytoplasm.  
Although the PEP are large (125 nm) they are still much smaller than the MMs (200-
400 nm) and so, PEP that had moved to the lumen of the ER or from fragmented 
weak nuclei during the isolation procedure could be encapsulated and isolated 
inside the MMs. Furthermore, host proteins involved in primary envelopment at the 
INM would be released in the ONM or ER. As such we expected to have a significant 
enrichment of host proteins participating in primary envelopment in the MMs fraction 








Figure 34. Schematic representation of the main hypothesis to detect host proteins 
involved in primary envelopment. NE in mock (top panel) and HSV-1 infected cells 
(bottom panel). NETs and potentially as yet unidentified egress proteins are only 
transiently in the ER and ONM after synthesis (top panel). These proteins laterally diffuse 
through the peripheral channels of the NPC to reach the INM where they are retained by 
interactions with other lamina components. In HSV-1 infected cells, some of these 
interactions are broken so that nucleocapsids bud at the INM (1) into the lumen of the NE 
followed by scission of the INM to form primary enveloped particles that include INM lipids 
and potentially any INM proteins either involved or captured in the process (2). During de-
envelopment the INM-derived primary envelope lipids and proteins fuse with the ONM 
releasing proteins involved or captured in primary envelopment (3). Due to continuity of the 
ONM with the ER these proteins can diffuse into the ER or re-translocate back to the INM. 
UL31 and UL34 are two known viral proteins involved in primary envelopment at the NE. 
We postulated that host cell proteins of the INM that are either captured during the process 
of primary envelopment/de-envelopment or actively participating in this process would be 




MMs extraction protocols have been well established in our lab to use proteins 
identified in MMs as an in silico subtractive fraction to compare with proteins isolated 
in proteomic analysis of the NE of muscle nuclei and leukocytes (Korfali, Fairley et 
al. 2009, Korfali, Florens et al. 2016). Taking advantage of the optimised protocols 
set up in our lab for many years and with the purpose to determine potential host 
proteins involved during herpesvirus nuclear egress, a proteomic analysis on 
isolated ER-enriched MMs from HSV-1 and mock infected cells was performed, 
searching for NE proteins that increased their abundance in the ER during viral 
infection (Figure 35). 
In addition, NEs from mock-infected cells were isolated to establish the composition 
of the NE specifically in Hela cells prior to infection. If proteins are involved in primary 
envelopment, I expect to have an enrichment of these proteins in HSV-1 infected 
MMs compared with mock-infected MMs. Furthermore, these proteins will be less 
abundant in mock-infected NEs compared with HSV-1 MMs as a result of 







Figure 35. Schematic representation of the isolation of MMs to detect host proteins 
involved in HSV-1 egress and potential primary enveloped particles (PEP) trapped in 
the ER. Nucleocapsids (NC) synthesized in the nucleus bud at the INM forming PEP that 
subsequently fuse with the ONM. In some cases, due to the continuity of the NE and ER 
lumen, they can also fuse with the ER. In both cases naked capsids are released into the 
cytoplasm while the primary envelope derived from the INM and containing host proteins 
remains in these structures (ER and ONM). Host proteins involved in primary envelopment 
and released into the ER and ONM during de-envelopment might be detected by the 
isolation of MMs (membranous structures from the ER). In addition, PEP might be captured 
inside MMs because as 200-400 nm structures they are large enough to accommodate the 
~125 nm PEP. 
 
As at least a portion of the total protein pool for proteins involved in secondary 
envelopment might diffuse into the ER, such changes might be measured as an 
increase in the MMs fraction. Thus, it was necessary to harvest cells for fractionation 
at a time when nuclear egress is heavily engaged, but before secondary 
envelopment proteins are being heavily produced.  These proteins will flood the ER 
in preparation for secondary envelopment, so that harvesting too late in infection 
might confuse the identification of nuclear egress proteins.  Therefore, it was 
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important to first determine the optimal time during infection where nuclear egress 
has started but before secondary envelopment. To do this, the expression of two 
viral proteins, US3 and gC was tracked during the course of the infection in Hela 
cells. US3 is a kinase expressed at early time points before primary envelopment. 
On the other hand, gC is a component of the final envelope that is acquired in the 
Golgi during secondary envelopment when viral particles have accumulated in the 
cytoplasm after their release from the nucleus. Thus, the expression of gC will 
indicate the prevalence of virus particles already in the cytoplasm. US3 expression 
in HSV-1 infected Hela cells was detectable at 3 hpi, but it began to be highly 
expressed at 9 hpi, reaching maximal levels by 12 hpi (Figure 36, A). At this time, 
gC started to be detectable, increasing expression levels by 24 hpi. These results 
suggested that the best time to increase the possibility of having viral particles in the 
process of nuclear egress and minimize capturing changes in the ER and Golgi 




Figure 36. Optimized conditions for HSV-1 MMs isolation. (A) An expression time 
course of US3 and gC viral proteins was analyzed by Western blot isolate HSV-1 infected 
MMs before significant secondary envelopment has occurred. Cell lysates from Hela cells 
infected at MOI 10 were prepared at indicated times post-infection. α-tubulin was used as 
a loading control. (B) Fluorescence microscopy images of an HSV-1 strain with VP26 capsid 
143 
 
protein fused with RFP in Hela cells after 8, 9 and 10 hpi. At 8 hpi most of VP26 signal was 
located inside the nuclei of infected cells. At 9 hpi cells started to show perinuclear 
localization of VP26. At 10hpi some viral particles were detected in the cytoplasm of infected 
cells. Scale bar, 10 µm 
 
As an independent measure, a parallel experiment was run to determine the cellular 
localization of HSV-1 at different times post infection. An HSV-1 strain containing 
the VP26 capsid protein tagged with RFP was followed in a time course experiment 
by fluorescence microscopy. VP26 is a basic 12 KDa protein encoded by the UL35 
gene that decorates the outer surface of the capsid shell forming a layer between 
the capsid and the tegument and it is acquired by the viral particle inside the nucleus 
of the infected cells. Fluorescence microscopy revealed that at 8 hpi most of infected 
cells contained viral particles inside the nuclei. However, at 9 hpi viral particles are 
visible in the periphery of the nucleus close to the NE while at 10 hpi some viral 
particles are already presented in the cytoplasm of infected cells (Figure 36, B). 
Based on this observation, together with the presence of gC at 12 hpi, ER-enriched 
MMs were isolated between 8 and 9 hpi in order to increase the probability of having 
viral particles in the process of nuclear egress  
Once the optimal time frame in which most of viral particles will be in the process of 
nuclear egress at the NE was established, I proceeded with the protocol to isolate 
MMs. For this, 30 L of Hela cells were grown in roller bottles and infected with HSV-
1 at a MOI of 10 in order to ensure a rapid and even infection throughout the cell 
population. After 8 hpi, cells were collected by trypsinization and collected by 
centrifugation.  
MMs and NEs were prepared following previous published protocols from the lab 
(Figure 37, A). To isolate NEs, nuclei were first isolated from Hela cells treated with 
hypotonic lyses buffer using a tight dounce homogenization (Figure 37, B). Nuclei 
were pelleted to separate them from small vesicles and other cytosolic components 
such as mitochondria, which will be present in the supernatant of the prep (post 
nuclear supernatant), also containing the ER (MMs). To float/remove contaminating 
membranes, nuclei were resuspended in a solution containing 1.8M sucrose and 
pelleted through a 2.1M sucrose cushion. NEs were then prepared from isolated 
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nuclei by multiple rounds of digestion in order to remove nucleoplasmic content. To 
break chromatin up into small pieces, enzymatic digestion of DNA and RNA was 
performed. To ensure efficient chromatin removal during NE preparation, DAPI 
staining was used to check under the fluorescent microscope that chromatin has 
been removed. The fluorescence intensity of NE digested samples is much fainter 
after chromatin digestion compared with control, with only the presence of chromatin 
in a few areas around the nuclear rim and little fluorescence signal remaining in the 
nucleoplasm (Figure 38, A). 
MMs from HSV-1 and mock infected cells were isolated following similar established 
procedures. Post-nuclear supernatant containing cytosolic components such as the 
ER (MMs) was first subjected to centrifugation to pellet and remove mitochondria 
and other debris. After this, MMs were resuspended in a 2M sucrose solution and 
overlaid with 1.86 M and 0.25 M sucrose layers. This was then subjected to 
centrifugation allowing MMs to float upward into the less dense sucrose layer. MMs 
were found at the interphase between the 1.8 M sucrose layer and the uppermost 
0.25 M sucrose layer, giving rise to a fluffy transparent-white fraction (Figure 38, B). 
The microsomal bands were recovered by aspiration and sucrose present in the 







Figure 37. Isolation of MMs and NEs for proteomic analysis. (A) Method schematic. 
Cells were disrupted and lysed using a dounce homogenizer after hypotonic swelling. Nuclei 
were subsequently cleaned of contaminating membranes by pelleting through sucrose 
gradients. NEs were prepared by subsequently digesting and removing DNA and RNA. 
Separately, MMs were prepared from the crude cellular membrane fraction by floating (after 
pelleting mitochondria) through sucrose gradients and collecting the microsome-enriched 
fraction. Cellular fractions from mock and HSV-1 infected cells were analysed by mass 
spectrometry to identify host proteins released into the ONM during HSV-1 egress, that 
once in the ONM can diffuse to the ER and INM. (B) Cell fractions. Mock and HSV-1 infected 
Hela cells were swollen hypotonically (middle panels) and dounce homogenized (right 
panel) to release nuclei.  Phase-contrast light microscope images are shown. Scale bars, 




Figure 38. MM and NE isolation. (A) Removal of chromatin from purified nuclei, nuclei stained 
with DAPI and imaged with fluorescence microscope. Purified nuclei without chromatin digestion 
(left image) compared with purified nuclei after digestion with DNase I and RNase (right image). 
The majority of chromatin has been removed except areas in where it is tightly associated with 
NE. (B) Isolation of MMs in a sucrose gradient. MMs are found at the interphase between the 





In order to analyse the purity of the NE and MM fractions, Western blot analyses 
were performed to detect the expression of specific NE and MM markers (Figure 39, 
A). In addition, a Golgi marker in both fractions was tested to assess contamination 
with Golgi membranes. In the case of the NE fractions, nuclear lamins and NETs 
should become significantly enriched after the isolation. NE markers Lap2β and 
Lamin A/C were only found in NE fractions while they were absent from ER fractions. 
On the other hand, the ER marker calnexin was predominantly expressed in the MM 
fraction with a small amount in the NE fraction (Figure 39, A). This result was 
expected since the ONM is continuous with the ER so many proteins are shared 
between these two structures. Importantly, both NE and MM fractions were free of 
contamination with the Golgi membranes that function in secondary envelopment 
as the Golgi marker GM-130 was absent from the fractions (Figure 39, B). In 
addition, Coomassie staining from MMs and NEs fractions showed that there was a 





Figure 39. Cell fraction purity. (A) Western blot of NE and MM fractions stained with ER 
and NE markers to determine fraction purity. The ER marker calnexin was present in both 
NE and MM fractions as expected because the ONM is continuous with the ER and many 
proteins are shared. In contrast, the NE markers lamin A/C and Lap2β were absent from 
MMs. Similar amounts of total protein were loaded as in (C). (B) Western blot of total protein 
lysates Hela, NE and MMs fractions stained with GM130, a Golgi marker to show the 
147 
 
absence of Golgi membranes in both fractions (C) Coomassie-stained gel of NE and MMs 
fractions showed a clear difference in protein composition. 
 
To further confirm the isolation of MMs, EM was performed on HSV-1 infected MMs 
with the assistance of Alexander Makarov. The electron micrographs clearly showed 
the presence of the expected single membrane vesicles corresponding to MMs. 
These microsomal structures are around 200-400 nm of diameter and in some 
cases they are presented as perfect spherical vesicles. However, some MMs seem 
to be open as a result of the processing of the sample for EM (Figure 40, A). In 
addition to this, some electron micrographs showed the presence of electron dense 
symmetrical structures of around 100 nm diameter inside these microsomal vesicles 
with the appearance of virus particles (Figure 40, B). These particles might have 
been produced during douncing due to the weakened NE or they might be PEP that 
have escaped from the NE lumen and diffused into the ER lumen. Based on only 
EM images alone I could not confirm the identification of these particles as primary 
enveloped virions. However, due to the MMs isolation time frame and the 
appearance of these structures under EM, it is likely that they are PEP that have 
been either trapped during the isolation procedure or released into the ER during 
primary envelopment at the NE. These particles observed in EM micrographs 
presented a smooth envelope and were characterised by a clear halo between the 
bordered rim of the nucleocapsid and primary tegument, thus further arguing they 
are PEP because no surface projections characteristic of secondary enveloped 
particles could be detected in the particle membranes. 
Although further experiments such as immunogold EM will be needed to confirm the 
identity of these particles trapped inside MMs by the identification of proteins already 
known to be part of the PEP, such as UL31 and UL34, this approach could 






Figure 40. Ultrastructure of isolated MMs from HSV-1 infected cells. Electron 
micrographs showed the characteristic single-membrane structure of the MMs. (A) MMs 
without presence of viral particles in its interior. (B) MMs containing electron dense 
symmetrical structures of around 100 nm diameter (arrows) that probably represent primary 
enveloped particles trapped in the ER during primary envelopment. Scale bars, 100 nm. 
Experiment performed with the assistance of Alexander Makarov. 
 
5.3. Identification of potential viral proteins present in 
primary enveloped virions 
 
The composition of primary enveloped virions is only partially known due to 
difficulties in isolating this intermediate viral form for proteomic analysis. Mass 
spectrometry analysis was performed by our collaborators Selene K. Swanson and 
Laurence Florens using Multi-Dimension Protein Identification Technology 
(MudPIT) LC/LC/MS/MS approach on each of the fractions. As expected from the 
EM structures with the appearance of viral particles, HSV-1 proteins were detected 
in the HSV-1 infected MMs.  Particularly, 35 HSV-1 proteins were identified and 
interestingly, 7 of these 35 identified proteins were previously found in a study that 
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attempted to isolate and identify the protein composition of primary enveloped 
virions (Padula, Sydnor et al. 2009). The 7 proteins (out of 8) that were found in this 
earlier study as well as in our proteomic data sets included different known tegument 
proteins such as VP22, the UL34 protein, already known for its role during 
herpesvirus egress at the NE and its unique presence in PEP and the gD protein, 
previously suggested to be associated with HSV-1 primary virions. Surprisingly, the 
viral protein UL31, which is known to be associated with UL34 forming the NEC 
complex during primary envelopment, failed to be identified in Padula´s study. 
However, both proteins were found in our datasets (Table 12). 
In addition to the proteins previously identified in Padula´s study, we managed to 
find several other tegument proteins and glycoproteins. It is important to note that 
the relative abundance of the glycoproteins identified in our study can be broken 
down into two groups based on their dNSAF scores, a measure of the percentage 
of the total mass of the mass spectrometry run accounted for by a particular protein 
based on spectral abundance and its molecular weight. The first group including gD, 
gB and gC were all based on abundance estimated from spectral counts present at 
roughly 6X greater abundance than the others detected in the second group of 
glycoproteins that included gE, gM, gH and gI (Table 12). 
This data is consistent with previous studies in which gD, gB and gC were 
associated with primary virions (Torrisi, Di Lazzaro et al. 1992, Jensen and Norrild 
1998). Moreover, gB has been shown to be implicated in fusion with the ONM during 
egress (Wisner, Wright et al. 2009). Hence, the glycoproteins presenting a higher 
spectral abundance are likely to be present in primary envelopes and participate in 
primary envelopment while the less abundant glycoproteins are simply beginning to 
be expressed in the ER and in the process of moving from the ER to the Golgi in 
where they will support secondary envelopment. Nonetheless, though the trend may 
be real, it is likely an oversimplification as gH was also implicated in ONM fusion 
(Farnsworth, Wisner et al. 2007, Wright, Wisner et al. 2009) despite that our data 
place it in the less abundant set. 
I postulate that the additional tegument proteins identified in our proteomic analyses 
are likely to belong to PEP. As these tegument proteins are not transmembrane 
proteins, they would have been lost during the purification of MMs unless they 
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belong to primary envelopes captured in the MMs as part of the de-envelopment 
process or as part of primary enveloped virions captured within the MMs (Figure 40, 
B). All viral proteins identified in HSV-1 MMs are listed in Table 12 with the unique 
peptides (P), spectral counts (S) and dNSAF values associated to them. 
 
Table 12. Abundance of viral proteins identified in HSV-1 MMs.  
Rank based on dNSAF values 
Viral Protein P S dNSAF 
US6 Glycoprotein D 7 38 0.00303 
UL27 Glycoprotein B 14 62 0.00216 
UL44 Glycoprotein C 6 30 0.00185 
Nuclear egress membrane protein pUL34 4 15 0.00171 
Virion protein US2 4 14 0.00151 
Membrane protein UL45 2 7 0.00128 
UL49 Tegument protein VP22 4 11 0.00115 
UL19/VP5 Major capsid protein 18 46 0.00105 
UL48 Tegument protein VP16 6 16 0.00103 
UL50 Deoxyuridine triphosphatase 3 12 0.00102 
US8 Glycoprotein E 8 16 0.00091 
UL18/VP23 Capsid triplex subunit 2 4 9 0.00089 
UL46 Tegument protein VP11/12 7 19 0.00083 
UL47 Tegument protein VP13/14 7 14 0.00063 
UL10 Glycoprotein M 1 8 0.00053 
UL42 DNA pol processivity subunit 4 8 0.00052 
US7 Glycoprotein I 3 6 0.00048 
UL40 Ribonucleotide reductase subunit 2 3 5 0.00046 
Tegument protein UL7 3 4 0.00042 
UL22 Glycoprotein H 5 11 0.00041 
pUL31 Nuclear egress lamina protein 2 4 0.00041 
UL29/ICP8 Single-stranded DNA binding 
protein 
7 15 0.00039 
UL39 Ribonucleotide reductase subunit 1 8 14 0.00039 
Tegument protein UL51 2 3 0.00039 
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ICP4 10 15 0.00036 
US10 2 3 0.0003 
UL12 Deoxyribonuclease 4 6 0.0003 
UL54 Multifunctional expression regulator 3 4 0.00025 
UL24 1 2 0.00023 
US1/ICP22 2 3 0.00023 
UL41 Tegument host shutoff protein 2 3 0.00019 
Tegument protein UL21 1 3 0.00018 
UL26/VP24/VP21 Capsid maturation protease 2 3 0.00015 
UL39/VP19C Capsid triplex subunit 1 1 2 0.00014 
Tegument protein UL25 2 2 0.00011 
 
 
5.4. Mass Spectrometry analysis for the identification of 
host proteins involved in HSV-1 nuclear egress 
 
It is reasonable to expect that proteins present in the INM recruited during primary 
envelopment and de-envelopment should be more abundant in the MMs fraction 
from HSV-1 infected cells compared with mock-infected cells as they would be 
released into the ONM during de-envelopment and diffuse into the ER. Thus, I 
expected the proteins of greatest interest to occur in the NE fraction before infection 
and later be increased in the HSV-1 infected MMs fraction. 
I calculated the relative enrichment ratio for each protein based in their dNSAF score 
in the HSV-1 MMs versus mock MMs. The Distributed Normalized Spectral 
Abundance Factor (dNSAF) is a value used to measure protein abundance based 
on spectral counts that are distributed to each protein based on the amount of 
unique peptides/spectral counts found for each protein and as a reflection of their 
mass out of the total mass for a particular mass spectrometry run. I extracted all 
proteins in the HSV-1 infected MMs that were at least 30% increased over the mock 
MMs based on their dNSAF values (all proteins with a ratio smaller than 1.3 were 
discarded from the analysis focusing only on those proteins presenting a HSV-1 
MMs/mock MMs ≥ 1.3). Only the 8.8% (146 host proteins) of the total proteins 
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detected in the dataset presented an increase of 30% or higher in HSV-1 MMs while 
around the 26.5% of proteins of the total proteins detected in the dataset were 
unchanging in dNSAF score. 















NOP10 0.000491 X 0.001925 INF INF 
ARF4 0.000349 X 0.000076 INF INF 
SELT 0.000322 X 0.000211 INF INF 
AGPAT5 0.000173 X 0.001128 INF INF 
APMAP 0.000151 X 0.000197 INF INF 
RAB38 0.000149 X 0.000778 INF INF 
SNRNP70 0.000144 X 0.000470 INF INF 
CHTOP 0.000127 X 0.000828 INF INF 
ZFPL1 0.000101 X 0.000662 INF INF 
RAB6B 0.000101 X 0.000632 INF INF 
ABHD12 0.000079 X 0.000206 INF INF 
MOSPD2 0.000069 X 0.000361 INF INF 
WLS 0.000058 X 0.000378 INF INF 
AATF 0.000056 X 0.000147 INF INF 
ATP8B2 0.000051 X 0.000067 INF INF 
SLC39A6 0.000042 X 0.000054 INF INF 
DDX27 0.000039 X 0.000103 INF INF 
ATP9B 0.000027 X 0.000107 INF INF 
IGF2R 0.000013 X 0.000016 INF INF 
NOP2 0.000149 0.000015 0.000049 9.933333 3.266667 
HNRNPC 0.000411 0.000042 0.000134 9.785714 3.190476 
Table 13. Abundance and relative ratios of host proteins with a 30% enrichment in HSV-1 infected MMs. 






TUBA1C 0.006650 0.000718 0.000079 9.261838 0.110028 
PAF1 0.000194 0.000026 0.000169 7.461538 6.500000 
TUBA8 0.000164 0.000022 0.000021 7.454545 0.954545 
AFG3L2 0.000237 0.000032 0.002009 7.406250 62.781250 
ITPR3 0.000035 0.000005 0.000323 7.000000 64.600000 
VAPB 0.002286 0.000363 0.003261 6.297521 8.983471 
SLC4A7 0.000333 0.000056 0.000218 5.946429 3.892857 
NOLC1 0.000090 0.000018 0.000478 5.000000 26.555556 
RAB34 0.000204 0.000041 0.000267 4.975610 6.512195 
PTGS2 0.000104 0.000021 0.000408 4.952381 19.428571 
VAMP7 0.000702 0.000142 0.002523 4.943662 17.767606 
HNRNPA2B1 0.001290 0.000261 0.000241 4.942529 0.923372 
STEAP2 0.000138 0.000028 0.000090 4.928571 3.214286 
LMNB1 0.000167 0.000034 0.000109 4.911765 3.205882 
EPHB4 0.000229 0.000047 0.000233 4.872340 4.957447 
GOLGA5 0.000129 0.000035 0.001236 3.685714 35.314286 
ATP11B 0.000080 0.000022 0.000314 3.636364 14.272727 
RPN1 0.002952 0.000817 0.001218 3.613219 1.490820 
HNRNPR 0.000297 0.000090 0.000194 3.300000 2.155556 
TMEM30A 0.000348 0.000106 0.000227 3.283019 2.141509 
STOM 0.000546 0.000177 0.000428 3.084746 2.418079 
PRPH 0.005996 0.001976 0.003582 3.034413 1.812753 
SPCS3 0.001048 0.000353 0.000912 2.968839 2.583569 
ALYREF 0.000714 0.000241 0.000467 2.962656 1.937759 
DES 0.001290 0.000460 0.000262 2.804348 0.569565 
TRPM4 0.000026 0.000010 0.000101 2.600000 10.100000 
ADAM17 0.000038 0.000015 0.000199 2.533333 13.266667 
PTGS1 0.000105 0.000042 0.000411 2.500000 9.785714 
PIGK 0.000080 0.000032 0.003742 2.500000 116.937500 
LUC7L 0.000085 0.000034 0.000569 2.500000 16.735294 
TM9SF3 0.000107 0.000043 0.001185 2.488372 27.558140 
PTPN1 0.000072 0.000029 0.000189 2.482759 6.517241 
PCDH19 0.000057 0.000023 0.000112 2.478261 4.869565 
PPIC 0.000297 0.000120 0.000387 2.475000 3.225000 
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RPS25 0.000754 0.000305 0.000328 2.472131 1.075410 
NDUFA4 0.000388 0.000157 0.001521 2.471338 9.687898 
DPM1 0.000242 0.000098 0.000158 2.469388 1.612245 
ARL6IP5 0.000669 0.000271 0.001092 2.468635 4.029520 
EBAG9 0.000148 0.000060 0.000771 2.466667 12.850000 
MYO1F 0.000086 0.000035 0.000037 2.457143 1.057143 
SORCS2 0.000054 0.000022 0.000283 2.454545 12.863636 
PTPRK 0.000044 0.000018 0.000029 2.444444 1.611111 
CLCN7 0.000078 0.000032 0.000102 2.437500 3.187500 
LRRC8C 0.000078 0.000032 0.000256 2.437500 8.000000 
SLC23A2 0.000048 0.000020 0.000126 2.400000 6.300000 
PPIB 0.002619 0.001178 0.001331 2.223260 1.129881 
LAMP1 0.000678 0.000305 0.000295 2.222951 0.967213 
HNRNPH2 0.000756 0.000351 0.000183 2.153846 0.521368 
P4HB 0.002289 0.001077 0.000242 2.125348 0.224698 
ARL8B 0.004056 0.001915 0.000662 2.118016 0.345692 
DDX21 0.000264 0.000125 0.000230 2.112000 1.840000 
ANKH 0.001980 0.000957 0.000083 2.068966 0.086729 
LMNA 0.000994 0.000498 0.002535 1.995984 5.090361 
RAB11B 0.007065 0.003560 0.012242 1.984551 3.438764 
MTDH 0.000216 0.000109 0.000494 1.981651 4.532110 
RPS19 0.001734 0.000877 0.000566 1.977195 0.645382 
HNRNPU 0.000624 0.000316 0.000204 1.974684 0.645570 
SRSF3 0.001078 0.000559 0.001051 1.928444 1.880143 
CD34 0.000571 0.000297 0.000107 1.922559 0.360269 
TMED10 0.002727 0.001452 0.001125 1.878099 0.774793 
RAB9A 0.000469 0.000253 0.001226 1.853755 4.845850 
EFNB2 0.000354 0.000191 0.000493 1.853403 2.581152 
ADAM10 0.000252 0.000136 0.000329 1.852941 2.419118 
KIDINS220 0.000053 0.000029 0.000672 1.827586 23.172414 
EPHB2 0.000423 0.000232 0.000525 1.823276 2.262931 
CSPG4 0.000068 0.000038 0.000088 1.789474 2.315789 
TARDBP 0.000380 0.000215 0.000099 1.767442 0.460465 
SPCS2 0.001391 0.000788 0.001635 1.765228 2.074873 
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ITGAV 0.000314 0.000178 0.000779 1.764045 4.376404 
PI4K2A 0.000328 0.000186 0.000429 1.763441 2.306452 
RPL3 0.001326 0.000758 0.000509 1.749340 0.671504 
SRSF7 0.000469 0.000270 0.000509 1.737037 1.885185 
HNRNPF 0.000617 0.000356 0.000198 1.733146 0.556180 
RAB1A 0.005357 0.003093 0.036801 1.731975 11.898157 
LMAN2 0.000618 0.000357 0.002537 1.731092 7.106443 
RAB18 0.003509 0.002038 0.045044 1.721786 22.102061 
TUBB 0.005893 0.003463 0.000555 1.701704 0.160266 
MET 0.000045 0.000027 0.000029 1.666667 1.074074 
HNRNPM 0.000431 0.000261 0.000112 1.651341 0.429119 
EMC3 0.000482 0.000292 0.001888 1.650685 6.465753 
STX7 0.000241 0.000146 0.001888 1.650685 12.931507 
FLNC 0.000652 0.000395 0.000060 1.650633 0.151899 
SEC61A1 0.000132 0.000080 0.000759 1.650000 9.487500 
SFXN3 0.000193 0.000117 0.000505 1.649573 4.316239 
NCAM1 0.000659 0.000400 0.000144 1.647500 0.360000 
SCAMP2 0.000382 0.000232 0.001248 1.646552 5.379310 
RAB23 0.000265 0.000161 0.000346 1.645963 2.149068 
FADS1 0.000125 0.000076 0.000492 1.644737 6.473684 
VCAM1 0.000291 0.000177 0.000254 1.644068 1.435028 
SLC25A1 0.000202 0.000123 0.000264 1.642276 2.146341 
MLEC 0.000215 0.000131 0.001406 1.641221 10.732824 
RNF121 0.000192 0.000117 0.000377 1.641026 3.222222 
DKC1 0.000124 0.000075 0.000081 1.640000 1.080000 
NPC1 0.000049 0.000030 0.000096 1.633333 3.200000 
FLOT2 0.001248 0.000773 0.001343 1.614489 1.737387 
HIST3H2A 0.004352 0.002733 0.002030 1.592389 0.742774 
ANXA2 0.046451 0.029388 0.003270 1.580611 0.111270 
NCL 0.001151 0.000735 0.000636 1.565986 0.865306 
GNAQ 0.001537 0.000995 0.000114 1.544724 0.114573 
ITGA6 0.000288 0.000187 0.000263 1.540107 1.406417 
GNAO1 0.001171 0.000771 0.000145 1.518807 0.188067 
KRAS 0.002006 0.001340 0.000109 1.497015 0.081343 
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SPTLC2 0.000168 0.000113 0.000146 1.486726 1.292035 
TMX3 0.000208 0.000140 0.000814 1.485714 5.814286 
SGCD 0.000653 0.000440 0.000852 1.484091 1.936364 
SLC1A5 0.000174 0.000118 0.000228 1.474576 1.932203 
H2AFV 0.000827 0.000567 0.000926 1.458554 1.633157 
PCBP1 0.000820 0.000570 0.000231 1.438596 0.405263 
CLPTM1 0.000376 0.000266 0.002025 1.413534 7.612782 
RPL36 0.001197 0.000848 0.003519 1.411557 4.149764 
SLC25A11 0.000400 0.000284 0.000523 1.408451 1.841549 
RAB2A 0.002520 0.001800 0.011039 1.400000 6.132778 
RAB35 0.002658 0.001899 0.002655 1.399684 1.398104 
MYO1B 0.001487 0.001074 0.000381 1.384544 0.354749 
RAP2C 0.001088 0.000787 0.000897 1.382465 1.139771 
SLC12A4 0.000146 0.000106 0.000908 1.377358 8.566038 
ECE1 0.000415 0.000302 0.000542 1.374172 1.794702 
SSR3 0.000849 0.000619 0.001775 1.371567 2.867528 
PTPRA 0.000396 0.000289 0.000518 1.370242 1.792388 
SACM1L 0.000321 0.000238 0.000769 1.348739 3.231092 
DDX17 0.000762 0.000571 0.000056 1.334501 0.098074 
MRC2 0.000149 0.000112 0.000861 1.330357 7.687500 
RHOA 0.002438 0.001841 0.000878 1.324280 0.476915 
NOLC1 0.000405 0.000309 0.002752 1.310680 8.906149 
NPM1 0.004811 0.003679 0.000559 1.307692 0.151943 
 
 
These proteins were analysed for specific gene ontology (GO) terms in order to 
determine if there were any functionally interesting categories of proteins that might 
be involved during HSV-1 egress at the NE. The relative proportions of the various 
GO-terms were calculated from the relative abundances of the genes identified from 
each GO category and they were plotted as pie charts. This was later compared to 
a pie chart compiled from all the genes in the human genome considering the same 
categories (Figure 41, A).  
Several GO-terms were strongly enriched in the select HSV-1-infected MMs 
including vesicle organization (GO:0016050), vesicle mediated transport proteins 
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(GO:0016192), nuclear transport (GO:0051169) and membrane fusion proteins 
(GO:0061025) (Figure 41A). The vesicle organization, the vesicle mediated 
transport and membrane fusion category presented a 6, 3 and 4-fold enrichment 
respectively in HSV-1 MMs (Figure 41, B). The presence of proteins involved in 
membrane organization and vesicle fusion events captured my attention, not only 
for the big increase they presented compared with the total human genome, but also 
for their potential relevance to herpesvirus nuclear egress as they might be 








Figure 41. Gen Ontology (GO) classification for enriched proteins from HSV-1 
infected MMs. (A) Proteins increased at least 30% in HSV-1 MMs versus mock MMs were 
analysed for specific GO terms and compared with their representation in the total human 
genome. (B) Representation of the relative abundance of specific GO terms for enriched 
proteins presented HSV-1 MMs (sample) versus the total human genome (HG). Vesicle 
mediated transport proteins represents 20% in HSV-1 MMs versus 6.6 % in the total human 
genome.   
 
These 146 selected proteins were then sorted based on their presence in the NE, 
considering only those that were at least 40% enriched in the NE versus the MMs 
control to suggest that they were reasonably abundant in the NE to begin with (all 
proteins with a ratio smaller than 1.4 were discarded from the analysis focusing only 
on those proteins presenting a Mock-infected NEs/Mock-infected MMs ≥ 1.4). 107 
of the 146 proteins followed these selection criteria based on their relative 
enrichment ratio Mock-infected NEs/Mock-infected MMs. Proteins involved in 
vesicle fusion events were still enriched in this 
 group of selected proteins (23.25%) compared with the number of vesicle fusion 




Figure 42. Vesicle mediated transport Gen Ontology (GO) term. Proteins with a 30% 
enrichment in HSV-1 MMs versus control and enriched at least 40% in NE versus MMs of 
mock cells were analysed for the GO term vesicle mediate transport (GO:0016192). Vesicle 
mediated transport proteins represent 23.25% of the enriched proteins detected in HSV-1 





Next, the 107 selected proteins were individually analysed for specific GO-terms 
that are represented in a table in which GO term categories such as vesicle 
organization (GO:0016050), small GTPase mediated signal transduction 
(GO:0007264), or endomembrane system organization (GO: 0010256) were highly 
overrepresented in some of the HSV-1 enriched proteins (Table 14).  
The rest of GO categories analysed were: single-organism membrane organization 
(GO:0044802), nucleocytoplasmic transport (GO:0006913), vesicle fusion (GO: 
0006906), intracellular protein transport (GO:0006886), membrane fusion 
(GO:0061025), kinase activity (GO:0016301), lipid transport (GO:0006869), cell 
adhesion (GO:0007155) and endocytosis (GO:0006897). 
Some proteins of this list did not present any of the GO terms mentioned above. 
However, they showed other GO terms and functions that were not considered on 
this analysis as for example HNRNPC, a protein involved in RNA splicing and gene 
expression (GO:0008380) or ARL6IP5, a protein involved in apoptotic signalling 














































































































































































































































AATF                         
ABHD12                         
ADAM10                         
ADAM17                         
AFG3L2                         
AGPAT5                         
ALYREF                         
APMAP                         
ARF4                         
ARL6IP5                         
ATP11B                         
ATP8B2                         
ATP9B                         
CHTOP                         
CLCN7                         
CLPTM1                         
CSPG4                         
DDX21                         
DDX27                         
DPM1                         
EBAG9                         
ECE1                         
EFNB2                         
EMC3                         
 




EPHB2                         
EPHB4                         
FADS1                         
FLOT2                         
GOLGA5                         
H2AFV                         
HNRNPC                         
HNRNPR                         
IGF2R                         
ITGA6                         
ITGAV                         
ITPR3                         
KIDINS220                         
LMAN2                         
LMNA                         
LMNB1                         
LRRC8C                         
LUC7L                         
MLEC                         
MOSPD2                         
MRC2                         
MTDH                         
NDUFA4                         
NOLC1                         
NOLC1                         
NOP10                         
NOP2                         
NPC1                         
PAF1                         
PCDH19                         
PI4K2A                         
PIGK                         
PPIC                         
PRPH                         
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PTGS1                         
PTGS2                         
PTPN1                         
PTPRA                         
PTPRK                         
RAB11B                         
RAB18                         
RAB1A                         
RAB23                         
RAB2A                         
RAB34                         
RAB38                         
RAB6B                         
RAB9A                         
RNF121                         
RPL36                         
RPN1                         
SACM1L                         
SCAMP2                         
SEC61A1                         
SELT                         
SFXN3                         
SGCD                         
SLC12A4                         
SLC1A5                         
SLC23A2                         
SLC25A1                         
SLC25A11                         
SLC39A6                         
SLC4A7                         
SNRNP70                         
SORCS2                         
SPCS2                         
SPCS3                         
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SRSF3                         
SRSF7                         
SSR3                         
STEAP2                         
STOM                         
STX7                         
TM9SF3                         
TMEM30A                         
TMX3                         
TRPM4                         
VAMP7                         
VAPB                         
VCAM1                         
WLS                         






















5.5. Summary of chapter 5 
 
In this chapter I used a well characterised method, the isolation of microsomes, 
within the context of HSV-1 nuclear egress as a novel approach to identify cellular 
proteins that might be playing a role during herpesvirus egress at the NE. EM studies 
of MMs isolated from HSV-1 infected cells revealed the presence of viral particles 
that are likely PEP captured within these structures. If so, this technique could 
provide the opportunity to isolate PEP and study their composition by mass 
spectrometry analysis.  
Mass spectrometry analysis on HSV-1 infected MMs revealed the enrichment of a 
certain type of host proteins, vesicle membrane fusion proteins, that could be 
potentially driving nuclear egress of herpesvirus particles. Three of these vesicle 
membrane fusion proteins that were identified on this study were analysed in detail 





















VAPB, Rab11b and 
Rab18 Contribute to 
HSV-1 Infectivity by 
Facilitating Egress 





As previously described in chapter 5, we postulated that host membrane proteins 
involved in virus nuclear egress would move from the INM to ONM due to membrane 
fusion events in primary envelopment and de-envelopment and then diffuse into the 
ER. For this, MMs and NEs from mock or HSV-1 infected cells were isolated to 
identify proteins that changed abundance in the ER with infection and might be 
involved in nuclear egress. One of the more abundant groups of proteins detected 
in HSV-1 MMs was the one falling under the “vesicle fusion” category. 
Herpesviruses frequently co-op host cell proteins to support different steps of their 
life cycle. Cellular vesicle fusion proteins have been previously described to be 
involved in EBV egress by the induction of vesicle formation. However, this was not 
observed for HSV-1 egress (Lee, Liu et al. 2012). The vesicle fusion protein 
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enrichment observed in HSV-1 MMs led us to hypothesize the potential role of these 
proteins during nuclear egress. 
In this chapter, I will describe the identification and functional characterisation of 
three vesicle fusion proteins identified in our mass spectrometry datasets, VAPB, 
Rab11b and Rab18 and their involvement during HSV-1 nuclear egress.  
 
6.2. Vesicle fusion proteins identified in HSV-1 infected 
MMs 
 
As mentioned before, several Gene Ontology (GO) terms for proteins enriched in 
HSV-1 infected MMs were strongly linked with vesicle fusion events.  Thus, some 
of the proteins categorized under biological processes for vesicle mediated transport 
(GO:0016192), vesicle organization (GO:0016050), membrane fusion 
(GO:0061025) and endomembrane system organization (GO: 0010256) were 
selected from the list of proteins that were previously ranked based on their 1.3-fold 
and 1.4-fold enrichment in HSV-1 MMs and mock NE respectively. The stringency 
of the selection criteria was then increased for this set of vesicle fusion proteins, 
only considering those candidates that had at least 5 spectra in the NE fraction 
suggesting their abundance in the sample. The relative enrichment in each of the 
fractions for these selected proteins was plotted (Figure 43) and their peptides, 





















Gene P S dNSAF P S dNSAF P S dNSAF 1 2 
VAPB 2 7 0.0023 1 3 0.0004 2 8 0.0033 6.3 9.0 
VAMP
7 
2 4 0.0007 1 2 0.0001 3 11 0.0025 4.9 17.8 
RAB1
1B 
7 49 0.0071 6 61 0.0036 7 65 0.0122 2.0 3.4 
RAB9
A 
2 3 0.0005 1 4 0.0003 3 6 0.0012 1.9 4.8 
RAB1
A 
4 35 0.0054 5 50 0.0031 5 184 0.0368 1.7 11.9 
RAB1
8 
8 23 0.0035 7 33 0.0020 8 226 0.0450 1.7 22.1 
STX7 1 2 0.0002 1 3 0.0001 4 12 0.0019 1.7 12.9 
RAB2
A 
4 17 0.0025 6 30 0.0018 9 57 0.0110 1.4 6.1 
RAB3
5 















Figure 43. Enrichment of vesicle fusion proteins in HSV-1 infected MMs identified by 
mass spectrometry. (A) Protein abundance estimates based on spectral counts and 
protein molecular weight as a percentage of the total mass of spectra identified per mass 
spectrometry run (dNSAF) were used to calculate the relative enrichment between the three 
mass spectrometry datasets (HSV-1 MMs, Mock-infected MMs and Mock NEs). The ratio 
of dNSAF values for different vesicle fusion proteins between HSV-1 infected MMs and 
mock-infected MMs (A) and between NEs and mock-infected MMs (B) are shown.  
 
 
Three proteins were chosen for detailed analysis upon HSV-1 infection, VAPB, 
Rab11b and Rab18. VAPB is a member of the Vesicle-associated membrane 
protein (VAMP)-Associated Protein family of ER C-tail anchored proteins. It 
functions as an adaptor protein to recruit target proteins to the ER and execute 
various cellular functions. It has been also suggested to be implicated in ER stress 
and the unfolded protein response (UPR), ER to Golgi transport and microtubule 
organization (Peretti, Dahan et al. 2008, Prosser, Tran et al. 2008, Ratnaparkhi, 
Lawless et al. 2008, Fasana, Fossati et al. 2010). Rab11b and Rab18 are 
membrane-associated proteins belonging to the Ras-related small GTPases. 
Rab11b is reported in the recycling and early endosomes (Ullrich, Reinsch et al. 
1996, Mammoto, Ohtsuka et al. 1999) while Rab18 is reported also in the ER, 




6.3. Knockdown of vesicle fusion proteins results in 
nuclear accumulation of virus particles and significant 
reduction of HSV-1 viral titers 
 
The proteins redistributed upon HSV-1 infection according to the mass spectrometry 
data could directly benefit the virus or reflect a general perturbation of vesicle 
trafficking during infection.  
To determine if they play a role during the life cycle of the virus, siRNA was used to 
knock down VAPB, Rab18 and Rab11b and the effect on viral titers tested. Rab24 
and Rab1a were also knocked down as controls. Rab24 was used as a negative 
control as it did not increase in the HSV-1 infected MMs compared to mock-infected 
MMs and it has been previously described as a non-target protein through HSV-1 
life cycle. Rab1a was used as a positive control because this protein required for 
ER-to Golgi complex transport has been shown to be involved in HSV-1 mature 
particle assembly (secondary envelopment) and there are studies showing that its 
knockdown reduces viral growth by 60% (Zenner, Yoshimura et al. 2011, Soo, 
Halloran et al. 2015).  
HeLa cells were transfected with siRNA oligos and after 48 h the cells were lysed 
and analyzed by Western blot (Figure 44, A). VAPB was knocked down to nearly 
undetectable levels (95%) while the Rab11b and Rab18 protein showed at least 
85% of protein silencing. The controls Rab1a and Rab24 were knocked down 
similarly to roughly 80%. Another set of siRNA transfections was undertaken and at 
48 h transfected cells were subsequently infected with HSV-1 at a MOI of 10. At 16 
hpi supernatant from these cells was collected and tested by virus titration assay. 
As expected by previous studies, very little effect of Rab24 knockdown could be 
observed, while Rab1a knock down reduced viral titers by 62% (Figure 44, B). 
Interestingly, VAPB, Rab11b and Rab18 vesicle fusion proteins identified by our 
proteomic approach exhibited a stronger reduction in virus titers than the Rab1a 
knockdown (Figure 44, B). As an average of three separate experiments, Rab18 
knockdown yielded ~70% reduction in virus titers. Rab11b knockdown had an even 
stronger effect with ~85% reduction in virus titers. Finally, VAPB knockdown showed 
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the highest effect on viral titres with an over 90% reduction in viral growth (Figure 
44, B).  
To further confirm these observations and exclude an off-target knockdown, siRNA 
resistant for VAPB, Rab11b and Rab1a were generated. As expected, the effect on 
viral titres previously observed was not off-target effect of the siRNAs as the rescue 
experiments yielded full recovery of virus titres (Figure 44, C). 
To determine if the reduction on viral titres is produced by a defect on viral release 
rather than in viral replication, the effect of VAPB, Rab11b and Rab18 on viral 
genomes produced was also tested. Supernatants and cell pellets were collected 
and analyzed by qPCR. As expected from the virus titer experiments, the 
knockdowns resulted in a very significant reduction in virion (as measured by viral 
DNA copy number) release from the cell with the control being unaffected, similar 
to what was found in the titration data (Figure 44, D, left graph). However, qPCR for 
viral genomes in the infected whole cell pellets revealed that virus production was 
not significantly altered between the control and VAPB, Rab11b or Rab18 
knockdowns (Figure 44, D, right graph). Interestingly, viral genome numbers in the 
siRNA treated infected cells were all slightly higher than the control, presumably 
because of their accumulation within the nucleus when the egress pathways are 
disrupted.  
This result suggests that viral replication is not affected when these three vesicle 
fusion proteins are depleted in HSV-1 infected cells. Thus, the reduction in excreted 
HSV-1 genomes and the effective viral production in the nucleus is consistent with 
a role of VAPB, Rab18 and Rab11b in steps for egress as opposed to replication. 
However, these analyses do not distinguish whether the loss in titers reflects a 
function in nuclear egress or secondary envelopment. The reduction of viral release 
could be affected in either the exit of the virus from the nucleus during primary 
envelopment or the exit of the virus from the ER/Golgi during secondary 
envelopment. To distinguish between these possibilities, EM of control and siRNA 
HSV-1 infected cells was performed with the assistance of our collaborators Swetha 
Vijayakrishnan and Marion McElwee the University of Glasgow. If these vesicle 
fusion proteins were involved in nuclear egress, viral particles would be observed to 






Figure 44. VAPB, Rab11b and Rab18 knockout inhibits HSV-1 infection. (A) HeLa cells 
were transfected with siRNA oligos for the indicated proteins and after 48 h the cells were 
lysed and analyzed by Western blot with the indicated antibodies to check protein 
knockdown. (B) Hela cells were transfected with the control, Rab24, Rab1a, VAPB, 
Rab11b, Rab18, or a combined VAPB and Rab11b siRNA. After 48 h, cells were infected 
with HSV-1 (MOI, 10) and supernatant virions were collected at 16 hpi. Titers were 
established on U2OS cells and bars represent the average of three independent 
experiments, normalized to the control siRNA. Error bars are to the standard deviation and 
the p-values for comparing each condition with the control are shown (****p ≤ 0.0001; * 
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p≤0.005). (C) Rescue experiments with cells expressing wild-type protein resistant to the 
siRNAs were performed. In all cases the cells carrying both the rescue plasmid and the 
siRNAs recovered to roughly 80-90% of the control virus titers. (D) HSV-1 genome copy 
numbers were determined from released viral particles and from cell pellets by qPCR. HSV-
1 genome copy number from viral particles released from infected cells is reduced by 87% 
in siRab11b, 80% in siRab18 HSV-1 and 90% in siVAPB. However, HSV-1 genome copy 
number is unaffected in cell-associated virus compared with control. The p-values for 
comparing each condition with the control indicate a statistical significance in released virus 
while there is no significant difference in cell-associated virus (ns). All statistical tests were 
performed by one-way ANOVA and multiple comparisons were done by Dunnett´s test. 
 
 
EM of control cells infected with virus yielded the expected distribution with some 
nuclear particles undergoing assembly and many virus particles accumulating in the 
cytoplasm at 16 hpi (Figure 45, upper left panel). The same phenotype was 
observed for the Rab24 knockdown infected cells (Figure 45, upper right panel). 
However, at 16 hpi, accumulation of a large amount of viral particles was observed 
in the nucleus of HSV-1 infected cells in where Rab11b, Rab18 and VAPB was 
depleted (Figure 45, other image panels). Interestingly for VAPB knockdown, some 
images revealed enveloped particles trapped in lumenal extensions of the NE 
(Figure 45,B). Quantification of nuclear and cytoplasmic particles in several EM 
images was consistent with the visually observed tendency to accumulate particles 
in the nucleus. VAPB knockdown cells showed around 6 times more viral particles 
accumulated in the nucleus while the number of cytoplasmic particles significantly 










Figure 45. Electron microscopy reveals accumulation of virus particles in the nucleus 
with vesicle protein knockdowns. In control and Rab24 knockdown cells some non-
enveloped virus particles could be observed in the nucleoplasm, but many both enveloped 
and non-enveloped particles could also be observed in the cytoplasm as well as released 
mature particles just outside the cell. In contrast many more nucleoplasmic non-enveloped 
particles were observed in the Rab11b, Rab18 and VAPB knockdowns. Very few enveloped 
particles were observed for these three knockdowns in either the cytoplasm or nucleus, but 
some seemingly enveloped particles could be seen for Rab11b and VAPB knockdowns in 
association with the nuclear envelope and non-enveloped particles for the Rab18 
knockdown. Bottom right panel. Quantification of particles for the control and Rab24 
knockdowns revealed relatively few particles in the nucleus compared to the cytoplasm 
whereas for the VAPB knockdown there were mostly particles in the nucleus and few in the 
cytoplasm. Further quantification was not engaged because this was done more accurately 
by fluorescence in situ hybridization (see next figure). Experiment performed with the 
assistance of Swetha Vijayakrishnan and Marion McElwee at the University of Glasgow. 
 
 
As EM only captures viral particles in a particular section of the nucleus, we sought 
to perform an improved analysis to better quantify the number of viral particles 
trapped in the nucleus by fluorescence in situ hybridization (FISH). This experiment 
was performed by Dr Rafal Czapiewski, member of Schirmer´s lab with high 
experience in FISH techniques.  
For this, infected cells with control and vesicle fusion protein knockdowns were 
hybridized with a biotin-labelled probe for the gene encoding the HSV-1 ICP27 
protein and subsequently visualized by incubation with streptavidin conjugated 
fluorophore. The cells were pre-treated with RNase so that ICP27 RNA transcripts 
would not be recognized, but only viral genomes. Co-staining with DAPI identified 
the nuclear boundaries and imaging revealed the presence of viral particles in the 
cytoplasm in the non-target siRNA control cells, the Rab24 knockdown that had not 
changed according to the mass spectrometry results, and the Rab1A knockdown 
that is known to affect secondary envelopment but not nuclear egress (Figure 46, 
A). In contrast, the FISH signal for viral genomes was visually restricted to the 
nucleus in the VAPB, Rab11b and Rab18 knockdowns (Figure 46, A). The intensity 
of total FISH signal in each cell and also that just in the nucleus using the DAPI 
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staining as a mask was determined. The total signal divided by the nuclear signal 
was then plotted so that the amount of signal outside the nucleus is reflected in 
values above 1 (Figure 46, B). All three controls exhibited a clear increase in 
cytoplasmic viral particles while VAPB, Rab11b and Rab18 knockdowns all 
remained around 1 showing a significant difference as compared with controls.  
These results clearly show that these three vesicle fusion proteins act at the level of 





Figure 46. Fluorescence in situ hybridization (FISH) to quantify nuclear and 
cytoplasmic virus particles in vesicle fusion protein knockdown cells. (A) The virus 
gene ICP27 was used as a probe and labelled with biotin. Cells were knocked down for 
vesicle fusion proteins as in Figures 4 and 5, infected with HSV-1 and at 16 hpi fixed and 
processed for FISH. The hybridized virus gene was visualized with streptavidin conjugated 
to Alexa488 dye and imaged by immunofluorescence microscopy. Cells were co-stained 
with DAPI to identify the nucleus. Scale bar, 10 μm. (B) Using the DAPI nuclear staining to 
generate a mask of the nuclear area the nuclear pools of hybridized virus ICP27 DNA were 
quantified. The total hybridized ICP27 DNA in the same cell was also quantified and plotted 
divided by the nuclear signal so that values above 1 reflect the cytoplasmic pool of viral 
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genomes. A clear increase in cytoplasmic viral genomes can be seen for the non-target 
siRNA control, the Rab24 and the Rab1A knockdowns while no notable increase in 
cytoplasmic viral genomes was observed for VAPB, Rab11b and Rab18 knockdowns. 
Statistical measurements were performed using a 2-tailed ANOVA analysis: ***p<0.001. 
 
6.4. VAPB is recruited to the NE during HSV-1 infection  
 
To further analyse the role of these vesicle fusion proteins in HSV-1 infection, the 
intracellular distribution of VAPB was explored by indirect immunofluorescence in 
HSV-1 infected Hela cells. For this Hela cells were infected, fixed and stained at 8 
and 16 hpi with HSV-1 MOI 10. Indirect immunofluorescence analysis was 
performed to confirm the VAPB NE localization indicated by the proteomics data 
(Figure 47, A). In order to select for analysis only those cells infected by HSV-1, the 
infection was performed using an HSV-1 strain in which ICP27 was tagged with 
GFP. Supporting the proteomics results, VAPB was visibly observed to accumulate 
at the NE over time in the infected cells compared to the mock-infected cells with 
the strength of the signal dissipating through the ER. 
To support this visual readout, this re-localization pattern was observed in three 
independent experiments and image pixel intensities were measure in the NE and 
in the ER. Results clearly demonstrated a statistically significant increase in 
detection of VAPB at the NE early in HSV-1 infection that it is maintained at late 
points post infection. To quantify the relative signal for VAPB in the NE and ER, 
multiple lines were drawn through the middle of the nucleus of at least 40 cells and 
the signal intensity at the edge of the nucleus based on DAPI staining for the DNA 
was measured and also the signal in the ER along the same line but 2 µm away 
from the nucleus was also measured. The ratio of NE to ER signal intensity was 
plotted (Figure 47, A lower graph panel), revealing a strongly statistically significant 
near doubling of the NE:ER signal ratio between the mock-infected cells and the 16 
hpi timepoint with the 8 hpi timepoint in between. 
To make sure this was not a general effect produced during HSV-1 infection on 
membrane proteins, the distribution of calnexin, an ER protein also present in the 
ONM, was also sampled. Staining for calnexin yielded no notable visible increase 
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at the NE in infected cells and quantification confirmed that there was no increase 
in the NE:ER ratio (Figure 47, B). 
To confirm that the VAPB increase observed at the NE during HSV-1 infection is not 
due to changes in the protein levels, total cell lysates were analysed by Western 
blot using LiCOR fluorescence intensity measurements in mock and HSV-1 infected 
cells. Results revealed that VAPB levels were unchanged throughout the infection 
suggesting that the NE accumulation observed in HSV-1 infected cells is due to a 







Figure 47. VAPB is recruited to the NE during HSV-1 infection. (A) Hela cells were 
either mock infected or infected with MOI 10 HSV-1 vBSGFP27 (encoding WT ICP27 fused 
to GFP). At 8 and 16 hpi cells were fixed and processed for immunofluorescence 
microscopy with VAPB mouse monoclonal antibodies and DNA stained with DAPI. ICP27-
GFP is shown to identify infected cells. Scale bar, 10 μm. The VAPB signal appeared 
visually to increase at the NE during infection. To quantify this putative NE redistribution, 
the relative pixel intensities in the ER and NE were quantified. For each cell five lines were 
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drawn through the middle of the nucleus and pixel intensity was measured at a point in the 
nuclear rim (based on DAPI staining) and at a point 2 μm distant into the ER and the NE/ER 
ratio was calculated. Boxplots from 30 cells are shown in the graph below the images with 
the median (central line) and the error bars (grey) marked. Each sample was compared with 
its control (mock cells) by one-way ANOVA analysis followed by Dunnett´s test multiple-
comparison test. Significant p-values (****p ≤ 0.0001) illustrate the general trend of these 
vesicle fusion proteins to accumulate at the NE upon infection. (B) As a control the same 
analysis was performed staining for the ER and ONM marker Calnexin. In this case no 
significant change in the relative distribution was observed. (C) Analysis of total protein 
levels of VAPB in HSV-1 infected cells during infection. Lysates were prepared from mock-
infected HeLa cells or HeLa cells infected with WT HSV-1 with MOI 10 after 8, 16 and 24 
hpi in three separate experiments. Each lysate was analyzed by Western blots with the 
antibodies shown and using fluorophore-conjugated secondary antibodies for quantification 
by Li-COR. No obvious differences were observed in VAPB protein levels at any of the time 
points. 
 
6.5. VAPB co-localizes with HSV-1 nuclear egress 
protein UL34 at and around the NE 
 
Previous studies have shown that HSV-1 nuclear egress is a highly regulated 
process driven by the heterodimeric viral complex of UL31 and UL34. This complex 
accumulates at the NE during infection where it recruits cellular kinases to 
phosphorylate lamins thus promoting their disassembly so that the virus has access 
to the inner nuclear membrane for fusion events. Moreover, this complex appears 
to also directly participate in primary envelopment since EM studies of infected cells 
showed no evidence of primary enveloped particles in the absence of this protein 
(Roller et al., 2000). 
VAPB exhibited almost complete co-localization with UL34 at the NE (Figure 48, A). 
The specificity of the co-localization with UL34 was underscored using an HSV-1 
strain in which ICP27 WT protein was tagged with GFP. ICP27 is both involved in 
nucleocytoplasmic trafficking of viral intronless mRNAs and targets host cell 
introncontaining RNAs for destruction (Sandri-Goldin 2008, Malik, Tabarraei et al. 
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2012). Accordingly, ICP27 accumulates partly at the NE and also in nucleoplasmic 
punctae; however, these are different from the sites of primary envelopment as 
ICP27 is also known not to be in the capsid or tegument of primary particles. No 
overlapping fluorescence signals were observed at all between ICP27 and VAPB 
(Figure 48, A most right panel). 
As a transmembrane protein, VAPB should in theory only be in the NE and not in 
the nucleoplasm. Yet some of the staining signal appeared to be several microns 
away from the NE, appearing to occur in punta in the nucleoplasm. This type of 
staining pattern has previously been reported for UL34 as infection often induces 
extensive invaginations of the NE. To confirm that VAPB punta are from 
invaginations, 0.2 µm sections were taken in imaging for several cells. Continuity to 
the membrane was observed when following puncta through individual sections, 
revealing these internal punctae to be membrane invaginations of the NE as well as 
showing co-localization between VAPB and UL34 throughout (Figure 48, B).  
To further confirm the colocalization between VAPB and pUL34, super resolution 
microscopy was performed using a Zeiss 880 confocal microscope with Airyscan by 
Charles Dixon. Results also showed a co-localization for both punta and at the 












Figure 48. VAPB colocalizes with pUL34 at the nuclear membrane of HSV-1 infected 
cells. (A) HeLa cells infected with HSV-1 vBSGFP27 (encoding WT ICP27 fused to GFP) 
at MOI 10 were fixed at 8 and 16 hpi, permeabilized, and stained with UL34 and VAPB 
antibodies. VAPB, but not control ICP27, co-localized with UL34. Scale bar, 10 μm. (B) As 
internal punctae were observed in addition to NE staining, z-series were also taken to 
determine whether VAPB punctae were from nuclear invaginations or other non-membrane 
associated structures. All images are deconvolved from stacks with individual sections 
shown. Sections (0.2 μm each step) clearly show that internal punctae (single arrows) are 
connected in different sections to the membrane. Scale bar, 10 μm. (C) HeLa cells infected 
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with wild-type HSV-1 strain 17+ were fixed at 10 hpi and stained with VAPB mouse 
monoclonal antibodies, UL34 chicken antibodies and DAPI. Images were taken using a 
Zeiss 880 confocal Airyscan super resolution microscope. Considerable co-localization was 
observed between VAPB and UL34. Scale bars, 5 μm. C was performed by Charles Dixon. 
 
6.6. VAPB participates in HSV-1 primary envelopment 
 
VAPB showed to be translocated to the NE in HSV-1 infected cells in both, 
proteomic and immunofluorescence analysis. Viral particles accumulated in the 
nucleus were observed by FISH and EM after depletion of this protein in HSV-1 
infected cells. Based on this results, it is clear that VAPB is playing a role during 
nuclear egress. However, HSV-1 nuclear egress is divided in primary envelopment, 
and de-envelopment.  
In order to investigate if VAPB was involved in either envelopment or de-
envelopment or both, immunogold labelling EM was performed by our collaborators 
Martin W. Goldberg and Christine A. Richardson at the University of Durham.   
If just involved in de-envelopment, VAPB might be expected to only accumulate in 
the ONM and not translocate to the INM. Thus its distribution between the 
membranes was investigated in both, mock infected and HSV-1 infected cells, by 
immunogold labelling EM. Observations of imunogold results showed that nearly all 
images examined had VAPB protein in both INM and ONM in both the mock infected 
(Figure 49, A) and HSV-1 infected cells Figure 49, B). The finding of VAPB in the 
NE of mock-infected cells is consistent with its identification in NEs by the mass 
spectrometry data (Table 15). Gold particles at the NE were counted, considering 
separately those in the ONM, the INM, the NE lumen, and at the NPC (Figure 49, 
C). This indicated an increase in the INM pool during HSV-1 infection, consistent 
with the NE increase observed by immunofluorescence microscopy (Figure 49, A). 
Most surprisingly was the capturing in several images of virus particles inside the 
nucleus that contained gold particles labelling the VAPB Figure 49, D and E). This 
strongly argues that VAPB normally participates in the process of primary 
envelopment. Whether it has an additional separate role in de-envelopment has yet 






Figure 49. VAPB accumulates in both the ONM and INM. Hela cells either mock infected 
or infected with WT HSV-1 MOI 10 for 16 h were fixed and cryosectioned prior to labelling 
with VAPB mouse monoclonal antibodies and anti-mouse conjugated gold particles for 
electron microscopy. In all panels the cytoplasm is on the top and the nucleoplasm is on 
the bottom with this labeled in the upper left panel by C and N respectively. This panel also 
contains two arrows with that facing down delineating the ONM and that facing up 
delineating the INM. All scale bars, 100 nm. (A) Mock infected cells. Note the lower right 
panel contains one gold particle in transit at the NPC and one in the INM. (B) HSV-1 infected 
cells. (C) Quantification of 206 and 163 gold particles at the NE from respectively the mock 
infected and HSV-1 infected populations. The percentage of total NE particles touching the 
ONM and the INM are given along with those in the NE lumen and those at the NPC are 
given. (D) High magnification image of a most likely HSV-1 primary enveloped particle with 
a gold particle indicating VAPB just under the primary envelope membrane. Note that this 
appears to be located in a membrane bound invagination, possibly from the NE lumen as a 
membrane can be distinguished within the nucleoplasm (rightward pointing arrows). This 
membrane also is associated with gold particles. The presumed primary envelope is 
indicated by the sole leftward pointing arrow. (E) Lower magnification images showing 
multiple nuclear associated virus particles labelling with the VAPB immunogold particles. 
Although it cannot be fully ascertained from these images if these particles have a primary 
envelope, comparison with the inset image from standard electron microscopy of the VAPB 
knockdown infected cells shows that they have more the appearance of the non-enveloped 
(left) than enveloped (right) particles.This experiment was performed by Martin W. Goldberg 












6.7. Summary of chapter 6 
 
In this chapter, we analysed the role of three vesicle fusion proteins, VAPB, Rab11b 
and Rab18 and found their unique contribution during HSV-1 nuclear egress. We 
found for the first time that HSV-1 utilizes a class of host proteins, the vesicle fusion 
proteins in viral nuclear egress.  
The knockdown of these proteins yielded reduced titers of released virus, 
furthermore EM studies of cells in which either VAPB, Rab11b and Rab18 was 
depleted showed an accumulation of virus particles within the nucleus. Interestingly, 
VAPB showed a clear NE accumulation in HSV-1 infected cells in where it co-
localizes with the UL34 viral protein. More strikingly, VAPB was observed by 








Chapter 7  
General Discussion  
 
Over the las years it has become evident that the NE is no longer considered as a 
simple barrier between the cytoplasm and components of the nucleus. Instead, lot 
of recent exciting new roles have been shown for this membrane that are vital for 
the cell. For instance, the NE participates in new ways of ribosome transport in which 
ribosomal proteins produced in the cytosol are imported into the nucleus, where they 
associate with newly synthesized ribosomal RNA (rRNA), and are then exported 
back to the cytoplasm to perform their function. Additionally, novel NE roles have 
been suggested in providing anchoring sites for chromosomes to the nuclear 
periphery in order to regulate gene expression regulation.  
The results presented in this thesis argues in favour of a previously uncharacterized 
nuclear role for the multifunctional protein NET23/STING potentially in both innate 
immune signalling and general chromatin architecture. Moreover, I presented data 
that could explain the involvement of NET23/STING itself in mediating IIR against 
RNA despite that it does not bind to RNA. 
This work additionally shed light on the nuclear egress of HSV-1, one of the less 
understood steps in herpesvirus life cycle. I identified a new group of host proteins, 
vesicle membrane fusion proteins that are involved in this step facilitating the exit of 








7.1. NET23/STING can mediate chromatin compaction 
from the NE 
 
NET23/STING was firstly introduced in a proteomics’ study as a NE integral protein 
(Schirmer, Florens et al. 2003). Since then, multiple studies have identified this 
protein in different compartments of the cell such as ER and mitochondria, linking 
its function to innate immune signaling pathways (Ishikawa and Barber 2008, Zhong, 
Yang et al. 2008, Ishikawa, Ma et al. 2009, Burdette and Vance 2013). However, 
the role of NET23/STING within the NE has been completely ignored. 
Epigenetic is a stably heritable phenotype that results as an alteration or 
modification in the DNA function but without modifying its sequence. These changes 
are produced by chemical modifications on both DNA and DNA-associated histones. 
During my PhD, I have shown for the first time the involvement of NET23/STING in 
promoting a chromatin compaction state and epigenetic changes from the NE.  
Quantification of clusters as a measure of chromatin compaction and EM 
observations of cells overexpressing NET23/STING clearly indicates that 
NET23/STING may contribute generally to chromatin compaction. The observed 
chromatin compaction phenotype identified in this study might also be produced by 
the recruitment of epigenetic factors or enzymes to the NE or by the direct effect of 
NET23/STING on chromatin as it is known this protein directly interacts with 
chromatin. This novel role is further supported by the identification of bromodomain 
proteins and chromatin-associated complexes as NET23/STING-NE binding 
partners that might mediate the previously mentioned involvement of NET23/STING 
in chromatin remodeling and other epigenetic alterations associated with its role in 
IIR.   
Upon a pathogen attack, host cells undergo enormous changes in their 
transcriptional program, resulting in the activation and repression of multiple genes 
involved in key processes (e.g., immunity, apoptosis, cell survival) to trigger an 
appropriate response (Bierne, Hamon et al. 2012). The principal goal of a cell 
infected with an external pathogen is to avoid the propagation of the infection within 
the host organism. For this propose, the cell activates innate immune signal 
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cascades for the release of interferons and cytokines in order to target the immune 
system to the infected cell. Multiple epigenetic changes related with the regulation 
of the IIR to face infections have been observed (Vanden Berghe, Ndlovu et al. 
2006, Kugelberg 2015). Thus, the process in which the IIR is activated by a 
pathogen infection can be influenced by epigenetic modifications within the infected 
cell. For example, the activation of TLRs by pathogens, results in the downstream 
activation of IIR genes involved in the production of proinflammatory factors and it 
is known that TLR gene expression is regulated by several alterations to the 
epigenetic signature such as histone modifications (Hennessy and McKernan 
2016).  
Acetylation of histone promotes a relaxed chromatin structure promoting gene 
transcription as transcription factors have access to the DNA resulting in gene 
expression. On the other hand, deacetylation of histone compacts the chromatin 
structure favoring gene silencing. Silencing epigenetic marks play a pivotal role in 
the global IIR (Stender and Glass 2013). It has been shown that the inhibition of 
histone deacetylases (HDACs) impairs essential biologic functions of the IIR of 
infected cells, as their ability to induce a proinflammatory response and kill 
pathogens is being reduced increasing the susceptibility to infection (Roger, Lugrin 
et al. 2011).  
Epigenetic modifications regulate the expression of the genome to produce multiple 
innate immune response signals as a cellular response to external stimuli. Recent 
studies have highlighted the possibility of certain pathogens such as virus and 
bacteria to directly target and influence diverse epigenetic factors like histone 
modifications and chromatin-associated complexes to either promote host defense 
or to allow pathogen persistence. For instance, histone deacetylase expression is 
found to increase upon infection of plants with pathogens and transgenic plants 
overexpressing the deacetylase are more susceptible to infection (Ding, Bellizzi 
Mdel et al. 2012). Also, Listeria monocytogenes, bacteria that is the main causative 
agent of listeriosis, has been shown to rapidly increase acetylation of histones 
(H3S10p, H3K14ac, and H4K8ac) resulting in the activation of the proinflammatory 
gene IL-8 (Schmeck et al. 2005; Opitz et al. 2006). Thus, there is likely a ‘‘tug-of-
war’’ effect going on in the infected cell between the pathogen efforts to block the 
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activation of the IIR within the host cell and the host cell to find the right balance in 
its response to block the spread of the infection within the rest of organism.  
An increase in the histone marks H3K9me3 has been shown at early times post 
infection in HSV-1 infected cells resulting in an increase in chromatin compaction 
that might suggest a defense mechanism of the host cell. This repression is known 
to be countered by the virus through the recruitment of the required enzymes to 
remove the repressive histone marks while installing the activating marks for the 
advantage of the virus (Arbuckle and Kristie 2014). This is consistent with the results 
presented in this thesis in which the depletion of NET23/STING prevented the 
increase of chromatin compaction that normally occurs early upon HSV-1 infection. 
Furthermore, these results showed the attenuation of HSV-1 in cells no longer 
expressing NET23/STING. Although it remains unclear why the effect of HSV-1 
infection in HT1080 cells was to reduce instead of increase chromatin compaction, 
though the nuclear size changes in this experiment could affect the output of the 
algorithm, the effect of the virus was mitigated by NET23/STING depletion. 
Furthermore, in order to confirm the role of NET23/STING in the alteration of the 
chromatin compaction state of HSV-1 infected cells, EM studies could be performed 
in order to analyze the state of chromatin on HSV-1 infected cells no longer 
expressing NET23/STING.  
Previous experiments performed in my lab showed that the distribution of 
NET23/STING at the NE was lost in lamin A knockout mouse embryonic fibroblasts 
(Malik, Korfali et al. 2010) suggesting a potential link of NET23/STING to lamin A. 
Thus, considering the interrelation between these two proteins, it follows logically 
that NET23/STING may be involved in some of the chromatin changes observed in 
NE-diseases in which lamin A is involved.  
Several NE diseases caused by defects in NETs, lamins and epigenetic marks 
presented an aberrant distribution of chromatin (Ognibene, Sabatelli et al. 1999, 
Sewry, Brown et al. 2001, Goldman, Shumaker et al. 2004). Considering the role of 
NET23/STING in promoting endogenous chromatin compaction from the NE, it is 
likely that this protein could also contribute to mediate chromatin epigenetic patterns 
in certain NE diseases.  This is supported by observations that both the 
NET23/STING compaction phenotype and the observed EM changes in chromatin 
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in some NE diseases have been linked to epigenetic modifications. For example, in 
fibroblast from Hutchison-Gilford Progeria patients, in which lamin A protein is 
mutated, there is a reduction of epigenetic marks associated with silenced chromatin 
such as H3K9me3 and H3K27me3 while there is an increase of H4K20me, 
epigenetic mark associated with active chromatin (De Sandre-Giovannoli, Bernard 
et al. 2003, Eriksson, Brown et al. 2003).  
 
7.2. Identification of RNA binding proteins as 
NET23/STING NE partners  
 
The data presented in this thesis points out a new potential role for this extremely 
multifunctional protein in acting as a transporter for NE-specific NET23/STING 
binding partners involved in innate immunity.   
This protein was firstly identified as an important cytoplasmic sensor by recognizing 
pathogen DNA, but not RNA, in the ER and triggering the activation of signaling 
cascades to promote the induction of IRF3/7 transcription factors. The role of this 
protein in response to RNA is much less clear (Zhong, Yang et al. 2008, Sun, Li et 
al. 2009, Chen, Sun et al. 2011). Several studies have shown a function of 
NET23/STING in host innate immunity against certain positive sense single strand 
RNA viruses with no DNA intermediaries. Of note, a study with NET23/STING 
knockout mice showed higher susceptibility to RNA virus infection such as Sendai 
virus (SeV) and vesicular stomatitis virus (VSV) (Ishikawa and Barber 2008). 
Furthermore, the initial characterization of mouse embryonic fibroblasts with 
depletion of NET23/STING presented a defect in the induction of the interferon 
response to RNA viruses. Additional studies have shown that although 
NET23/STING interacts with key elements of the RNA-sensing pathways like RIG-I 
and MAVS (Zhong, Yang et al. 2008, Sun, Li et al. 2009, Zhong, Zhang et al. 2009) 
and it may be essential for the induction of certain STAT6 target genes, it is not an 
absolute requirement for the activation of the interferon response to RNA, 
presumably because there are redundant pathways that can activate IRF3/7 
transcription factors for the production of interferons (Ishikawa and Barber 2008, 
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Chen, Sun et al. 2011, Sauer, Sotelo-Troha et al. 2011). The many disparate roles 
of NET23/STING make it difficult to distinguish details of NET23/STING signaling 
pathways and how this protein might mediate IIR against RNA viruses without 
binding RNA. However, our finding that multiple NET23/STING NE-binding partners 
were RNA binding factors could explain the greater sensitivity to RNA virus infection 
in NET23/STING knockout mice, indicating the involvement of this protein in 
mediating IIR against RNA virus.  
 
7.3. Partner protein distribution changes  
 
Additionally, I found that NET23/STING mediates shuttling of NE binding 
proteins in and out the nucleus in response to an external signal such as HSV-1 
infection or Poly I:C treatment. Two STING-NE co-IP partners, Syncrip and 
MEN1 that normally shuttle between the nucleus and cytoplasm during IIR, failed 
to redistributed in NET23/STING depleted cells. This means that the distribution 
of these partners is NET23/STING dependent upon IIR activation arguing that 
this transmembrane protein can carry proteins in either direction as a response 
to external stimuli.  
To our knowledge, no IIR roles have been reported for Syncrip or MEN1. Thus, their 
contribution to IIR has been lately tested in my lab.  For this, a luciferase assay was 
performed in which NFкB, ISRE, ISG56 and IFNß-luciferase reporters (IIR reporters 
used to quantify IIR activity) were activated upon co/transfection of STING and cyclic 
GMP-AMP synthase (cGAS). As previously stated, cGAS produces a second 
messenger (cGAMP) that is bound by STING/NET23 during IIR. This assay allowed 
to determine whether a binding partner protein was important for the IIR activation 
based on a loss of luciferase activity compared to controls. The luciferase signal 
from some of the reporters was mitigated when Syncrip and MEN1 were depleted 
from cells in which the IIR was activated by poly I:C. This data supported that the 




It is known that RNA viruses often activate IIR through NFкB mediated signaling 
pathways (Schmitz, Kracht et al. 2014). Interestingly cells no longer expressing 
Syncrip showed a reduction in the activation of the NFкB -reporter known to be 
activated by RNA viruses (Zhong, Yang et al. 2008), indicating the potential 
involvement of Syncrip in NET23/STING-mediated IIR. These data argued that 
Syncrip RNA-binding function could mediate NET23/STING functions in RNA 
induced IIR. 
 
7.4. NET23/STING shuttling in the NE 
 
The NE FRAP experiments performed in this thesis, showed that the translocation 
of NET23/STING in HSV-1 infected cells is significantly increase compared with 
mock-infected cells. As NE FRAP experiments predominantly quantifies the 
translocation of NE transmembrane proteins from the ER to the NE through the NPC 
peripheral channels and the observation that some NE-binding partners such as 
Syncrip and MEN1 failed to redistributed in cells no longer expressing 
NET23/STING, we could speculate that NET23/STING is acting as a shuttling 
protein carrying signals upon IIR activation. Although further studies such as PA 
experiments will need to shed light on the dynamics of NET23/STING, this could 
provide a multiply redundant backup mechanism for activating IIR through 
peripheral channel transport of the NET23/STING-NE binding partners previously 
identified that can interact with IRF3/7 partners activating immune cascade signals.  
 
7.5. NET23/STING provides an alternative transport 
pathway via the NPC peripheral channels 
 
Data presented in this thesis indicates that NET23/STING is not just an upstream 
activator of the IIR, but presents a previously uncharacterized nuclear role for this 
multifunctional protein in both general chromatin architecture acting as a chromatin 
regulator and in innate immune signaling as a nucleo-cytoplasmic driver for NE-
specific NET23/STING binding partners involved in IIR. 
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These new roles may also reflect an alternative and creative mechanisms for the 
host cell to get around the efforts of the pathogen to block the IIR. Numerous 
pathogens have evolved different mechanisms to hijack and block the central 
channels of the NPC to inhibit host nucleocytoplasmic transport pathways facilitating 
viral infection (Le Sage and Mouland 2013). For example, ICP27 herpesvirus protein 
and HIV-1 viral ribonucleoproteins (vRNP) have been shown to interact with Nup62, 
a nucleoporin present in the NPC central channel (Chang, Lee et al. 2012, Malik, 
Tabarraei et al. 2012). But NETs can still travel through the peripheral channels of 
the NPC (Zuleger, Kerr et al. 2012). Thus, in cases in which transport through the 
NPC central channels is blocked due to the infection of the host cell by certain 
pathogens, NET23/ STING is likely to still be able to target to the INM where it could 
engage its nuclear functions such as promoting chromatin compaction. 
NETs, like all membrane proteins are synthesized in the ER and to reach the INM 
they have to move within the ER towards the ONM in where they finally translocate 
into the INM via the NPCs. NETs targeting to the INM bind to nuclear components 
in the nucleoplasm like lamins and chromatin. Some of these NETs can recruit 
heterochromatin by either direct interaction with it or by the recruitment of specific 
epigenetic marks such as silencing factors, adding new epigenetic signatures to 
chromatin once it is at the periphery (Stancheva and Schirmer 2014).  
The transmission of epigenetic changes in response to signaling through the 
peripheral channels is a relatively novel concept, however, some NETs have been 
shown to promote epigenetic marks by binding to silencing factors and recruiting 
them to the NE. For example, the NET LBR can bind DNA methylation enzyme 
MeCP2 and the NETs LAP2b and emerin can bind the histone deacetylase HDAC3 
(Somech, Shaklai et al. 2005, Guarda, Bolognese et al. 2009, Demmerle, Koch et 
al. 2012).  Thus, epigenetic marks could be transmitted in response to IIR signals 
through the peripheral channels by the recruitment of some of these enzymes by 
transmembrane proteins present in the NE. The significant increase in H3K9me3 of 
cells overexpressing NET23/STING by Western blot and its first appearance at the 
nuclear periphery by immunofluorescence microscopy in the cells exogenously 
expressing NET23/STING suggests that this NET may directly recruit histone 
modifying enzymes to the NE in addition to other epigenetic marks as an extra 
194 
 
defense mechanism for the host cell.  Furthermore, upon IIR activation, 
NET23/STING might be carrying some of the identified NE binding partners such as 
bromodomain proteins involved in chromatin remodeling through the peripheral 
channels in order to regulate chromatin architecture. Future work will need to test 
whether the depletion of some of these proteins identified by co-IP block the effects 
on chromatin marks associated with NET23/STING overexpression.  
The increase in translocation observed for NET23/STING in the NE after HSV-1 
infection together with the failed redistribution of some NE binding partners identified 
to be involved in IIR (Syncrip and MEN1), let me to propose a model in which 
NET23/STING, in response to pathogen infection, might be activated and 
redistributed from the ER to the NE while carrying NE-binding partners involved in 
immune cascade signaling through the peripheral channels. In addition, 
NET23/STING could promote epigenetic changes from the INM resulting in 
modifications in chromatin architecture that could activate or repress epigenetic 

























































Figure 50.  Model for NET23/STING acting as a chromatin regulator and serving as a transport 
receptor. NET23/STING promotes epigenetic marks such as H3K9me3 that may compact chromatin 
in response to infection. Also, NET23/STING might act as a carrier for proteins involved in IIR such 
as Syncrip and MEN1 facilitating their translocation through the peripheral channels. When the central 
channel of NPC is disrupted by pathogen infections, NET23/STING could use the peripheral channels 
to carry binding partners between the nucleus and cytoplasm or activate epigenetic enzymes to 




7.6. Future Experimental Directions  
 
7.6.1 Distinguishing central from peripheral channel transport 
 
In order to get more insights into the role of NET23/STING within the NE, it will be 
necessary to capture the translocation of Syncrip and MEN1 at the peripheral 
channels of the NPC to confirm that both proteins translocate together with 
NET23/STING through these channels in response to external stimuli. It is important 
to mention that, as Syncrip and MEN1 are soluble cargoes, they could use both, 
central and peripheral channels to translocate and that the NET23/STING effects 
are only a backup mechanism for cases where central channel transport has been 
blocked by pathogens. 
Thus, to study if the transit of NET23/STING NE-binding partners such as Syncrip 
and MEN1 are restricted to the peripheral channels, the IIR could be activated in +/- 
NET23/STING depleted cells after microinjections with WGA antibody to block the 
central channel transport or gp210 antibody to block peripheral channel transport 
(Ohba, Schirmer et al. 2004) in order to analyze the localization of NET23/STING 
binding partners.   
To attempt to capture NET23/STING binding partners in the peripheral channels, 
FRB-FKBP rapamycin trap system could be used (Chen, Zheng et al. 1995, Klemm, 
Beals et al. 1997). For this purpose, stable cell lines expressing FRB fused with 
either Nup62 (nucleoporin from the central channel) or Nup35 (nucleoporin from the 
peripheral channel) could be used to trap FKBP-Syncrip or FKBP-MEN1 fusions 
upon addition of rapamycin.  Thus, if the NET23/STING binding partners translocate 
through the peripheral channel, it should be captured just with Nup35; if it goes just 
through the central channels, it should be captured just with Nup62 and if it uses 
both, central and peripheral channels, then both Nups will capture these 








Separately, I could use SPEED (Single-Point Edge-Excitation subDiffraction)  
microscopy, a super resolution approach developed by Weidong Yang which allows 
the study of 3D transport routes at the NPC, being able to distinguish transport  
through the peripheral NPC channels (Ma, Kelich et al. 2016). GFP-labelled 
NET23/STING, Syncrip and MEN1 could be analyzed for peripheral channel 
transport upon IIR activation using polyI:C and infection by viruses known to 
interfere with central channel transport such as HSV-1 and HIV. 
 
7.6.2 Regulation of NET23/ STING activity at the NE 
 
Additionally, it has been shown that NET23/STING is phosphorylated by TBK1 at 
the C-terminus upon the activation of the IIR. This phosphorylation is essential to 
later recruit and activate IRF3, resulting in the stimulation of interferons and 
cytokines (Tanaka and Chen 2012, Liu, Cai et al. 2015). It is logical to suggest that 
the phosphorylation of NET23/STING might disrupt its connection with other NE 
proteins such as the previously mentioned interaction with lamin A, so that, 
Figure 51. Schematic representation of FRB/FKBP rapamycin capture experiment. 
Upon the addition of the drug rapamycin, FKBP-GFP fusion proteins (Syncrip or MEN1) are 
expected to be captured in the NPC peripheral channels in cells expressing Nup35-mRFP-
FRB, a peripheral channel trap protein, while be able to pass freely through peripheral 
channels in cells expressing FRB-mRFP-Nup62, a central channel trap protein.  
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NET23/STING would become more mobile facilitating its increased shuttling. Thus, 
the study of the mobility of NET23/STING by FRAP and PA techniques using a 
phoshonull and phosphomimic NET23/STING mutant could confirm an increased 
translocation of this protein confirming its role as a transmembrane peripheral 
channel transport receptor. 
 
7.6.3 Mediation of RNA IIR 
 
It has been suggested that NET23/STING mediates IIR to RNA viruses but does not 
bind to RNA. However, the identification of ss and dsRNA NET23/STING binding 
partners may have a functional relevance for this protein that could be involved in 
sensing a wider variety of pathogen nucleic acids and carry these binding partners 
to the nucleus. The identification of the RNA-binding protein Syncrip as a novel IIR 
mediator suggests that the NET23/STING shuttling of RNA-binding partners could 
explain how NET23/STING activates the IIR in response to RNA viruses without 
binding RNA.   
Other NET23/STING NE-binding partners identified by co-IP, such as ZRANBP2, 
PRPF40A, SNRNP70, RPS27A and DDX5, are also reported as RNA-binding 
proteins.  Of these, only DDX5 has a known IIR link, being targeted by hepatitis C 
and several other viruses to shut down IRF3 transcription factor (Li, Ge et al. 2013, 
Moy, Cole et al. 2014, Upadya, Aweya et al. 2014, Zhao, Ge et al. 2015).   
An interesting direction would be to test the effects that the knockdown of these 
NET23/STING NE binding proteins could have in the IIR using a IIR luciferase 
reporter assay. Once several partners would be identified as having an effect on the 
IIR, CRAC techniques could be performance during viral infection in order to identify 
actual viral RNAs bound to these NET23/STING NE binding partners and get 
insights into their role during IIR signaling.  
 
In order to confirm the involvement of several novel IIR mediators that likely function 
redundantly to provide, through NET23/STING, a backup mechanism for the cell to 
activate the IIR when central channel of NPC is blocked and further support the 
results from the luciferase assay, it would be interesting to study whether some of 
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these NET23/STING RNA-binding partners hamper viral growth. For this, viral titers 
could be performed in individual and combinatorial depleted cells. 
 
7.7. Herpesvirus nuclear egress 
 
In the last few years it has become clear that herpesvirus capsids leave the nucleus 
following a membrane envelopment process at the NE by a vesicle-mediated 
process that enables budding of nucleocapsids at the INM resulting in the formation 
of PEP in the NE lumen. Then, these particles fuse with the ONM releasing naked 
capsids into the cytoplasm where a second envelopment process takes place. There 
are two well-known viral proteins that play a role in this process and that are 
conserved among the herpesviridae family, UL31 and UL34 (Bigalke and Heldwein 
2015, Bosse and Enquist 2016, Hellberg, Passvogel et al. 2016). Before reaching 
the INM, nucleocapsids need to face the nuclear lamina, a dense meshwork of 
filaments, nuclear lamin binding proteins and NETs that maintain the structure of the 
nucleus. The involvement of cellular kinases, such as Cdk1 and PKC has been 
previously suggested in order to phosphorylate and soften the nuclear lamina 
facilitating the access of the viral nucleocapsids to the INM (Morrison and DeLassus 
2011).  
In the work presented in this thesis I aimed to shed light on the nuclear egress of 
HSV-1 by the identification of host cellular proteins that might be co-operating with 
UL31 and UL34 or be involved in alternative pathways helping viral nucleocapsids 
to cross the NE.  Furthermore, as the NE contains hundreds of transmembrane 
proteins interacting with lamins and chromatin, it is likely to hypothesize that in order 
to achieve a successful nuclear egress, HSV-1 must target and disrupt some of 






7.7.1. Potential identification of multiple viral proteins as part 
of primary enveloped particles 
 
One of the hypotheses we pursued in order to identify host cellular proteins involved 
in herpesvirus nuclear egress was that proteins from the INM captured during the 
process of primary envelopment/de-envelopment or actively participating in the 
primary envelope are released into the ONM and diffuse into the ER. With this idea 
in mind, MMs from HSV-1 infected cells were isolated and subjected to MS 
analyses. Although the core purpose of this study was not the isolation of PEP, the 
EM observation of viral particles inside isolated MMs that presented similar 
characteristics and appearance to PEP suggested that this approach in combination 
with immunogold labeling could be used in the future to obtain a pure fraction of 
PEP trapped in the NE lumen. The isolation of PEP could be subjected to an in-
depth proteome analysis that will provide new insights into HSV-1 biology. Sucrose 
gradients could be used to concentrate and purify PEP from HSV-1 infected MMs. 
Immunogold labelling using already known viral proteins present in PEP should 
confirm the isolation of these particles. 
The composition of PEP is only partially known due to difficulties in isolating this 
assembly intermediate viral form for complete proteomic analysis. Until the moment, 
only a limited study performed by Padula and colleagues attempted to isolate 
primary virions and identified 8 viral proteins as part of the primary envelope 
(Padula, Sydnor et al. 2009).  Although only gD of the viral coat glycoproteins was 
identified in this study as being part of the primary enveloped, other studies have 
indicated the presence of gB and gC (Torrisi, Di Lazzaro et al. 1992, Jensen and 
Norrild 1998) that we found of similar abundance to gD in our mass spectrometry 
analysis. Thus, it is reasonable to suggest that our MS datasets contain most or all 
of the proteins, both viral and host cell-encoded, that are in PEP. Even though I 
performed different experiments to determine the optimal time during infection 
where nuclear egress has started but before secondary envelopment, I cannot 
clearly distinguish which proteins were present due to synthesis in the ER and which 
are in captured PEP. Nevertheless, the grouping of higher abundance glycoproteins 
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that were all previously reported in PEP suggests that other virion proteins may be 
identified by similar abundance groupings. 
While capsid and some tegument proteins are expected in the PEP, the functional 
significance and role, if any, for glycoproteins in nuclear egress is unclear. During 
secondary envelopment viral glycoproteins located in the TGN interact with 
tegument proteins presented in the surface of capsids helping to pull the host 
membranes around viral particles. Thus, it is possible that during primary 
envelopment viral glycoproteins play a part in anchoring the INM onto the capsid in 
a similar way as during secondary envelopment. Evidence supporting this 
hypothesis came from the colocalisation of gB, gH, UL31 and UL34 at the NE 
together with cellular proteins CD98hc and β1-intergrin. This study argues that these 
cellular proteins probably interact directly and/or indirectly with viral proteins gB, gH, 
UL31 and UL34 regulating HSV-1 nuclear egress (Hirohata, Arii et al. 2015).  Thus, 
it is likely that these viral protein complexes may recruit other host proteins needed 
for both primary and secondary envelopment such as vesicle fusion proteins that 
could drive membrane fusion events at the NE. 
 
7.7.2. Vesicle fusion membrane proteins involved in 
nuclear egress  
 
Recent studies have shown that the process of nuclear egress is not exclusive to 
herpesviruses as it has also been observed during the export of RNPs, large 
synaptic ribonucleoparticles in Drosophila (Speese, Ashley et al. 2012, Fradkin and 
Budnik 2016). These particles are too large to cross the NPC, therefore as in the 
case of herpesviruses, RNPs need to develop new mechanisms to cross through 
the NE. The existence of nuclear egress events in non-infected cells argues that 
herpesviruses might usurp or mimic this cellular pathway during infection. Although 
different studies suggested common biological mechanism between the nuclear 
egress of RNPs and herpesvirus PEP, no cellular proteins have been yet identified 
to be involved in HSV-1 nuclear egress.  
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Recently EM-tomography studies have argued that only electron density for UL31 
and UL34 is observed at sites of fusion with the INM, suggesting that the presence 
of only these two viral proteins is sufficient to push the INM around the 
nucleocapsids (Hagen, Dent et al. 2015). But this process is likely much more 
complex as UL31 is a phosphoprotein that does not present transmembrane 
domains and it localizes to the INM through interaction with UL34, a protein which 
is still uncertain whether is a full transmembrane protein or it is ectopically 
associated to the NE. To our knowledge no study has ever directly tested whether 
UL34 is a transmembrane protein or ectopically associated with the membrane. In 
Shiba paper, the topology of UL34 is investigated in order to study in which cellular 
compartment the N-terminal region of the protein was inserted (Shiba, Daikoku et 
al. 2000). However, this study did not perform any experiment to test whether the 
C-terminus extended into the opposing cellular compartment. Although this study 
stated that this C-terminus is likely a type II transmembrane protein based on the 
use of a hydrophobic stretch of 22 to 37 residues near the C-terminus, this could 
also be observed for an ectopically associated protein. Moreover, they did not 
directly test its membrane insertion. The digitonin permeabilization experiment, 
previously used to distinguish between antigens on the nuclear and cytoplasmic side 
of the NE, could be used to directly test the membrane insertion of UL34. However, 
this could be a difficult experiment to perform in the case of this viral protein. If UL34 
is a transmembrane protein, there would be only three aminoacids in the NE lumen 
making difficult the production of a specific antibody for only these three amino acids 
and adding a tag would be likely to alter normal topology. 
Thus, as UL34 seems to be presenting a weak association to the membrane as 
compared to other proteins presenting multiple transmembrane domains within the 
NE and taking into account that herpesviruses frequently co-op host cell machinery 
to support various aspects of their life cycle, it is likely that other cellular proteins are 
being used for a more efficient nuclear egress by being involved in membrane 
curvature for budding at the NE or by co-operating with UL31 and UL34 pulling the 
INM around the new viral particles. This argument is further supported by the need 
of proteins to be strongly associated to membrane through the interaction with other 
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protein complexes in order to effect membrane curvature and be able to pull the 
surrounding membrane around a specific cargo (Jarsch, Daste et al. 2016).   
Accordingly, the involvement of host proteins such as ESCRT proteins has recently 
been shown for Epstein-Barr virus EBV. In this case, the Chmp4b protein important 
for scission complex assembly largely co-localized in perinuclear aggregates with 
EBV protein BFRF1 and inhibition of the Alix bridging protein resulted in 
accumulation of capsid proteins in the nucleus. However, they also reported that the 
ability to induce vesicle formation was not found for HSV-1 UL34 protein (Lee, Liu 
et al. 2012).  The identification of VAPB, Rab11b and Rab18 as vesicle fusion 
proteins contributing to virus egress points out the possibility of other host proteins 
contributing to herpesvirus egress  
VAPB is a member of the Vesicle-associated membrane protein (VAMP) Associated 
Protein family of ER C-tail anchored proteins. It functions as an adaptor protein to 
recruit target proteins to the ER and execute various cellular functions such as lipid 
transport, membrane trafficking and membrane fusion (Lev, Ben Halevy et al. 2008). 
A nuclear link has also previously been found for VAPB where its knockdown 
resulted in a failure of NPC proteins gp210 and Nup214 and the nuclear membrane 
protein emerin to accumulate at the nuclear envelope (Tran, Chalhoub et al. 2012). 
However, as VAPB was predominantly found in the ER in this study, this could as 
easily reflect general disruption of protein synthesis, post-translational modifications 
and trafficking caused by VAPB knockdown which is known to induce Golgi 
fragmentation and disrupted ER to ERGIC (ER-Golgi Intermediate Compartment) to 
Golgi trafficking (Peretti, Dahan et al. 2008, Kuijpers, Yu et al. 2013). In contrast we 
found clear accumulation of VAPB in the nuclear membrane during HSV-1 infection 
and its considerable co-localization with UL34 suggesting a direct function in nuclear 
egress. This does not discount the possibility that VAPB has both direct and indirect 
effects on HSV-1 processing and trafficking or a possible additional role in 
secondary envelopment.  
A potential additional role for the two Rab proteins tested in secondary envelopment 
is also a possibility, especially as a previous study reported Rab11b involvement in 
secondary envelopment (Hollinshead, Johns et al. 2012). Rab proteins are 
membrane-associated proteins belonging to the Ras-related small GTPases. There 
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are over 50 Rab proteins encoded by mammalian genomes with only 19 of them 
having functions in the Golgi and only 6 of these functioning exclusively in the Golgi 
(Liu and Storrie 2012). Moreover, Rab11b is reported also in the recycling and early 
endosomes (Ullrich, Reinsch et al. 1996) and Rab18 is reported also in the ER, 
endosome and lipid droplets (Lutcke, Parton et al. 1994, Brasaemle, Dolios et al. 
2004). Functionally, Rab proteins have been shown to be crucial regulators for many 
aspects of membrane trafficking including vesicle formation, budding, docking and 
fusion so that they could contribute to multiple aspects of both envelopment and de-
envelopment, as well as secondary envelopment.   
The only previously known functional links between Rab11b and viruses are a study 
showing its involvement in herpes secondary envelopment in the Golgi (Hollinshead, 
Johns et al. 2012) and a report of its involvement in hantavirus release from cells 
(Rowe, Suszko et al. 2008). Rab18, in contrast, is linked to multiple RNA viruses for 
their assembly around lipid droplets in the cytoplasm, including hepatitis C and 
Dengue virus (Salloum, Wang et al. 2013, Dansako, Hiramoto et al. 2014); however, 
such functions are clearly distinct from its contribution to herpesvirus nuclear egress.  
Nonetheless, due to the wide range of functions linked to Rab proteins it remains 
possible that some of their effects on the virus could be indirect. For example, 
Rab11b was recently shown to be involved in proper sorting of the protease-
activated receptor-1 protein (Grimsey, Coronel et al. 2016), thus raising the 
possibility that Rab protein recruitment of as yet unknown proteins to the NE could 
contribute to post-translational processing of herpesvirus proteins. 
Although only the depletion of VAPB, Rab11b and Rab18 were tested for viral titers, 
additional vesicle membrane fusion proteins such as VAMP7, Rab9a, Rab2A and 
STX7 were identified to have similar NE localization and an increase in HSV-1 
infected MMs compared to mock-infected MMs. These finding indicated the potential 
interplay of other host cell vesicle fusion proteins during viral nuclear egress 
suggesting the potential redundancy in the use of vesicle membrane fusion proteins 
that can readily explain why combined knockdowns did not yield a greater reduction 
in viral titers.  
Thus, based on my results and previous studies for other herpesviruses, vesicle 
membrane fusion proteins might be involved in HSV-1 nuclear egress perhaps 
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affecting the curvature of the INM or ONM or co-operate with UL31, UL34 or other 
viral proteins facilitating viral budding into the NE lumen. Further experiments will 
need to confirm the specific mechanisms by which these vesicle fusion proteins are 
being involved in HSV-1 nuclear egress. For instance, an interesting direction would 
be to determine whether the vesicle fusion proteins identified in this thesis physically 
interact with UL31 and/or UL34 by the performance of pulldown assays.  
 
7.7.3. Vesicle fusion proteins involved in envelopment or 
de-envelopment? 
  
One of the main questions that remains about the role of these vesicle membrane 
fusion proteins is whether they contribute to primary envelopment, de-envelopment 
or both during herpesvirus nuclear egress. The immunogold labelling EM data 
showed VAPB associating with nucleoplasmic virus particles, making a role in 
primary envelopment almost certain. However, the immunogold EM data also clearly 
shows VAPB localizes both to the ONM and the INM during HSV-1 infection, which 
indicates that its potential contribution could affect either or both steps. It is important 
to note that while the appearance in either membrane could reflect functionality, if 
these transmembrane proteins translocate by lateral diffusion in the membrane 
through the peripheral NPC channels similarly to other NETs, then the presence in 
both membranes could also simply reflect this diffusion process due to the many 
NPCs in the membrane. In considering a possible dual function, it is important to 
note that previous studies of gB and gH depletion or mutants revealed an 
accumulation of PEP in both the nucleoplasm and in the NE lumen (Farnsworth, 
Wisner et al. 2007, Wright, Wisner et al. 2009). In contrast, knockdown of VAPB, 
Rab11b and Rab18 all resulted principally in accumulation of non-enveloped 
encapsidated virus particles in the nucleoplasm with very few observed in the NE 
lumen. This observation is more what would be expected for a role in primary 
envelopment at the INM as the depletion of these proteins are hampering the ability 
of these particles to become wrapped by the INM reaching the NE lumen and, 
accordingly, is consistent with the observation of VAPB in both the INM and ONM 
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during normal infection, as any protein in the INM that got into PEP would be 
redistributed to the ONM upon de-envelopment. It is important to note that this does 
not contradict any of the previous studies in which UL31 and UL34 depletion showed 
reduced HSV-1 titers when compared with wild type infection as HSV-1 has been 
shown to still get out of the nucleus in the absence of these two viral proteins (Miller, 
Hill et al. 1976, Wagenaar, Pol et al. 1995, Klupp, Granzow et al. 2001, Haugo, 
Szpara et al. 2011) suggesting the presence of multiple mechanisms by which 
herpesvirus is able to cross the NE. 
 
7.7.4. NETs might be playing a role in herpesvirus nuclear 
egress 
 
The presence of hundreds of different NETs within the NE and the numerous 
interactions with the nuclear lamina likely suggest that these transmembrane 
proteins might be either targeted by herpesvirus capsids prior to envelopment at the 
INM or they might be assisting viral fusion events with capsid and/or tegument 
protein, like glycoproteins do in secondary envelopment, facilitating a proximal 
access of viral particles to the INM that will result in membrane deformation. 
Previously, some NETs such as LBR have been shown to undergo a partial 
redistribution from a predominantly INM localization to a significant proportion 
accumulating in the ER upon HSV-1 infection (Scott and O'Hare 2001). Thus, it is 
not surprising the relocalization suffered by some other NETs observed by 
immunofluorescence microscopy in this thesis. Interestingly, NET29 and NET39 are 
known to have a direct role in chromosome organization and their observed 
accumulation at cytoplasmic or ER compartment during HSV-1 infection could 
implicate the break of connections between NETs and chromatin in order to facilitate 
viral access to the INM arguing the possibility of other NETs being removed from 
the NE in order to facilitate primary envelopment. 
This is just preliminary data; so further experiments are needed to confirm these 
observations. There is still the question of whether these NETs are being targeted 
directly by the virus or the observed redistribution is an indirect consequence of a 
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disruption between chromatin, lamins and NETs.  One direction that would be 
interesting to pursue is if the absence of some of these NETs is affecting viral 
growth. To address this question, viral titers could be performed in infected cells in 
which the knockdown of multiple rather than individual NETs would be tested as it 
is likely that the silencing of a single NET would not yield a greater reduction in viral 
titers due to the complex interplay of these proteins during viral nuclear egress.  
It is also important to have in mind that some of these NETs, as shown for emerin, 
might be suffering post-translational modifications such as phosphorylation (Leach, 
Bjerke et al. 2007, Morris, Hofemeister et al. 2007). The identification of new cellular 
kinases in our MS dataset suggesting their potential involvement in nuclear egress 
clearly supports this idea.  
These post-translational modifications might be induced during viral infection in 
order to alter the tethering of NETs with chromatin at the NE facilitating the access 
of nucleocapsids to the membrane. Thus, another approach will be to test if some 
of the screened NETs present phosphorylation as a consequence of HSV-1 
infection. For this, MS analysis should be performed on HSV-1 MMs previously 
isolated using phosphatase inhibitors buffers in order to block dephosphorylation of 
proteins.  
 
7.7.5. Herpesvirus nuclear egress final remarks 
 
This work provides an advance in the field of herpesvirus nuclear egress in which I 
have found for the first time for HSV-1 the involvement of multiple vesicle fusion 
proteins in this viral step.  
Despite recent studies arguing that UL31/34 is sufficient to allow membrane 
invaginations at the NE (Bigalke, Heuser et al. 2014) (Hagen, Dent et al. 2015) and 
pointing out that neither of these studies measured the efficiency of membrane 
budding compared to a normal infection, it seems likely that the discovery of vesicle 
fusion proteins in this thesis might provide an alternative pathway for herpesvirus 
nuclear egress besides the already known UL31 and UL34 proteins. However, there 
are many questions still to be answered. What is the relative contribution of UL31/34 
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and these vesicle fusion proteins to primary envelopment? What viral proteins 
recruit the vesicle fusion proteins and do they directly interact?  
Additionally, the novel approach presented in this thesis in which MMs from HSV-1 
infected cells are isolated in order to find potential host proteins involved in nuclear 
egress could be modified in the future to isolate a pure fraction of PEP in order to 
gain a deep understanding of the protein composition of these particles.  
The study presented in this thesis presents novel insights into one of the least 
understood steps in HSV-1 life cycle through the identification of vesicle fusion host 
proteins that are being involved in viral egress and could possibility represent novel 






Agarwal, S. K., S. C. Guru, C. Heppner, M. R. Erdos, R. M. Collins, S. Y. Park, S. Saggar, S. C. 
Chandrasekharappa, F. S. Collins, A. M. Spiegel, S. J. Marx and A. L. Burns (1999). "Menin interacts 
with the AP1 transcription factor JunD and represses JunD-activated transcription." Cell 96(1): 143-
152. 
Akhtar, J. and D. Shukla (2009). "Viral entry mechanisms: cellular and viral mediators of herpes 
simplex virus entry." FEBS J 276(24): 7228-7236. 
Akira, S., S. Uematsu and O. Takeuchi (2006). "Pathogen recognition and innate immunity." Cell 
124(4): 783-801. 
Arbuckle, J. H. and T. M. Kristie (2014). "Epigenetic repression of herpes simplex virus infection by 
the nucleosome remodeler CHD3." MBio 5(1): e01027-01013. 
Aydin, I., S. Weber, B. Snijder, P. Samperio Ventayol, A. Kuhbacher, M. Becker, P. M. Day, J. T. 
Schiller, M. Kann, L. Pelkmans, A. Helenius and M. Schelhaas (2014). "Large scale RNAi reveals 
the requirement of nuclear envelope breakdown for nuclear import of human papillomaviruses." 
PLoS Pathog 10(5): e1004162. 
Baines, J. D., E. Wills, R. J. Jacob, J. Pennington and B. Roizman (2007). "Glycoprotein M of herpes 
simplex virus 1 is incorporated into virions during budding at the inner nuclear membrane." J Virol 
81(2): 800-812. 
Bannai, H., K. Fukatsu, A. Mizutani, T. Natsume, S. Iemura, T. Ikegami, T. Inoue and K. Mikoshiba 
(2004). "An RNA-interacting protein, SYNCRIP (heterogeneous nuclear ribonuclear protein 
Q1/NSAP1) is a component of mRNA granule transported with inositol 1,4,5-trisphosphate receptor 
type 1 mRNA in neuronal dendrites." J Biol Chem 279(51): 53427-53434. 
Barber, G. N. (2011). "Innate immune DNA sensing pathways: STING, AIMII and the regulation of 
interferon production and inflammatory responses." Curr Opin Immunol 23(1): 10-20. 
Baricheva, E. A., M. Berrios, S. S. Bogachev, I. V. Borisevich, E. R. Lapik, I. V. Sharakhov, N. 
Stuurman and P. A. Fisher (1996). "DNA from Drosophila melanogaster beta-heterochromatin binds 
specifically to nuclear lamins in vitro and the nuclear envelope in situ." Gene 171(2): 171-176. 
Berk, J. M., K. E. Tifft and K. L. Wilson (2013). "The nuclear envelope LEM-domain protein emerin." 
Nucleus 4(4): 298-314. 
Bhuin, T. and J. K. Roy (2014). "Rab proteins: the key regulators of intracellular vesicle transport." 
Exp Cell Res 328(1): 1-19. 
Bickmore, W. A. and B. van Steensel (2013). "Genome architecture: domain organization of 
interphase chromosomes." Cell 152(6): 1270-1284. 
Bierne, H., M. Hamon and P. Cossart (2012). "Epigenetics and bacterial infections." Cold Spring 
Harb Perspect Med 2(12): a010272. 
210 
 
Bigalke, J. M. and E. E. Heldwein (2015). "The Great (Nuclear) Escape: New Insights into the Role 
of the Nuclear Egress Complex of Herpesviruses." J Virol 89(18): 9150-9153. 
Bigalke, J. M. and E. E. Heldwein (2016). "Nuclear Exodus: Herpesviruses Lead the Way." Annu Rev 
Virol 3(1): 387-409. 
Bigalke, J. M., T. Heuser, D. Nicastro and E. E. Heldwein (2014). "Membrane deformation and 
scission by the HSV-1 nuclear egress complex." Nat Commun 5: 4131. 
Bione, S., E. Maestrini, S. Rivella, M. Mancini, S. Regis, G. Romeo and D. Toniolo (1994). 
"Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy." Nat 
Genet 8(4): 323-327. 
Bjerke, S. L. and R. J. Roller (2006). "Roles for herpes simplex virus type 1 UL34 and US3 proteins 
in disrupting the nuclear lamina during herpes simplex virus type 1 egress." Virology 347(2): 261-
276. 
Boehmer, P. E. and I. R. Lehman (1997). "Herpes simplex virus DNA replication." Annu Rev Biochem 
66: 347-384. 
Bonifacino, J. S. and B. S. Glick (2004). "The mechanisms of vesicle budding and fusion." Cell 
116(2): 153-166. 
Bonne, G., M. R. Di Barletta, S. Varnous, H. M. Becane, E. H. Hammouda, L. Merlini, F. Muntoni, C. 
R. Greenberg, F. Gary, J. A. Urtizberea, D. Duboc, M. Fardeau, D. Toniolo and K. Schwartz (1999). 
"Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular 
dystrophy." Nat Genet 21(3): 285-288. 
Bonne, G., F. Leturcq and R. Ben Yaou (1993). Emery-Dreifuss Muscular Dystrophy. 
GeneReviews(R). R. A. Pagon, M. P. Adam, H. H. Ardinger et al. Seattle (WA). 
Bosse, J. B. and L. W. Enquist (2016). "The diffusive way out: Herpesviruses remodel the host 
nucleus, enabling capsids to access the inner nuclear membrane." Nucleus 7(1): 13-19. 
Bosse, J. B., I. B. Hogue, M. Feric, S. Y. Thiberge, B. Sodeik, C. P. Brangwynne and L. W. Enquist 
(2015). "Remodeling nuclear architecture allows efficient transport of herpesvirus capsids by 
diffusion." Proc Natl Acad Sci U S A 112(42): E5725-5733. 
Brack, A. R., J. M. Dijkstra, H. Granzow, B. G. Klupp and T. C. Mettenleiter (1999). "Inhibition of 
virion maturation by simultaneous deletion of glycoproteins E, I, and M of pseudorabies virus." J Virol 
73(7): 5364-5372. 
Brack, A. R., B. G. Klupp, H. Granzow, R. Tirabassi, L. W. Enquist and T. C. Mettenleiter (2000). 
"Role of the cytoplasmic tail of pseudorabies virus glycoprotein E in virion formation." J Virol 74(9): 
4004-4016. 
Brasaemle, D. L., G. Dolios, L. Shapiro and R. Wang (2004). "Proteomic analysis of proteins 
associated with lipid droplets of basal and lipolytically stimulated 3T3-L1 adipocytes." J Biol Chem 
279(45): 46835-46842. 
Bruns, H. (1980). "Electron microscopic studies of herpes simplex virus type 1 infection of 
macrophages, T- and B-lymphocytes of mice." Arch Virol 64(3): 257-268. 
211 
 
Burdette, D. L. and R. E. Vance (2013). "STING and the innate immune response to nucleic acids in 
the cytosol." Nat Immunol 14(1): 19-26. 
Cai, M., Y. Huang, R. Ghirlando, K. L. Wilson, R. Craigie and G. M. Clore (2001). "Solution structure 
of the constant region of nuclear envelope protein LAP2 reveals two LEM-domain structures: one 
binds BAF and the other binds DNA." EMBO J 20(16): 4399-4407. 
Caillet, M., K. Janvier, A. Pelchen-Matthews, D. Delcroix-Genete, G. Camus, M. Marsh and C. 
Berlioz-Torrent (2011). "Rab7A is required for efficient production of infectious HIV-1." PLoS Pathog 
7(11): e1002347. 
Callan, H. G. and S. G. Tomlin (1950). "Experimental studies on amphibian oocyte nuclei. I. 
Investigation of the structure of the nuclear membrane by means of the electron microscope." Proc 
R Soc Lond B Biol Sci 137(888): 367-378. 
Calle, A., I. Ugrinova, A. L. Epstein, P. Bouvet, J. J. Diaz and A. Greco (2008). "Nucleolin is required 
for an efficient herpes simplex virus type 1 infection." J Virol 82(10): 4762-4773. 
Caputo, S., J. Couprie, I. Duband-Goulet, E. Konde, F. Lin, S. Braud, M. Gondry, B. Gilquin, H. J. 
Worman and S. Zinn-Justin (2006). "The carboxyl-terminal nucleoplasmic region of MAN1 exhibits a 
DNA binding winged helix domain." J Biol Chem 281(26): 18208-18215. 
Carbon, S., A. Ireland, C. J. Mungall, S. Shu, B. Marshall, S. Lewis, G. O. H. Ami and G. Web 
Presence Working (2009). "AmiGO: online access to ontology and annotation data." Bioinformatics 
25(2): 288-289. 
Chang, C. W., C. P. Lee, Y. H. Huang, P. W. Yang, J. T. Wang and M. R. Chen (2012). "Epstein-
Barr virus protein kinase BGLF4 targets the nucleus through interaction with nucleoporins." J Virol 
86(15): 8072-8085. 
Chang, Y. E. and B. Roizman (1993). "The product of the UL31 gene of herpes simplex virus 1 is a 
nuclear phosphoprotein which partitions with the nuclear matrix." J Virol 67(11): 6348-6356. 
Chen, H., H. Sun, F. You, W. Sun, X. Zhou, L. Chen, J. Yang, Y. Wang, H. Tang, Y. Guan, W. Xia, 
J. Gu, H. Ishikawa, D. Gutman, G. Barber, Z. Qin and Z. Jiang (2011). "Activation of STAT6 by STING 
is critical for antiviral innate immunity." Cell 147(2): 436-446. 
Chen, J., X. F. Zheng, E. J. Brown and S. L. Schreiber (1995). "Identification of an 11-kDa FKBP12-
rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and 
characterization of a critical serine residue." Proc Natl Acad Sci U S A 92(11): 4947-4951. 
Chiacchia, K. B. and K. Drickamer (1984). "Direct evidence for the transmembrane orientation of the 
hepatic glycoprotein receptors." J Biol Chem 259(24): 15440-15446. 
Choi, K. S., A. Mizutani and M. M. Lai (2004). "SYNCRIP, a member of the heterogeneous nuclear 
ribonucleoprotein family, is involved in mouse hepatitis virus RNA synthesis." J Virol 78(23): 13153-
13162. 
Christensen, M. H., S. B. Jensen, J. J. Miettinen, S. Luecke, T. Prabakaran, L. S. Reinert, T. 
Mettenleiter, Z. J. Chen, D. M. Knipe, R. M. Sandri-Goldin, L. W. Enquist, R. Hartmann, T. H. 
Mogensen, S. A. Rice, T. A. Nyman, S. Matikainen and S. R. Paludan (2016). "HSV-1 ICP27 targets 
212 
 
the TBK1-activated STING signalsome to inhibit virus-induced type I IFN expression." EMBO J 
35(13): 1385-1399. 
Christensen, M. H., S. B. Jensen, J. J. Miettinen, S. Luecke, T. Prabakaran, L. S. Reinert, T. 
Mettenleiter, Z. J. Chen, D. M. Knipe, R. M. Sandri-Goldin, L. W. Enquist, R. Hartmann, T. H. 
Mogensen, S. A. Rice, T. A. Nyman, S. Matikainen and S. R. Paludan (2016). "HSV-1 ICP27 targets 
the TBK1-activated STING signalsome to inhibit virus-induced type I IFN expression." EMBO J. 
Cohen, S., S. Au and N. Pante (2011). "How viruses access the nucleus." Biochim Biophys Acta 
1813(9): 1634-1645. 
Columbaro, M., C. Capanni, E. Mattioli, G. Novelli, V. K. Parnaik, S. Squarzoni, N. M. Maraldi and 
G. Lattanzi (2005). "Rescue of heterochromatin organization in Hutchinson-Gilford progeria by drug 
treatment." Cell Mol Life Sci 62(22): 2669-2678. 
Conn, K. L. and L. M. Schang (2013). "Chromatin dynamics during lytic infection with herpes simplex 
virus 1." Viruses 5(7): 1758-1786. 
Connolly, S. A., J. O. Jackson, T. S. Jardetzky and R. Longnecker (2011). "Fusing structure and 
function: a structural view of the herpesvirus entry machinery." Nat Rev Microbiol 9(5): 369-381. 
Cook, A., F. Bono, M. Jinek and E. Conti (2007). "Structural biology of nucleocytoplasmic transport." 
Annu Rev Biochem 76: 647-671. 
Copeland, A. M., W. W. Newcomb and J. C. Brown (2009). "Herpes simplex virus replication: roles 
of viral proteins and nucleoporins in capsid-nucleus attachment." J Virol 83(4): 1660-1668. 
Courvalin, J. C., N. Segil, G. Blobel and H. J. Worman (1992). "The lamin B receptor of the inner 
nuclear membrane undergoes mitosis-specific phosphorylation and is a substrate for p34cdc2-type 
protein kinase." J Biol Chem 267(27): 19035-19038. 
Czapiewski, R., M. I. Robson and E. C. Schirmer (2016). "Anchoring a Leviathan: How the Nuclear 
Membrane Tethers the Genome." Front Genet 7: 82. 
Dahl, K. N., S. M. Kahn, K. L. Wilson and D. E. Discher (2004). "The nuclear envelope lamina network 
has elasticity and a compressibility limit suggestive of a molecular shock absorber." J Cell Sci 117(Pt 
20): 4779-4786. 
Dahl, K. N., A. J. Ribeiro and J. Lammerding (2008). "Nuclear shape, mechanics, and 
mechanotransduction." Circ Res 102(11): 1307-1318. 
Dansako, H., H. Hiramoto, M. Ikeda, T. Wakita and N. Kato (2014). "Rab18 is required for viral 
assembly of hepatitis C virus through trafficking of the core protein to lipid droplets." Virology 462-
463: 166-174. 
Davison, A. J. (2010). "Herpesvirus systematics." Vet Microbiol 143(1): 52-69. 
De Sandre-Giovannoli, A., R. Bernard, P. Cau, C. Navarro, J. Amiel, I. Boccaccio, S. Lyonnet, C. L. 
Stewart, A. Munnich, M. Le Merrer and N. Levy (2003). "Lamin a truncation in Hutchinson-Gilford 
progeria." Science 300(5628): 2055. 
De Santa, F., V. Narang, Z. H. Yap, B. K. Tusi, T. Burgold, L. Austenaa, G. Bucci, M. Caganova, S. 
Notarbartolo, S. Casola, G. Testa, W. K. Sung, C. L. Wei and G. Natoli (2009). "Jmjd3 contributes to 
the control of gene expression in LPS-activated macrophages." EMBO J 28(21): 3341-3352. 
213 
 
De Santa, F., M. G. Totaro, E. Prosperini, S. Notarbartolo, G. Testa and G. Natoli (2007). "The 
histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene 
silencing." Cell 130(6): 1083-1094. 
De Vos, K. J., G. M. Morotz, R. Stoica, E. L. Tudor, K. F. Lau, S. Ackerley, A. Warley, C. E. Shaw 
and C. C. Miller (2012). "VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium 
homeostasis." Hum Mol Genet 21(6): 1299-1311. 
Dechat, T., J. Gotzmann, A. Stockinger, C. A. Harris, M. A. Talle, J. J. Siekierka and R. Foisner 
(1998). "Detergent-salt resistance of LAP2alpha in interphase nuclei and phosphorylation-dependent 
association with chromosomes early in nuclear assembly implies functions in nuclear structure 
dynamics." EMBO J 17(16): 4887-4902. 
Demmerle, J., A. J. Koch and J. M. Holaska (2012). "The nuclear envelope protein emerin binds 
directly to histone deacetylase 3 (HDAC3) and activates HDAC3 activity." J Biol Chem 287(26): 
22080-22088. 
Dempsey, A. and A. G. Bowie (2015). "Innate immune recognition of DNA: A recent history." Virology 
479-480: 146-152. 
Diefenbach, R. J., M. Miranda-Saksena, M. W. Douglas and A. L. Cunningham (2008). "Transport 
and egress of herpes simplex virus in neurons." Rev Med Virol 18(1): 35-51. 
Ding, B., R. Bellizzi Mdel, Y. Ning, B. C. Meyers and G. L. Wang (2012). "HDT701, a histone H4 
deacetylase, negatively regulates plant innate immunity by modulating histone H4 acetylation of 
defense-related genes in rice." Plant Cell 24(9): 3783-3794. 
Dreger, M., L. Bengtsson, T. Schoneberg, H. Otto and F. Hucho (2001). "Nuclear envelope 
proteomics: novel integral membrane proteins of the inner nuclear membrane." Proc Natl Acad Sci 
U S A 98(21): 11943-11948. 
Duffy, C., J. H. Lavail, A. N. Tauscher, E. G. Wills, J. A. Blaho and J. D. Baines (2006). 
"Characterization of a UL49-null mutant: VP22 of herpes simplex virus type 1 facilitates viral spread 
in cultured cells and the mouse cornea." J Virol 80(17): 8664-8675. 
Dwyer, D. E. and A. L. Cunningham (2002). "10: Herpes simplex and varicella-zoster virus 
infections." Med J Aust 177(5): 267-273. 
Eibauer, M., M. Pellanda, Y. Turgay, A. Dubrovsky, A. Wild and O. Medalia (2015). "Structure and 
gating of the nuclear pore complex." Nat Commun 6: 7532. 
Eisenberg, R. J., D. Atanasiu, T. M. Cairns, J. R. Gallagher, C. Krummenacher and G. H. Cohen 
(2012). "Herpes virus fusion and entry: a story with many characters." Viruses 4(5): 800-832. 
Elliott, G., G. Mouzakitis and P. O'Hare (1995). "VP16 interacts via its activation domain with VP22, 
a tegument protein of herpes simplex virus, and is relocated to a novel macromolecular assembly in 
coexpressing cells." J Virol 69(12): 7932-7941. 
Eng, J. K., A. L. McCormack and J. R. Yates (1994). "An approach to correlate tandem mass spectral 




Eriksson, M., W. T. Brown, L. B. Gordon, M. W. Glynn, J. Singer, L. Scott, M. R. Erdos, C. M. Robbins, 
T. Y. Moses, P. Berglund, A. Dutra, E. Pak, S. Durkin, A. B. Csoka, M. Boehnke, T. W. Glover and 
F. S. Collins (2003). "Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria 
syndrome." Nature 423(6937): 293-298. 
Farnsworth, A., K. Goldsmith and D. C. Johnson (2003). "Herpes simplex virus glycoproteins gD and 
gE/gI serve essential but redundant functions during acquisition of the virion envelope in the 
cytoplasm." J Virol 77(15): 8481-8494. 
Farnsworth, A., T. W. Wisner, M. Webb, R. Roller, G. Cohen, R. Eisenberg and D. C. Johnson (2007). 
"Herpes simplex virus glycoproteins gB and gH function in fusion between the virion envelope and 
the outer nuclear membrane." Proc Natl Acad Sci U S A 104(24): 10187-10192. 
Fasana, E., M. Fossati, A. Ruggiano, S. Brambillasca, C. C. Hoogenraad, F. Navone, M. Francolini 
and N. Borgese (2010). "A VAPB mutant linked to amyotrophic lateral sclerosis generates a novel 
form of organized smooth endoplasmic reticulum." FASEB J 24(5): 1419-1430. 
Fatahzadeh, M. and R. A. Schwartz (2007). "Human herpes simplex virus infections: epidemiology, 
pathogenesis, symptomatology, diagnosis, and management." J Am Acad Dermatol 57(5): 737-763; 
quiz 764-736. 
Fawcett, D. W. (1966). "On the occurrence of a fibrous lamina on the inner aspect of the nuclear 
envelope in certain cells of vertebrates." Am J Anat 119(1): 129-145. 
Fawcett, D. W., S. Doxsey and G. Buscher (1981). "Salivary gland of the tick vector (R. 
appendiculatus) of East Coast fever. I. Ultrastructure of the type III acinus." Tissue Cell 13(2): 209-
230. 
Fidzianska, A., D. Toniolo and I. Hausmanowa-Petrusewicz (1998). "Ultrastructural abnormality of 
sarcolemmal nuclei in Emery-Dreifuss muscular dystrophy (EDMD)." J Neurol Sci 159(1): 88-93. 
Fields, A. P. and L. J. Thompson (1995). "The regulation of mitotic nuclear envelope breakdown: a 
role for multiple lamin kinases." Prog Cell Cycle Res 1: 271-286. 
Florens, L., N. Korfali and E. C. Schirmer (2008). "Subcellular fractionation and proteomics of nuclear 
envelopes." Methods Mol Biol 432: 117-137. 
Florens, L. and M. P. Washburn (2006). "Proteomic analysis by multidimensional protein 
identification technology." Methods Mol Biol 328: 159-175. 
Foisner, R. and L. Gerace (1993). "Integral membrane proteins of the nuclear envelope interact with 
lamins and chromosomes, and binding is modulated by mitotic phosphorylation." Cell 73(7): 1267-
1279. 
Fossum, E., C. C. Friedel, S. V. Rajagopala, B. Titz, A. Baiker, T. Schmidt, T. Kraus, T. Stellberger, 
C. Rutenberg, S. Suthram, S. Bandyopadhyay, D. Rose, A. von Brunn, M. Uhlmann, C. Zeretzke, Y. 
A. Dong, H. Boulet, M. Koegl, S. M. Bailer, U. Koszinowski, T. Ideker, P. Uetz, R. Zimmer and J. 
Haas (2009). "Evolutionarily conserved herpesviral protein interaction networks." PLoS Pathog 5(9): 
e1000570. 
Fradkin, L. G. and V. Budnik (2016). "This bud's for you: mechanisms of cellular nucleocytoplasmic 
trafficking via nuclear envelope budding." Curr Opin Cell Biol 41: 125-131. 
215 
 
Franke, W. W., U. Scheer, G. Krohne and E. D. Jarasch (1981). "The nuclear envelope and the 
architecture of the nuclear periphery." J Cell Biol 91(3 Pt 2): 39s-50s. 
Fuchs, W., B. G. Klupp, H. Granzow, N. Osterrieder and T. C. Mettenleiter (2002). "The Interacting 
UL31 and UL34 Gene Products of Pseudorabies Virus Are Involved in Egress from the Host-Cell 
Nucleus and Represent Components of Primary Enveloped but Not Mature Virions." Journal of 
Virology 76(1): 364-378. 
Fuchs, W., B. G. Klupp, H. Granzow, N. Osterrieder and T. C. Mettenleiter (2002). "The interacting 
UL31 and UL34 gene products of pseudorabies virus are involved in egress from the host-cell 
nucleus and represent components of primary enveloped but not mature virions." J Virol 76(1): 364-
378. 
Funk, C., M. Ott, V. Raschbichler, C. H. Nagel, A. Binz, B. Sodeik, R. Bauerfeind and S. M. Bailer 
(2015). "The Herpes Simplex Virus Protein pUL31 Escorts Nucleocapsids to Sites of Nuclear Egress, 
a Process Coordinated by Its N-Terminal Domain." PLoS Pathog 11(6): e1004957. 
Furukawa, K. (1999). "LAP2 binding protein 1 (L2BP1/BAF) is a candidate mediator of LAP2-
chromatin interaction." J Cell Sci 112 ( Pt 15): 2485-2492. 
Galdiero, S., A. Falanga, M. Vitiello, H. Browne, C. Pedone and M. Galdiero (2005). "Fusogenic 
domains in herpes simplex virus type 1 glycoprotein H." J Biol Chem 280(31): 28632-28643. 
Gerace, L. and G. Blobel (1980). "The nuclear envelope lamina is reversibly depolymerized during 
mitosis." Cell 19(1): 277-287. 
Gerace, L. and B. Burke (1988). "Functional organization of the nuclear envelope." Annu Rev Cell 
Biol 4: 335-374. 
Geumann, U., S. V. Barysch, P. Hoopmann, R. Jahn and S. O. Rizzoli (2008). "SNARE function is 
not involved in early endosome docking." Mol Biol Cell 19(12): 5327-5337. 
Gillen, J., W. Li, Q. Liang, D. Avey, J. Wu, F. Wu, J. Myoung and F. Zhu (2015). "A survey of the 
interactome of Kaposi's sarcoma-associated herpesvirus ORF45 revealed its binding to viral ORF33 
and cellular USP7, resulting in stabilization of ORF33 that is required for production of progeny 
viruses." J Virol 89(9): 4918-4931. 
Goldberg, M., A. Harel, M. Brandeis, T. Rechsteiner, T. J. Richmond, A. M. Weiss and Y. Gruenbaum 
(1999). "The tail domain of lamin Dm0 binds histones H2A and H2B." Proc Natl Acad Sci U S A 96(6): 
2852-2857. 
Goldman, R. D., D. K. Shumaker, M. R. Erdos, M. Eriksson, A. E. Goldman, L. B. Gordon, Y. 
Gruenbaum, S. Khuon, M. Mendez, R. Varga and F. S. Collins (2004). "Accumulation of mutant lamin 
A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome." 
Proc Natl Acad Sci U S A 101(24): 8963-8968. 
Gordon, M. R., B. D. Pope, J. Sima and D. M. Gilbert (2015). "Many paths lead chromatin to the 
nuclear periphery." Bioessays 37(8): 862-866. 
Gorlich, D. and U. Kutay (1999). "Transport between the cell nucleus and the cytoplasm." Annu Rev 
Cell Dev Biol 15: 607-660. 
216 
 
Gracanin, A., K. M. Dreijerink, R. B. van der Luijt, C. J. Lips and J. W. Hoppener (2009). "Tissue 
selectivity in multiple endocrine neoplasia type 1-associated tumorigenesis." Cancer Res 69(16): 
6371-6374. 
Granzow, H., B. G. Klupp, W. Fuchs, J. Veits, N. Osterrieder and T. C. Mettenleiter (2001). "Egress 
of alphaherpesviruses: comparative ultrastructural study." J Virol 75(8): 3675-3684. 
Granzow, H., B. G. Klupp and T. C. Mettenleiter (2004). "The Pseudorabies Virus US3 Protein Is a 
Component of Primary and of Mature Virions." Journal of Virology 78(3): 1314-1323. 
Griffiths, S. J., M. Koegl, C. Boutell, H. L. Zenner, C. M. Crump, F. Pica, O. Gonzalez, C. C. Friedel, 
G. Barry, K. Martin, M. H. Craigon, R. Chen, L. N. Kaza, E. Fossum, J. K. Fazakerley, S. Efstathiou, 
A. Volpi, R. Zimmer, P. Ghazal and J. Haas (2013). "A systematic analysis of host factors reveals a 
Med23-interferon-lambda regulatory axis against herpes simplex virus type 1 replication." PLoS 
Pathog 9(8): e1003514. 
Grimsey, N. J., L. J. Coronel, I. C. Cordova and J. Trejo (2016). "Recycling and Endosomal Sorting 
of Protease-activated Receptor-1 Is Distinctly Regulated by Rab11A and Rab11B Proteins." J Biol 
Chem 291(5): 2223-2236. 
Gross, S. T., C. A. Harley and D. W. Wilson (2003). "The cytoplasmic tail of Herpes simplex virus 
glycoprotein H binds to the tegument protein VP16 in vitro and in vivo." Virology 317(1): 1-12. 
Gruenbaum, Y., A. Margalit, R. D. Goldman, D. K. Shumaker and K. L. Wilson (2005). "The nuclear 
lamina comes of age." Nat Rev Mol Cell Biol 6(1): 21-31. 
Guarda, A., F. Bolognese, I. M. Bonapace and G. Badaracco (2009). "Interaction between the inner 
nuclear membrane lamin B receptor and the heterochromatic methyl binding protein, MeCP2." Exp 
Cell Res 315(11): 1895-1903. 
Guttinger, S., E. Laurell and U. Kutay (2009). "Orchestrating nuclear envelope disassembly and 
reassembly during mitosis." Nat Rev Mol Cell Biol 10(3): 178-191. 
Hagen, C., K. C. Dent, T. Zeev-Ben-Mordehai, M. Grange, J. B. Bosse, C. Whittle, B. G. Klupp, C. 
A. Siebert, D. Vasishtan, F. J. Bauerlein, J. Cheleski, S. Werner, P. Guttmann, S. Rehbein, K. 
Henzler, J. Demmerle, B. Adler, U. Koszinowski, L. Schermelleh, G. Schneider, L. W. Enquist, J. M. 
Plitzko, T. C. Mettenleiter and K. Grunewald (2015). "Structural Basis of Vesicle Formation at the 
Inner Nuclear Membrane." Cell 163(7): 1692-1701. 
Haugo, A. C., M. L. Szpara, L. Parsons, L. W. Enquist and R. J. Roller (2011). "Herpes simplex virus 
1 pUL34 plays a critical role in cell-to-cell spread of virus in addition to its role in virus replication." J 
Virol 85(14): 7203-7215. 
Heessen, S. and M. Fornerod (2007). "The inner nuclear envelope as a transcription factor resting 
place." EMBO Rep 8(10): 914-919. 
Hellberg, T., L. Passvogel, K. S. Schulz, B. G. Klupp and T. C. Mettenleiter (2016). "Nuclear Egress 
of Herpesviruses: The Prototypic Vesicular Nucleocytoplasmic Transport." Adv Virus Res 94: 81-
140. 
Hennessy, C. and D. P. McKernan (2016). "Epigenetics and innate immunity: the 'unTolld' story." 
Immunol Cell Biol 94(7): 631-639. 
217 
 
Heppner, C., K. Y. Bilimoria, S. K. Agarwal, M. Kester, L. J. Whitty, S. C. Guru, S. C. 
Chandrasekharappa, F. S. Collins, A. M. Spiegel, S. J. Marx and A. L. Burns (2001). "The tumor 
suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated 
transactivation." Oncogene 20(36): 4917-4925. 
Hill, G. M., E. S. Ku and S. Dwarakanathan (2014). "Herpes simplex keratitis." Dis Mon 60(6): 239-
246. 
Hinshaw, J. E., B. O. Carragher and R. A. Milligan (1992). "Architecture and design of the nuclear 
pore complex." Cell 69(7): 1133-1141. 
Hirohata, Y., J. Arii, Z. Liu, K. Shindo, M. Oyama, H. Kozuka-Hata, H. Sagara, A. Kato and Y. 
Kawaguchi (2015). "Herpes Simplex Virus 1 Recruits CD98 Heavy Chain and beta1 Integrin to the 
Nuclear Membrane for Viral De-Envelopment." J Virol 89(15): 7799-7812. 
Hoffmann, K., C. K. Dreger, A. L. Olins, D. E. Olins, L. D. Shultz, B. Lucke, H. Karl, R. Kaps, D. 
Muller, A. Vaya, J. Aznar, R. E. Ware, N. Sotelo Cruz, T. H. Lindner, H. Herrmann, A. Reis and K. 
Sperling (2002). "Mutations in the gene encoding the lamin B receptor produce an altered nuclear 
morphology in granulocytes (Pelger-Huet anomaly)." Nat Genet 31(4): 410-414. 
Hoger, T. H., G. Krohne and J. A. Kleinschmidt (1991). "Interaction of Xenopus lamins A and LII with 
chromatin in vitro mediated by a sequence element in the carboxyterminal domain." Exp Cell Res 
197(2): 280-289. 
Hollinshead, M., H. L. Johns, C. L. Sayers, C. Gonzalez-Lopez, G. L. Smith and G. Elliott (2012). 
"Endocytic tubules regulated by Rab GTPases 5 and 11 are used for envelopment of herpes simplex 
virus." EMBO J 31(21): 4204-4220. 
Holm, C. K., S. B. Jensen, M. R. Jakobsen, N. Cheshenko, K. A. Horan, H. B. Moeller, R. Gonzalez-
Dosal, S. B. Rasmussen, M. H. Christensen, T. O. Yarovinsky, F. J. Rixon, B. C. Herold, K. A. 
Fitzgerald and S. R. Paludan (2012). "Virus-cell fusion as a trigger of innate immunity dependent on 
the adaptor STING." Nat Immunol 13(8): 737-743. 
Holm, C. K., S. H. Rahbek, H. H. Gad, R. O. Bak, M. R. Jakobsen, Z. Jiang, A. L. Hansen, S. K. 
Jensen, C. Sun, M. K. Thomsen, A. Laustsen, C. G. Nielsen, K. Severinsen, Y. Xiong, D. L. Burdette, 
V. Hornung, R. J. Lebbink, M. Duch, K. A. Fitzgerald, S. Bahrami, J. G. Mikkelsen, R. Hartmann and 
S. R. Paludan (2016). "Influenza A virus targets a cGAS-independent STING pathway that controls 
enveloped RNA viruses." Nat Commun 7: 10680. 
Holmer, L. and H. J. Worman (2001). "Inner nuclear membrane proteins: functions and targeting." 
Cell Mol Life Sci 58(12-13): 1741-1747. 
Ikeo, Y., W. Yumita, A. Sakurai and K. Hashizume (2004). "JunD-menin interaction regulates c-Jun-
mediated AP-1 transactivation." Endocr J 51(3): 333-342. 
Ishikawa, H. and G. N. Barber (2008). "STING is an endoplasmic reticulum adaptor that facilitates 
innate immune signalling." Nature 455(7213): 674-678. 
Ishikawa, H. and G. N. Barber (2011). "The STING pathway and regulation of innate immune 
signaling in response to DNA pathogens." Cell Mol Life Sci 68(7): 1157-1165. 
218 
 
Ishikawa, H., Z. Ma and G. N. Barber (2009). "STING regulates intracellular DNA-mediated, type I 
interferon-dependent innate immunity." Nature 461(7265): 788-792. 
Jarsch, I. K., F. Daste and J. L. Gallop (2016). "Membrane curvature in cell biology: An integration of 
molecular mechanisms." J Cell Biol 214(4): 375-387. 
Jensen, H. L. and B. Norrild (1998). "Herpes simplex virus type 1-infected human embryonic lung 
cells studied by optimized immunogold cryosection electron microscopy." J Histochem Cytochem 
46(4): 487-496. 
Johns, H. L., C. Gonzalez-Lopez, C. L. Sayers, M. Hollinshead and G. Elliott (2014). "Rab6 
dependent post-Golgi trafficking of HSV1 envelope proteins to sites of virus envelopment." Traffic 
15(2): 157-178. 
Johnson, D. C. and P. G. Spear (1982). "Monensin inhibits the processing of herpes simplex virus 
glycoproteins, their transport to the cell surface, and the egress of virions from infected cells." J Virol 
43(3): 1102-1112. 
Johnson, D. C., T. W. Wisner and C. C. Wright (2011). "Herpes simplex virus glycoproteins gB and 
gD function in a redundant fashion to promote secondary envelopment." J Virol 85(10): 4910-4926. 
Jones, F. and C. Grose (1988). "Role of cytoplasmic vacuoles in varicella-zoster virus glycoprotein 
trafficking and virion envelopment." J Virol 62(8): 2701-2711. 
Kelly, B. J., C. Fraefel, A. L. Cunningham and R. J. Diefenbach (2009). "Functional roles of the 
tegument proteins of herpes simplex virus type 1." Virus Res 145(2): 173-186. 
Klemm, J. D., C. R. Beals and G. R. Crabtree (1997). "Rapid targeting of nuclear proteins to the 
cytoplasm." Curr Biol 7(9): 638-644. 
Klupp, B., J. Altenschmidt, H. Granzow, W. Fuchs and T. C. Mettenleiter (2008). "Glycoproteins 
required for entry are not necessary for egress of pseudorabies virus." J Virol 82(13): 6299-6309. 
Klupp, B. G., W. Fuchs, H. Granzow, R. Nixdorf and T. C. Mettenleiter (2002). "Pseudorabies virus 
UL36 tegument protein physically interacts with the UL37 protein." J Virol 76(6): 3065-3071. 
Klupp, B. G., H. Granzow, W. Fuchs, G. M. Keil, S. Finke and T. C. Mettenleiter (2007). "Vesicle 
formation from the nuclear membrane is induced by coexpression of two conserved herpesvirus 
proteins." Proc Natl Acad Sci U S A 104(17): 7241-7246. 
Klupp, B. G., H. Granzow and T. C. Mettenleiter (2000). "Primary envelopment of pseudorabies virus 
at the nuclear membrane requires the UL34 gene product." J Virol 74(21): 10063-10073. 
Klupp, B. G., H. Granzow and T. C. Mettenleiter (2001). "Effect of the pseudorabies virus US3 protein 
on nuclear membrane localization of the UL34 protein and virus egress from the nucleus." J Gen 
Virol 82(Pt 10): 2363-2371. 
Knipe, D. M. and A. Cliffe (2008). "Chromatin control of herpes simplex virus lytic and latent infection." 
Nat Rev Microbiol 6(3): 211-221. 
Kobiler, O., N. Drayman, V. Butin-Israeli and A. Oppenheim (2012). "Virus strategies for passing the 
nuclear envelope barrier." Nucleus 3(6): 526-539. 
219 
 
Korfali, N., E. A. Fairley, S. K. Swanson, L. Florens and E. C. Schirmer (2009). "Use of sequential 
chemical extractions to purify nuclear membrane proteins for proteomics identification." Methods Mol 
Biol 528: 201-225. 
Korfali, N., L. Florens and E. C. Schirmer (2016). "Isolation, Proteomic Analysis, and Microscopy 
Confirmation of the Liver Nuclear Envelope Proteome." Methods Mol Biol 1411: 3-44. 
Korfali, N., G. S. Wilkie, S. K. Swanson, V. Srsen, D. G. Batrakou, E. A. Fairley, P. Malik, N. Zuleger, 
A. Goncharevich, J. de Las Heras, D. A. Kelly, A. R. Kerr, L. Florens and E. C. Schirmer (2010). "The 
leukocyte nuclear envelope proteome varies with cell activation and contains novel transmembrane 
proteins that affect genome architecture." Mol Cell Proteomics 9(12): 2571-2585. 
Kugelberg, E. (2015). "Macrophages: Controlling innate immune memory." Nat Rev Immunol 15(10): 
596. 
Kuijpers, M., K. L. Yu, E. Teuling, A. Akhmanova, D. Jaarsma and C. C. Hoogenraad (2013). "The 
ALS8 protein VAPB interacts with the ER-Golgi recycling protein YIF1A and regulates membrane 
delivery into dendrites." EMBO J 32(14): 2056-2072. 
Kumar, K. P., K. M. McBride, B. K. Weaver, C. Dingwall and N. C. Reich (2000). "Regulated nuclear-
cytoplasmic localization of interferon regulatory factor 3, a subunit of double-stranded RNA-activated 
factor 1." Mol Cell Biol 20(11): 4159-4168. 
Kupper, K., A. Kolbl, D. Biener, S. Dittrich, J. von Hase, T. Thormeyer, H. Fiegler, N. P. Carter, M. 
R. Speicher, T. Cremer and M. Cremer (2007). "Radial chromatin positioning is shaped by local gene 
density, not by gene expression." Chromosoma 116(3): 285-306. 
Laba, J. K., A. Steen and L. M. Veenhoff (2014). "Traffic to the inner membrane of the nuclear 
envelope." Curr Opin Cell Biol 28: 36-45. 
Lanctot, C., T. Cheutin, M. Cremer, G. Cavalli and T. Cremer (2007). "Dynamic genome architecture 
in the nuclear space: regulation of gene expression in three dimensions." Nat Rev Genet 8(2): 104-
115. 
Lattanzi, G., M. Columbaro, E. Mattioli, V. Cenni, D. Camozzi, M. Wehnert, S. Santi, M. Riccio, R. 
Del Coco, N. M. Maraldi, S. Squarzoni, R. Foisner and C. Capanni (2007). "Pre-Lamin A processing 
is linked to heterochromatin organization." J Cell Biochem 102(5): 1149-1159. 
Lau, L., E. E. Gray, R. L. Brunette and D. B. Stetson (2015). "DNA tumor virus oncogenes antagonize 
the cGAS-STING DNA-sensing pathway." Science 350(6260): 568-571. 
Le Sage, V. and A. J. Mouland (2013). "Viral subversion of the nuclear pore complex." Viruses 5(8): 
2019-2042. 
Leach, N., S. L. Bjerke, D. K. Christensen, J. M. Bouchard, F. Mou, R. Park, J. Baines, T. Haraguchi 
and R. J. Roller (2007). "Emerin is hyperphosphorylated and redistributed in herpes simplex virus 
type 1-infected cells in a manner dependent on both UL34 and US3." J Virol 81(19): 10792-10803. 
Leach, N. R. and R. J. Roller (2010). "Significance of host cell kinases in herpes simplex virus type 




Lee, C. P., P. T. Liu, H. N. Kung, M. T. Su, H. H. Chua, Y. H. Chang, C. W. Chang, C. H. Tsai, F. T. 
Liu and M. R. Chen (2012). "The ESCRT machinery is recruited by the viral BFRF1 protein to the 
nucleus-associated membrane for the maturation of Epstein-Barr Virus." PLoS Pathog 8(9): 
e1002904. 
Lee, K. K., T. Haraguchi, R. S. Lee, T. Koujin, Y. Hiraoka and K. L. Wilson (2001). "Distinct functional 
domains in emerin bind lamin A and DNA-bridging protein BAF." J Cell Sci 114(Pt 24): 4567-4573. 
Leuzinger, H., U. Ziegler, E. M. Schraner, C. Fraefel, D. L. Glauser, I. Heid, M. Ackermann, M. 
Mueller and P. Wild (2005). "Herpes simplex virus 1 envelopment follows two diverse pathways." J 
Virol 79(20): 13047-13059. 
Lev, S., D. Ben Halevy, D. Peretti and N. Dahan (2008). "The VAP protein family: from cellular 
functions to motor neuron disease." Trends Cell Biol 18(6): 282-290. 
Li, C., L. L. Ge, P. P. Li, Y. Wang, M. X. Sun, L. Huang, H. Ishag, D. D. Di, Z. Q. Shen, W. X. Fan 
and X. Mao (2013). "The DEAD-box RNA helicase DDX5 acts as a positive regulator of Japanese 
encephalitis virus replication by binding to viral 3' UTR." Antiviral Res 100(2): 487-499. 
Li, H., J. Zhang, A. Kumar, M. Zheng, S. S. Atherton and F. S. Yu (2006). "Herpes simplex virus 1 
infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human 
corneal epithelial cells." Immunology 117(2): 167-176. 
Likhacheva, E. V. and S. S. Bogachev (2001). "Lamins and their functions in cell cycle." Membr Cell 
Biol 14(5): 565-577. 
Liu, H. M., H. Aizaki, K. S. Choi, K. Machida, J. J. Ou and M. M. Lai (2009). "SYNCRIP 
(synaptotagmin-binding, cytoplasmic RNA-interacting protein) is a host factor involved in hepatitis C 
virus RNA replication." Virology 386(2): 249-256. 
Liu, S., X. Cai, J. Wu, Q. Cong, X. Chen, T. Li, F. Du, J. Ren, Y. T. Wu, N. V. Grishin and Z. J. Chen 
(2015). "Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 
activation." Science 347(6227): aaa2630. 
Liu, S. and B. Storrie (2012). "Are Rab proteins the link between Golgi organization and membrane 
trafficking?" Cell Mol Life Sci 69(24): 4093-4106. 
Liu, Y., J. Li, J. Chen, Y. Li, W. Wang, X. Du, W. Song, W. Zhang, L. Lin and Z. Yuan (2015). 
"Hepatitis B virus polymerase disrupts K63-linked ubiquitination of STING to block innate cytosolic 
DNA-sensing pathways." J Virol 89(4): 2287-2300. 
Loret, S., G. Guay and R. Lippe (2008). "Comprehensive characterization of extracellular herpes 
simplex virus type 1 virions." J Virol 82(17): 8605-8618. 
Lutcke, A., R. G. Parton, C. Murphy, V. M. Olkkonen, P. Dupree, A. Valencia, K. Simons and M. 
Zerial (1994). "Cloning and subcellular localization of novel rab proteins reveals polarized and cell 
type-specific expression." J Cell Sci 107 ( Pt 12): 3437-3448. 
Ma, J., J. M. Kelich and W. Yang (2016). "SPEED Microscopy and Its Application in 
Nucleocytoplasmic Transport." Methods Mol Biol 1411: 503-518. 
221 
 
Maelfait, J., E. Seiradake and J. Rehwinkel (2014). "Keeping your armour intact: how HIV-1 evades 
detection by the innate immune system: HIV-1 capsid controls detection of reverse transcription 
products by the cytosolic DNA sensor cGAS." Bioessays 36(7): 649-657. 
Maison, C., A. Pyrpasopoulou, P. A. Theodoropoulos and S. D. Georgatos (1997). "The inner nuclear 
membrane protein LAP1 forms a native complex with B-type lamins and partitions with spindle-
associated mitotic vesicles." EMBO J 16(16): 4839-4850. 
Malhas, A. N. and D. J. Vaux (2009). "Transcription factor sequestration by nuclear envelope 
components." Cell Cycle 8(7): 959-960. 
Malik, P., N. Korfali, V. Srsen, V. Lazou, D. G. Batrakou, N. Zuleger, D. M. Kavanagh, G. S. Wilkie, 
M. W. Goldberg and E. C. Schirmer (2010). "Cell-specific and lamin-dependent targeting of novel 
transmembrane proteins in the nuclear envelope." Cell Mol Life Sci 67(8): 1353-1369. 
Malik, P., A. Tabarraei, R. H. Kehlenbach, N. Korfali, R. Iwasawa, S. V. Graham and E. C. Schirmer 
(2012). "Herpes simplex virus ICP27 protein directly interacts with the nuclear pore complex through 
Nup62, inhibiting host nucleocytoplasmic transport pathways." J Biol Chem 287(15): 12277-12292. 
Malik, P., N. Zuleger, J. I. de las Heras, N. Saiz-Ros, A. A. Makarov, V. Lazou, P. Meinke, M. 
Waterfall, D. A. Kelly and E. C. Schirmer (2014). "NET23/STING promotes chromatin compaction 
from the nuclear envelope." PLoS One 9(11): e111851. 
Mammoto, A., T. Ohtsuka, I. Hotta, T. Sasaki and Y. Takai (1999). "Rab11BP/Rabphilin-11, a 
downstream target of rab11 small G protein implicated in vesicle recycling." J Biol Chem 274(36): 
25517-25524. 
Manilal, S., T. M. Nguyen, C. A. Sewry and G. E. Morris (1996). "The Emery-Dreifuss muscular 
dystrophy protein, emerin, is a nuclear membrane protein." Hum Mol Genet 5(6): 801-808. 
Manna, D., J. Aligo, C. Xu, W. S. Park, H. Koc, W. D. Heo and K. V. Konan (2010). "Endocytic Rab 
proteins are required for hepatitis C virus replication complex formation." Virology 398(1): 21-37. 
Margalit, A., S. Vlcek, Y. Gruenbaum and R. Foisner (2005). "Breaking and making of the nuclear 
envelope." J Cell Biochem 95(3): 454-465. 
Maric, M., A. C. Haugo, W. Dauer, D. Johnson and R. J. Roller (2014). "Nuclear envelope breakdown 
induced by herpes simplex virus type 1 involves the activity of viral fusion proteins." Virology 460-
461: 128-137. 
Martinez, V., E. Caumes and O. Chosidow (2008). "Treatment to prevent recurrent genital herpes." 
Curr Opin Infect Dis 21(1): 42-48. 
Mattout-Drubezki, A. and Y. Gruenbaum (2003). "Dynamic interactions of nuclear lamina proteins 
with chromatin and transcriptional machinery." Cell Mol Life Sci 60(10): 2053-2063. 
McDonald, W. H., D. L. Tabb, R. G. Sadygov, M. J. MacCoss, J. Venable, J. Graumann, J. R. 
Johnson, D. Cociorva and J. R. Yates, 3rd (2004). "MS1, MS2, and SQT-three unified, compact, and 
easily parsed file formats for the storage of shotgun proteomic spectra and identifications." Rapid 
Commun Mass Spectrom 18(18): 2162-2168. 
222 
 
McGeoch, D. J., M. A. Dalrymple, A. J. Davison, A. Dolan, M. C. Frame, D. McNab, L. J. Perry, J. E. 
Scott and P. Taylor (1988). "The complete DNA sequence of the long unique region in the genome 
of herpes simplex virus type 1." J Gen Virol 69 ( Pt 7): 1531-1574. 
McGeoch, D. J., F. J. Rixon and A. J. Davison (2006). "Topics in herpesvirus genomics and 
evolution." Virus Res 117(1): 90-104. 
Melcon, G., S. Kozlov, D. A. Cutler, T. Sullivan, L. Hernandez, P. Zhao, S. Mitchell, G. Nader, M. 
Bakay, J. N. Rottman, E. P. Hoffman and C. L. Stewart (2006). "Loss of emerin at the nuclear 
envelope disrupts the Rb1/E2F and MyoD pathways during muscle regeneration." Hum Mol Genet 
15(4): 637-651. 
Mellerick, D. M. and N. W. Fraser (1987). "Physical state of the latent herpes simplex virus genome 
in a mouse model system: evidence suggesting an episomal state." Virology 158(2): 265-275. 
Mettenleiter, T. C. (2002). "Herpesvirus Assembly and Egress." Journal of Virology 76(4): 1537-1547. 
Mettenleiter, T. C. (2004). "Budding events in herpesvirus morphogenesis." Virus Res 106(2): 167-
180. 
Mettenleiter, T. C. (2016). "Breaching the Barrier-The Nuclear Envelope in Virus Infection." J Mol 
Biol 428(10 Pt A): 1949-1961. 
Mettenleiter, T. C., B. G. Klupp and H. Granzow (2009). "Herpesvirus assembly: an update." Virus 
Res 143(2): 222-234. 
Milbradt, J., R. Webel, S. Auerochs, H. Sticht and M. Marschall (2010). "Novel mode of 
phosphorylation-triggered reorganization of the nuclear lamina during nuclear egress of human 
cytomegalovirus." J Biol Chem 285(18): 13979-13989. 
Miller, N. G., M. W. Hill and M. W. Smith (1976). "Positional and species analysis of membrane 
phospholipids extracted from goldfish adapted to different environmental temperatures." Biochim 
Biophys Acta 455(3): 644-654. 
Miranda-Saksena, M., R. A. Boadle, P. Armati and A. L. Cunningham (2002). "In rat dorsal root 
ganglion neurons, herpes simplex virus type 1 tegument forms in the cytoplasm of the cell body." J 
Virol 76(19): 9934-9951. 
Mizutani, A., M. Fukuda, K. Ibata, Y. Shiraishi and K. Mikoshiba (2000). "SYNCRIP, a cytoplasmic 
counterpart of heterogeneous nuclear ribonucleoprotein R, interacts with ubiquitous synaptotagmin 
isoforms." J Biol Chem 275(13): 9823-9831. 
Monier, K., J. C. Armas, S. Etteldorf, P. Ghazal and K. F. Sullivan (2000). "Annexation of the 
interchromosomal space during viral infection." Nat Cell Biol 2(9): 661-665. 
Morris, J. B., H. Hofemeister and P. O'Hare (2007). "Herpes simplex virus infection induces 
phosphorylation and delocalization of emerin, a key inner nuclear membrane protein." J Virol 81(9): 
4429-4437. 
Morrison, L. A. and G. S. DeLassus (2011). "Breach of the nuclear lamina during assembly of herpes 
simplex viruses." Nucleus 2(4): 271-276. 
Moses, M. J. (1956). "Studies on nuclei using correlated cytochemical, light, and electron microscope 
techniques." J Biophys Biochem Cytol 2(4 Suppl): 397-406. 
223 
 
Mou, F., E. G. Wills, R. Park and J. D. Baines (2008). "Effects of lamin A/C, lamin B1, and viral US3 
kinase activity on viral infectivity, virion egress, and the targeting of herpes simplex virus U(L)34-
encoded protein to the inner nuclear membrane." J Virol 82(16): 8094-8104. 
Moy, R. H., B. S. Cole, A. Yasunaga, B. Gold, G. Shankarling, A. Varble, J. M. Molleston, B. R. 
tenOever, K. W. Lynch and S. Cherry (2014). "Stem-loop recognition by DDX17 facilitates miRNA 
processing and antiviral defense." Cell 158(4): 764-777. 
Muranyi, W., J. Haas, M. Wagner, G. Krohne and U. H. Koszinowski (2002). "Cytomegalovirus 
recruitment of cellular kinases to dissolve the nuclear lamina." Science 297(5582): 854-857. 
Naldinho-Souto, R., H. Browne and T. Minson (2006). "Herpes simplex virus tegument protein VP16 
is a component of primary enveloped virions." J Virol 80(5): 2582-2584. 
Ni, L., S. Wang and C. Zheng (2012). "The nucleolus and herpesviral usurpation." J Med Microbiol 
61(Pt 12): 1637-1643. 
Ognibene, A., P. Sabatelli, S. Petrini, S. Squarzoni, M. Riccio, S. Santi, M. Villanova, S. Palmeri, L. 
Merlini and N. M. Maraldi (1999). "Nuclear changes in a case of X-linked Emery-Dreifuss muscular 
dystrophy." Muscle Nerve 22(7): 864-869. 
Ohba, T., E. C. Schirmer, T. Nishimoto and L. Gerace (2004). "Energy- and temperature-dependent 
transport of integral proteins to the inner nuclear membrane via the nuclear pore." J Cell Biol 167(6): 
1051-1062. 
Ohzeki, J., J. H. Bergmann, N. Kouprina, V. N. Noskov, M. Nakano, H. Kimura, W. C. Earnshaw, V. 
Larionov and H. Masumoto (2012). "Breaking the HAC Barrier: histone H3K9 acetyl/methyl balance 
regulates CENP-A assembly." EMBO J 31(10): 2391-2402. 
Ojala, P. M., B. Sodeik, M. W. Ebersold, U. Kutay and A. Helenius (2000). "Herpes simplex virus 
type 1 entry into host cells: reconstitution of capsid binding and uncoating at the nuclear pore complex 
in vitro." Mol Cell Biol 20(13): 4922-4931. 
Okada, Y., T. Suzuki, Y. Sunden, Y. Orba, S. Kose, N. Imamoto, H. Takahashi, S. Tanaka, W. W. 
Hall, K. Nagashima and H. Sawa (2005). "Dissociation of heterochromatin protein 1 from lamin B 
receptor induced by human polyomavirus agnoprotein: role in nuclear egress of viral particles." 
EMBO Rep 6(5): 452-457. 
Olins, A. L., G. Rhodes, D. B. Welch, M. Zwerger and D. E. Olins (2010). "Lamin B receptor: multi-
tasking at the nuclear envelope." Nucleus 1(1): 53-70. 
Orzalli, M. H., N. A. DeLuca and D. M. Knipe (2012). "Nuclear IFI16 induction of IRF-3 signaling 
during herpesviral infection and degradation of IFI16 by the viral ICP0 protein." Proc Natl Acad Sci 
U S A 109(44): E3008-3017. 
Osada, S., S. Y. Ohmori and M. Taira (2003). "XMAN1, an inner nuclear membrane protein, 
antagonizes BMP signaling by interacting with Smad1 in Xenopus embryos." Development 130(9): 
1783-1794. 
Ostlund, C., T. Sullivan, C. L. Stewart and H. J. Worman (2006). "Dependence of diffusional mobility 
of integral inner nuclear membrane proteins on A-type lamins." Biochemistry 45(5): 1374-1382. 
224 
 
Owen, D. J., C. M. Crump and S. C. Graham (2015). "Tegument Assembly and Secondary 
Envelopment of Alphaherpesviruses." Viruses 7(9): 5084-5114. 
Padula, M. E., M. L. Sydnor and D. W. Wilson (2009). "Isolation and preliminary characterization of 
herpes simplex virus 1 primary enveloped virions from the perinuclear space." J Virol 83(10): 4757-
4765. 
Paludan, S. R. and A. G. Bowie (2013). "Immune sensing of DNA." Immunity 38(5): 870-880. 
Park, R. and J. D. Baines (2006). "Herpes simplex virus type 1 infection induces activation and 
recruitment of protein kinase C to the nuclear membrane and increased phosphorylation of lamin B." 
J Virol 80(1): 494-504. 
Pasdeloup, D., F. Beilstein, A. P. Roberts, M. McElwee, D. McNab and F. J. Rixon (2010). "Inner 
tegument protein pUL37 of herpes simplex virus type 1 is involved in directing capsids to the trans-
Golgi network for envelopment." J Gen Virol 91(Pt 9): 2145-2151. 
Pasdeloup, D., D. Blondel, A. L. Isidro and F. J. Rixon (2009). "Herpesvirus capsid association with 
the nuclear pore complex and viral DNA release involve the nucleoporin CAN/Nup214 and the capsid 
protein pUL25." J Virol 83(13): 6610-6623. 
Passvogel, L., B. G. Klupp, H. Granzow, W. Fuchs and T. C. Mettenleiter (2015). "Functional 
characterization of nuclear trafficking signals in pseudorabies virus pUL31." J Virol 89(4): 2002-2012. 
Penfold, M. E., P. Armati and A. L. Cunningham (1994). "Axonal transport of herpes simplex virions 
to epidermal cells: evidence for a specialized mode of virus transport and assembly." Proc Natl Acad 
Sci U S A 91(14): 6529-6533. 
Peretti, D., N. Dahan, E. Shimoni, K. Hirschberg and S. Lev (2008). "Coordinated lipid transfer 
between the endoplasmic reticulum and the Golgi complex requires the VAP proteins and is essential 
for Golgi-mediated transport." Mol Biol Cell 19(9): 3871-3884. 
Peter, M., J. S. Sanghera, S. L. Pelech and E. A. Nigg (1992). "Mitogen-activated protein kinases 
phosphorylate nuclear lamins and display sequence specificity overlapping that of mitotic protein 
kinase p34cdc2." Eur J Biochem 205(1): 287-294. 
Phair, R. D. and T. Misteli (2001). "Kinetic modelling approaches to in vivo imaging." Nat Rev Mol 
Cell Biol 2(12): 898-907. 
Pignatelli, S., P. Dal Monte, M. P. Landini, B. Severi, R. Nassiri, J. Gilloteaux, J. M. Papadimitriou, 
G. R. Shellam, T. Mertens, C. Buser, D. Michel and P. Walther (2007). "Cytomegalovirus primary 
envelopment at large nuclear membrane infoldings: what's new?" J Virol 81(13): 7320-7321; author 
reply 7321-7322. 
Placek, B. J. and S. L. Berger (2010). "Chromatin dynamics during herpes simplex virus-1 lytic 
infection." Biochim Biophys Acta 1799(3-4): 223-227. 
Polioudaki, H., N. Kourmouli, V. Drosou, A. Bakou, P. A. Theodoropoulos, P. B. Singh, T. 
Giannakouros and S. D. Georgatos (2001). "Histones H3/H4 form a tight complex with the inner 
nuclear membrane protein LBR and heterochromatin protein 1." EMBO Rep 2(10): 920-925. 
225 
 
Prosser, D. C., D. Tran, P. Y. Gougeon, C. Verly and J. K. Ngsee (2008). "FFAT rescues VAPA-
mediated inhibition of ER-to-Golgi transport and VAPB-mediated ER aggregation." J Cell Sci 121(Pt 
18): 3052-3061. 
Prunuske, A. J. and K. S. Ullman (2006). "The nuclear envelope: form and reformation." Curr Opin 
Cell Biol 18(1): 108-116. 
Ratnaparkhi, A., G. M. Lawless, F. E. Schweizer, P. Golshani and G. R. Jackson (2008). "A 
Drosophila model of ALS: human ALS-associated mutation in VAP33A suggests a dominant negative 
mechanism." PLoS One 3(6): e2334. 
Reiman, A., J. E. Powell, K. J. Flavell, R. G. Grundy, J. R. Mann, S. Parkes, D. Redfern, L. S. Young 
and P. G. Murray (2003). "Seasonal differences in the onset of the EBV-positive and -negative forms 
of paediatric Hodgkin's lymphoma." Br J Cancer 89(7): 1200-1201. 
Reske, A., G. Pollara, C. Krummenacher, B. M. Chain and D. R. Katz (2007). "Understanding HSV-
1 entry glycoproteins." Rev Med Virol 17(3): 205-215. 
Reyland, M. E. (2009). "Protein kinase C isoforms: Multi-functional regulators of cell life and death." 
Front Biosci (Landmark Ed) 14: 2386-2399. 
Reynolds, A. E., L. Liang and J. D. Baines (2004). "Conformational changes in the nuclear lamina 
induced by herpes simplex virus type 1 require genes U(L)31 and U(L)34." J Virol 78(11): 5564-5575. 
Reynolds, A. E., B. J. Ryckman, J. D. Baines, Y. Zhou, L. Liang and R. J. Roller (2001). "UL31 and 
UL34 Proteins of Herpes Simplex Virus Type 1 Form a Complex That Accumulates at the Nuclear 
Rim and Is Required for Envelopment of Nucleocapsids." Journal of Virology 75(18): 8803-8817. 
Reynolds, A. E., E. G. Wills, R. J. Roller, B. J. Ryckman and J. D. Baines (2002). "Ultrastructural 
Localization of the Herpes Simplex Virus Type 1 UL31, UL34, and US3 Proteins Suggests Specific 
Roles in Primary Envelopment and Egress of Nucleocapsids." Journal of Virology 76(17): 8939-8952. 
Rice, J. A. (1997). "Community health assessment: a new generation." Hosp Technol Ser 16(4): 1-
31. 
Rice, S. A. and D. M. Knipe (1990). "Genetic evidence for two distinct transactivation functions of the 
herpes simplex virus alpha protein ICP27." J Virol 64(4): 1704-1715. 
Robson, M. I., J. I. de Las Heras, R. Czapiewski, P. Le Thanh, D. G. Booth, D. A. Kelly, S. Webb, A. 
R. Kerr and E. C. Schirmer (2016). "Tissue-Specific Gene Repositioning by Muscle Nuclear 
Membrane Proteins Enhances Repression of Critical Developmental Genes during Myogenesis." Mol 
Cell 62(6): 834-847. 
Roger, T., J. Lugrin, D. Le Roy, G. Goy, M. Mombelli, T. Koessler, X. C. Ding, A. L. Chanson, M. K. 
Reymond, I. Miconnet, J. Schrenzel, P. Francois and T. Calandra (2011). "Histone deacetylase 
inhibitors impair innate immune responses to Toll-like receptor agonists and to infection." Blood 
117(4): 1205-1217. 
Rolls, M. M., P. A. Stein, S. S. Taylor, E. Ha, F. McKeon and T. A. Rapoport (1999). "A visual screen 




Rowe, R. K., J. W. Suszko and A. Pekosz (2008). "Roles for the recycling endosome, Rab8, and 
Rab11 in hantavirus release from epithelial cells." Virology 382(2): 239-249. 
Sabbattini, P., M. Sjoberg, S. Nikic, A. Frangini, P. H. Holmqvist, N. Kunowska, T. Carroll, E. Brookes, 
S. J. Arthur, A. Pombo and N. Dillon (2014). "An H3K9/S10 methyl-phospho switch modulates 
Polycomb and Pol II binding at repressed genes during differentiation." Mol Biol Cell 25(6): 904-915. 
Sagou, K., M. Uema and Y. Kawaguchi (2010). "Nucleolin is required for efficient nuclear egress of 
herpes simplex virus type 1 nucleocapsids." J Virol 84(4): 2110-2121. 
Salloum, S., H. Wang, C. Ferguson, R. G. Parton and A. W. Tai (2013). "Rab18 binds to hepatitis C 
virus NS5A and promotes interaction between sites of viral replication and lipid droplets." PLoS 
Pathog 9(8): e1003513. 
Sandri-Goldin, R. M. (2008). "The many roles of the regulatory protein ICP27 during herpes simplex 
virus infection." Front Biosci 13: 5241-5256. 
Sandri-Goldin, R. M. (2011). "The many roles of the highly interactive HSV protein ICP27, a key 
regulator of infection." Future Microbiol 6(11): 1261-1277. 
Sato, M., S. Matsubara, A. Miyauchi, H. Ohye, H. Imachi, K. Murao and J. Takahara (1998). 
"Identification of five novel germline mutations of the MEN1 gene in Japanese multiple endocrine 
neoplasia type 1 (MEN1) families." J Med Genet 35(11): 915-919. 
Sauer, J. D., K. Sotelo-Troha, J. von Moltke, K. M. Monroe, C. S. Rae, S. W. Brubaker, M. Hyodo, 
Y. Hayakawa, J. J. Woodward, D. A. Portnoy and R. E. Vance (2011). "The N-ethyl-N-nitrosourea-
induced Goldenticket mouse mutant reveals an essential function of Sting in the in vivo interferon 
response to Listeria monocytogenes and cyclic dinucleotides." Infect Immun 79(2): 688-694. 
Schirmer, E. C., L. Florens, T. Guan, J. R. Yates, 3rd and L. Gerace (2003). "Nuclear membrane 
proteins with potential disease links found by subtractive proteomics." Science 301(5638): 1380-
1382. 
Schirmer, E. C., L. Florens, T. Guan, J. R. Yates, 3rd and L. Gerace (2005). "Identification of novel 
integral membrane proteins of the nuclear envelope with potential disease links using subtractive 
proteomics." Novartis Found Symp 264: 63-76; discussion 76-80, 227-230. 
Schirmer, E. C. and R. Foisner (2007). "Proteins that associate with lamins: many faces, many 
functions." Exp Cell Res 313(10): 2167-2179. 
Schirmer, E. C. and L. Gerace (2005). "The nuclear membrane proteome: extending the envelope." 
Trends Biochem Sci 30(10): 551-558. 
Schmitz, M. L., M. Kracht and V. V. Saul (2014). "The intricate interplay between RNA viruses and 
NF-kappaB." Biochim Biophys Acta 1843(11): 2754-2764. 
Schulz, K. S., B. G. Klupp, H. Granzow, L. Passvogel and T. C. Mettenleiter (2015). "Herpesvirus 
nuclear egress: Pseudorabies Virus can simultaneously induce nuclear envelope breakdown and 
exit the nucleus via the envelopment-deenvelopment-pathway." Virus Res 209: 76-86. 
Scott, E. S. and P. O'Hare (2001). "Fate of the Inner Nuclear Membrane Protein Lamin B Receptor 




Senior, A. and L. Gerace (1988). "Integral membrane proteins specific to the inner nuclear membrane 
and associated with the nuclear lamina." J Cell Biol 107(6 Pt 1): 2029-2036. 
Sewry, C. A., S. C. Brown, E. Mercuri, G. Bonne, L. Feng, G. Camici, G. E. Morris and F. Muntoni 
(2001). "Skeletal muscle pathology in autosomal dominant Emery-Dreifuss muscular dystrophy with 
lamin A/C mutations." Neuropathol Appl Neurobiol 27(4): 281-290. 
Sharma, M., B. J. Bender, J. P. Kamil, M. F. Lye, J. M. Pesola, N. I. Reim, J. M. Hogle and D. M. 
Coen (2015). "Human cytomegalovirus UL97 phosphorylates the viral nuclear egress complex." J 
Virol 89(1): 523-534. 
Shiba, C., T. Daikoku, F. Goshima, H. Takakuwa, Y. Yamauchi, O. Koiwai and Y. Nishiyama (2000). 
"The UL34 gene product of herpes simplex virus type 2 is a tail-anchored type II membrane protein 
that is significant for virus envelopment." J Gen Virol 81(Pt 10): 2397-2405. 
Shoeman, R. L. and P. Traub (1990). "The in vitro DNA-binding properties of purified nuclear lamin 
proteins and vimentin." J Biol Chem 265(16): 9055-9061. 
Shu, H. B. and Y. Y. Wang (2014). "Adding to the STING." Immunity 41(6): 871-873. 
Shumaker, D. K., T. Dechat, A. Kohlmaier, S. A. Adam, M. R. Bozovsky, M. R. Erdos, M. Eriksson, 
A. E. Goldman, S. Khuon, F. S. Collins, T. Jenuwein and R. D. Goldman (2006). "Mutant nuclear 
lamin A leads to progressive alterations of epigenetic control in premature aging." Proc Natl Acad 
Sci U S A 103(23): 8703-8708. 
Simmons, A. (2002). "Clinical manifestations and treatment considerations of herpes simplex virus 
infection." J Infect Dis 186 Suppl 1: S71-77. 
Simpson-Holley, M., J. Baines, R. Roller and D. M. Knipe (2004). "Herpes simplex virus 1 U(L)31 
and U(L)34 gene products promote the late maturation of viral replication compartments to the 
nuclear periphery." J Virol 78(11): 5591-5600. 
Simpson-Holley, M., R. C. Colgrove, G. Nalepa, J. W. Harper and D. M. Knipe (2005). "Identification 
and functional evaluation of cellular and viral factors involved in the alteration of nuclear architecture 
during herpes simplex virus 1 infection." J Virol 79(20): 12840-12851. 
Skepper, J. N., A. Whiteley, H. Browne and A. Minson (2001). "Herpes simplex virus nucleocapsids 
mature to progeny virions by an envelopment --> deenvelopment --> reenvelopment pathway." J 
Virol 75(12): 5697-5702. 
Smoyer, C. J. and S. L. Jaspersen (2014). "Breaking down the wall: the nuclear envelope during 
mitosis." Curr Opin Cell Biol 26: 1-9. 
Sola, I., C. Galan, P. A. Mateos-Gomez, L. Palacio, S. Zuniga, J. L. Cruz, F. Almazan and L. 
Enjuanes (2011). "The polypyrimidine tract-binding protein affects coronavirus RNA accumulation 
levels and relocalizes viral RNAs to novel cytoplasmic domains different from replication-transcription 
sites." J Virol 85(10): 5136-5149. 
Soliman, T. M., R. M. Sandri-Goldin and S. J. Silverstein (1997). "Shuttling of the herpes simplex 
virus type 1 regulatory protein ICP27 between the nucleus and cytoplasm mediates the expression 
of late proteins." J Virol 71(12): 9188-9197. 
228 
 
Somech, R., S. Shaklai, O. Geller, N. Amariglio, A. J. Simon, G. Rechavi and E. N. Gal-Yam (2005). 
"The nuclear-envelope protein and transcriptional repressor LAP2beta interacts with HDAC3 at the 
nuclear periphery, and induces histone H4 deacetylation." J Cell Sci 118(Pt 17): 4017-4025. 
Soo, K. Y., M. Halloran, V. Sundaramoorthy, S. Parakh, R. P. Toth, K. A. Southam, C. A. McLean, 
P. Lock, A. King, M. A. Farg and J. D. Atkin (2015). "Rab1-dependent ER-Golgi transport dysfunction 
is a common pathogenic mechanism in SOD1, TDP-43 and FUS-associated ALS." Acta Neuropathol 
130(5): 679-697. 
Soullam, B. and H. J. Worman (1993). "The amino-terminal domain of the lamin B receptor is a 
nuclear envelope targeting signal." J Cell Biol 120(5): 1093-1100. 
Speese, S. D., J. Ashley, V. Jokhi, J. Nunnari, R. Barria, Y. Li, B. Ataman, A. Koon, Y. T. Chang, Q. 
Li, M. J. Moore and V. Budnik (2012). "Nuclear envelope budding enables large ribonucleoprotein 
particle export during synaptic Wnt signaling." Cell 149(4): 832-846. 
Stancheva, I. and E. C. Schirmer (2014). "Nuclear envelope: connecting structural genome 
organization to regulation of gene expression." Adv Exp Med Biol 773: 209-244. 
Stannard, L. M., S. Himmelhoch and S. Wynchank (1996). "Intra-nuclear localization of two envelope 
proteins, gB and gD, of herpes simplex virus." Arch Virol 141(3-4): 505-524. 
Stender, J. D. and C. K. Glass (2013). "Epigenomic control of the innate immune response." Curr 
Opin Pharmacol 13(4): 582-587. 
Sun, W., Y. Li, L. Chen, H. Chen, F. You, X. Zhou, Y. Zhou, Z. Zhai, D. Chen and Z. Jiang (2009). 
"ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through 
dimerization." Proc Natl Acad Sci U S A 106(21): 8653-8658. 
Tabb, D. L., W. H. McDonald and J. R. Yates, 3rd (2002). "DTASelect and Contrast: tools for 
assembling and comparing protein identifications from shotgun proteomics." J Proteome Res 1(1): 
21-26. 
Tanaka, Y. and Z. J. Chen (2012). "STING specifies IRF3 phosphorylation by TBK1 in the cytosolic 
DNA signaling pathway." Sci Signal 5(214): ra20. 
Tandon, R., E. S. Mocarski and J. F. Conway (2015). "The A, B, Cs of herpesvirus capsids." Viruses 
7(3): 899-914. 
Taniura, H., C. Glass and L. Gerace (1995). "A chromatin binding site in the tail domain of nuclear 
lamins that interacts with core histones." J Cell Biol 131(1): 33-44. 
Taylor, M. P., O. Kobiler and L. W. Enquist (2012). "Alphaherpesvirus axon-to-cell spread involves 
limited virion transmission." Proc Natl Acad Sci U S A 109(42): 17046-17051. 
Tokuyasu, K. T. (1973). "A technique for ultracryotomy of cell suspensions and tissues." J Cell Biol 
57(2): 551-565. 
Torrisi, M. R., C. Di Lazzaro, A. Pavan, L. Pereira and G. Campadelli-Fiume (1992). "Herpes simplex 
virus envelopment and maturation studied by fracture label." J Virol 66(1): 554-561. 
Tran, D., A. Chalhoub, A. Schooley, W. Zhang and J. K. Ngsee (2012). "A mutation in VAPB that 




Ullrich, O., S. Reinsch, S. Urbe, M. Zerial and R. G. Parton (1996). "Rab11 regulates recycling 
through the pericentriolar recycling endosome." J Cell Biol 135(4): 913-924. 
Ungar, D. and F. M. Hughson (2003). "SNARE protein structure and function." Annu Rev Cell Dev 
Biol 19: 493-517. 
Ungricht, R., M. Klann, P. Horvath and U. Kutay (2015). "Diffusion and retention are major 
determinants of protein targeting to the inner nuclear membrane." J Cell Biol 209(5): 687-703. 
Ungricht, R. and U. Kutay (2015). "Establishment of NE asymmetry-targeting of membrane proteins 
to the inner nuclear membrane." Curr Opin Cell Biol 34: 135-141. 
Upadya, M. H., J. J. Aweya and Y. J. Tan (2014). "Understanding the interaction of hepatitis C virus 
with host DEAD-box RNA helicases." World J Gastroenterol 20(11): 2913-2926. 
Vanden Berghe, W., M. N. Ndlovu, R. Hoya-Arias, N. Dijsselbloem, S. Gerlo and G. Haegeman 
(2006). "Keeping up NF-kappaB appearances: epigenetic control of immunity or inflammation-
triggered epigenetics." Biochem Pharmacol 72(9): 1114-1131. 
Wagenaar, F., J. M. Pol, B. Peeters, A. L. Gielkens, N. de Wind and T. G. Kimman (1995). "The US3-
encoded protein kinase from pseudorabies virus affects egress of virions from the nucleus." J Gen 
Virol 76 ( Pt 7): 1851-1859. 
Wandinger-Ness, A. and M. Zerial (2014). "Rab proteins and the compartmentalization of the 
endosomal system." Cold Spring Harb Perspect Biol 6(11): a022616. 
Wang, L., K. S. Jeng and M. M. Lai (2011). "Poly(C)-binding protein 2 interacts with sequences 
required for viral replication in the hepatitis C virus (HCV) 5' untranslated region and directs HCV 
RNA replication through circularizing the viral genome." J Virol 85(16): 7954-7964. 
Wang, Y., A. J. Herron and H. J. Worman (2006). "Pathology and nuclear abnormalities in hearts of 
transgenic mice expressing M371K lamin A encoded by an LMNA mutation causing Emery-Dreifuss 
muscular dystrophy." Hum Mol Genet 15(16): 2479-2489. 
Washburn, M. P., D. Wolters and J. R. Yates, 3rd (2001). "Large-scale analysis of the yeast proteome 
by multidimensional protein identification technology." Nat Biotechnol 19(3): 242-247. 
Weidmann, M., U. Meyer-Konig and F. T. Hufert (2003). "Rapid detection of herpes simplex virus 
and varicella-zoster virus infections by real-time PCR." J Clin Microbiol 41(4): 1565-1568. 
Wen, K. W. and B. Damania (2010). "Kaposi sarcoma-associated herpesvirus (KSHV): molecular 
biology and oncogenesis." Cancer Lett 289(2): 140-150. 
Whitley, R. J. and B. Roizman (2001). "Herpes simplex virus infections." Lancet 357(9267): 1513-
1518. 
Wild, P., M. Engels, C. Senn, K. Tobler, U. Ziegler, E. M. Schraner, E. Loepfe, M. Ackermann, M. 
Mueller and P. Walther (2005). "Impairment of nuclear pores in bovine herpesvirus 1-infected MDBK 
cells." J Virol 79(2): 1071-1083. 
Wild, P., C. Senn, C. L. Manera, E. Sutter, E. M. Schraner, K. Tobler, M. Ackermann, U. Ziegler, M. 
S. Lucas and A. Kaech (2009). "Exploring the nuclear envelope of herpes simplex virus 1-infected 
cells by high-resolution microscopy." J Virol 83(1): 408-419. 
230 
 
Wilkie, G. S., N. Korfali, S. K. Swanson, P. Malik, V. Srsen, D. G. Batrakou, J. de las Heras, N. 
Zuleger, A. R. Kerr, L. Florens and E. C. Schirmer (2011). "Several novel nuclear envelope 
transmembrane proteins identified in skeletal muscle have cytoskeletal associations." Mol Cell 
Proteomics 10(1): M110 003129. 
Wills, E., F. Mou and J. D. Baines (2009). "The U(L)31 and U(L)34 gene products of herpes simplex 
virus 1 are required for optimal localization of viral glycoproteins D and M to the inner nuclear 
membranes of infected cells." J Virol 83(10): 4800-4809. 
Wisner, T. W., C. C. Wright, A. Kato, Y. Kawaguchi, F. Mou, J. D. Baines, R. J. Roller and D. C. 
Johnson (2009). "Herpesvirus gB-induced fusion between the virion envelope and outer nuclear 
membrane during virus egress is regulated by the viral US3 kinase." J Virol 83(7): 3115-3126. 
Wollert, T., D. Yang, X. Ren, H. H. Lee, Y. J. Im and J. H. Hurley (2009). "The ESCRT machinery at 
a glance." J Cell Sci 122(Pt 13): 2163-2166. 
Worman, H. J., C. D. Evans and G. Blobel (1990). "The lamin B receptor of the nuclear envelope 
inner membrane: a polytopic protein with eight potential transmembrane domains." J Cell Biol 111(4): 
1535-1542. 
Worman, H. J. and E. C. Schirmer (2015). "Nuclear membrane diversity: underlying tissue-specific 
pathologies in disease?" Curr Opin Cell Biol 34: 101-112. 
Worman, H. J., J. Yuan, G. Blobel and S. D. Georgatos (1988). "A lamin B receptor in the nuclear 
envelope." Proc Natl Acad Sci U S A 85(22): 8531-8534. 
Wright, C. C., T. W. Wisner, B. P. Hannah, R. J. Eisenberg, G. H. Cohen and D. C. Johnson (2009). 
"Fusion between perinuclear virions and the outer nuclear membrane requires the fusogenic activity 
of herpes simplex virus gB." J Virol 83(22): 11847-11856. 
Wu, J. and Z. J. Chen (2014). "Innate immune sensing and signaling of cytosolic nucleic acids." Annu 
Rev Immunol 32: 461-488. 
Wu, W., F. Lin and H. J. Worman (2002). "Intracellular trafficking of MAN1, an integral protein of the 
nuclear envelope inner membrane." J Cell Sci 115(Pt 7): 1361-1371. 
Yamauchi, Y., C. Shiba, F. Goshima, A. Nawa, T. Murata and Y. Nishiyama (2001). "Herpes simplex 
virus type 2 UL34 protein requires UL31 protein for its relocation to the internal nuclear membrane 
in transfected cells." J Gen Virol 82(Pt 6): 1423-1428. 
Ye, Q. and H. J. Worman (1996). "Interaction between an integral protein of the nuclear envelope 
inner membrane and human chromodomain proteins homologous to Drosophila HP1." J Biol Chem 
271(25): 14653-14656. 
Zeev-Ben-Mordehai, T., D. Vasishtan, C. A. Siebert, C. Whittle and K. Grunewald (2014). 
"Extracellular vesicles: a platform for the structure determination of membrane proteins by Cryo-EM." 
Structure 22(11): 1687-1692. 
Zenner, H. L., S. Yoshimura, F. A. Barr and C. M. Crump (2011). "Analysis of Rab GTPase-activating 
proteins indicates that Rab1a/b and Rab43 are important for herpes simplex virus 1 secondary 
envelopment." J Virol 85(16): 8012-8021. 
231 
 
Zerial, M. and H. McBride (2001). "Rab proteins as membrane organizers." Nat Rev Mol Cell Biol 
2(2): 107-117. 
Zhang, Y., Z. Wen, M. P. Washburn and L. Florens (2011). "Improving proteomics mass accuracy 
by dynamic offline lock mass." Anal Chem 83(24): 9344-9351. 
Zhao, S., X. Ge, X. Wang, A. Liu, X. Guo, L. Zhou, K. Yu and H. Yang (2015). "The DEAD-box RNA 
helicase 5 positively regulates the replication of porcine reproductive and respiratory syndrome virus 
by interacting with viral Nsp9 in vitro." Virus Res 195: 217-224. 
Zhong, B., Y. Yang, S. Li, Y. Y. Wang, Y. Li, F. Diao, C. Lei, X. He, L. Zhang, P. Tien and H. B. Shu 
(2008). "The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor 
activation." Immunity 29(4): 538-550. 
Zhong, B., L. Zhang, C. Lei, Y. Li, A. P. Mao, Y. Yang, Y. Y. Wang, X. L. Zhang and H. B. Shu (2009). 
"The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor 
protein MITA." Immunity 30(3): 397-407. 
Zhu, M., T. Fang, S. Li, K. Meng and D. Guo (2015). "Bipartite Nuclear Localization Signal Controls 
Nuclear Import and DNA-Binding Activity of IFN Regulatory Factor 3." J Immunol 195(1): 289-297. 
Zimmerberg, J. and K. Gawrisch (2006). "The physical chemistry of biological membranes." Nat 
Chem Biol 2(11): 564-567. 
Zufferey, R., T. Dull, R. J. Mandel, A. Bukovsky, D. Quiroz, L. Naldini and D. Trono (1998). "Self-
inactivating lentivirus vector for safe and efficient in vivo gene delivery." J Virol 72(12): 9873-9880. 
Zuleger, N., S. Boyle, D. A. Kelly, J. I. de las Heras, V. Lazou, N. Korfali, D. G. Batrakou, K. N. 
Randles, G. E. Morris, D. J. Harrison, W. A. Bickmore and E. C. Schirmer (2013). "Specific nuclear 
envelope transmembrane proteins can promote the location of chromosomes to and from the nuclear 
periphery." Genome Biol 14(2): R14. 
Zuleger, N., D. A. Kelly, A. C. Richardson, A. R. Kerr, M. W. Goldberg, A. B. Goryachev and E. C. 
Schirmer (2011). "System analysis shows distinct mechanisms and common principles of nuclear 
envelope protein dynamics." J Cell Biol 193(1): 109-123. 
Zuleger, N., A. R. Kerr and E. C. Schirmer (2012). "Many mechanisms, one entrance: membrane 
protein translocation into the nucleus." Cell Mol Life Sci 69(13): 2205-2216. 
Zuleger, N., N. Korfali and E. C. Schirmer (2008). "Inner nuclear membrane protein transport is 







Please, kindly refer to the electronic copy (CD) in order to have a detailed 
information of the proteomic dataset.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
233 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
234 
 
 
 
 
